| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_adsipsc_promoter_p_RM_14_98_5 |
 |
 |
1 |
0.2 |
4.46E-04 |
GNPAT |
glycerone-phosphate O-acyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_331_17 |
 |
 |
5 |
0.8 |
4.14E-04 |
FZD3,
ITGA3,
TACC3,
HIF1A,
NR2F2,
STXBP1,
CDK5R1,
EGLN2 |
protein domain specific binding [MF],
neuron migration [BP],
regulation of neuron apoptotic process [BP],
cerebral cortex development [BP] |
| CG_adsipsc_promoter_p_RM_12_308_8 |
 |
 |
4 |
0.6 |
2.07E-04 |
ADCY1,
GNAS,
GPR3 |
adenylate cyclase activity [MF],
adenylate cyclase-activating G-protein coupled receptor signaling pathway [BP],
genetic imprinting [BP] |
| CG_adsipsc_promoter_p_RM_14_185_4 |
 |
 |
1 |
0.2 |
1.76E-04 |
UBE2D1,
TRAF4,
IL4R,
RNF182,
NLGN2 |
respiratory gaseous exchange [BP],
interleukin-4 receptor activity [MF],
positive regulation of inhibitory postsynaptic membrane potential [BP],
ubiquitin-protein ligase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_261_11 |
 |
 |
2 |
0.4 |
3.68E-04 |
ACADVL,
GCDH,
EEF2K |
glutaryl-CoA dehydrogenase activity [MF],
elongation factor-2 kinase activity [MF],
flavin adenine dinucleotide binding [MF],
fatty acid oxidation [BP],
acyl-CoA dehydrogenase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_247_9 |
 |
 |
2 |
0.4 |
2.57E-04 |
INHBB |
negative regulation of hepatocyte growth factor biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_14_159_2 |
 |
 |
2 |
0.2 |
2.58E-04 |
FOXO3 |
initiation of primordial ovarian follicle growth [BP] |
| CG_adsipsc_promoter_p_RM_14_239_4 |
 |
 |
1 |
0.2 |
2.00E-04 |
MGAT2,
LSM11,
UROD |
U7 snRNA binding [MF],
alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF],
uroporphyrinogen decarboxylase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_338_3 |
 |
 |
2 |
0.2 |
2.64E-04 |
COL13A1 |
collagen type XIII [CC] |
| CG_adsipsc_promoter_p_RM_14_395_7 |
 |
 |
2 |
0.2 |
1.45E-04 |
CDKN2C,
RPS27A,
HLA-G,
RARA,
SPPL2B |
G1 phase of mitotic cell cycle [BP],
regulation of immune response [BP],
integral to lumenal side of endoplasmic reticulum membrane [CC],
Sertoli cell fate commitment [BP] |
| CG_adsipsc_promoter_p_RM_12_122_7 |
 |
 |
4 |
0.6 |
1.59E-04 |
SPHK2,
FXN,
ERBB2 |
regulation of ferrochelatase activity [BP],
aerobic respiration [BP],
RNA polymerase I core binding [MF],
iron chaperone activity [MF],
sphinganine-1-phosphate biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_192_14 |
 |
 |
4 |
0.8 |
2.97E-04 |
BMP2,
SMAD1,
CYP26A1,
INA,
DRAXIN,
SMARCB1 |
dorsal spinal cord development [BP],
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [BP],
cellular response to BMP stimulus [BP],
central nervous system development [BP],
positive regulation of cartilage development [BP],
nervous system development [BP] |
| CG_adsipsc_promoter_p_RM_12_328_28 |
 |
 |
7 |
1.0 |
2.90E-04 |
LHX4,
ATP2A2,
IFT81,
TLX1,
RYR2,
LMO4,
MIB1,
LMX1B,
RUNX2,
POU4F2,
NEO1,
TFDP1,
RBM15,
MSX1,
PRPF6,
BCL2L11,
ADM,
MAPK14,
USF2,
MINK1 |
tube formation [BP],
muscle cell differentiation [BP],
odontogenesis of dentin-containing tooth [BP],
organ morphogenesis [BP],
positive regulation of heart rate [BP],
neuron differentiation [BP],
positive regulation of transcription from RNA polymerase II promoter [BP],
striated muscle cell differentiation [BP],
multicellular organismal development [BP],
spleen development [BP],
neural tube formation [BP],
cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_14_409_8 |
 |
 |
2 |
0.2 |
2.18E-04 |
TRAF2 |
internal side of plasma membrane [CC] |
| CG_adsipsc_promoter_p_RM_14_179_6 |
 |
 |
1 |
0.2 |
2.30E-04 |
BRSK2,
NRTN,
NFKB1 |
negative regulation of interleukin-12 biosynthetic process [BP],
axonogenesis [BP],
neuron differentiation [BP],
neuron projection development [BP] |
| CG_adsipsc_promoter_p_RM_14_94_6 |
 |
 |
2 |
0.2 |
3.48E-04 |
SOX8,
KDM3A,
YY1,
ZNF131,
ZIC2 |
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_14_258_8 |
 |
 |
3 |
0.4 |
1.08E-04 |
P2RY1,
NAGS,
MTRR,
KRT18 |
A1 adenosine receptor binding [MF],
[methionine synthase] reductase activity [MF],
acetyl-CoA:L-glutamate N-acetyltransferase activity [MF],
scaffold protein binding [MF] |
| CG_adsipsc_promoter_p_RM_14_96_6 |
 |
 |
1 |
0.2 |
3.29E-04 |
RASD2,
NAT8L |
rough endoplasmic reticulum membrane [CC],
synaptic transmission, dopaminergic [BP] |
| CG_adsipsc_promoter_p_RM_12_282_9 |
 |
 |
2 |
0.4 |
3.46E-04 |
MELK,
MAP3K1,
OXSR1,
SLK,
ALPK1 |
protein serine/threonine kinase activity [MF],
protein kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_56_8 |
 |
 |
5 |
0.6 |
2.91E-04 |
IGF1R,
SEC61A1,
PSMD13,
PSMC6,
BUB3 |
regulation of JNK cascade [BP],
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [BP],
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP] |
| CG_adsipsc_promoter_p_RM_12_309_19 |
 |
 |
4 |
0.6 |
2.52E-04 |
STUB1,
RIN3,
KIT,
KDM4C,
PTK2B,
BLK,
TRIM54,
F10,
ADAM9,
CNDP2,
NFATC1 |
intrinsic to external side of plasma membrane [CC],
enzyme binding [MF],
intracellular signal transduction [BP],
signal transduction [BP],
proteolysis [BP],
intracellular protein kinase cascade [BP] |
| CG_adsipsc_promoter_p_RM_14_118_3 |
 |
 |
2 |
0.2 |
2.38E-04 |
CLN5,
IRX5 |
neuron maturation [BP] |
| CG_adsipsc_promoter_p_RM_12_333_9 |
 |
 |
4 |
0.8 |
2.77E-04 |
AGL |
isoamylase complex [CC],
glycogen debranching enzyme activity [MF],
amylo-alpha-1,6-glucosidase activity [MF],
4-alpha-glucanotransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_302_10 |
 |
 |
5 |
0.8 |
4.16E-04 |
GRIN1,
TANC1,
SYNGAP1 |
visual learning [BP] |
| CG_adsipsc_promoter_p_RM_14_115_8 |
 |
 |
2 |
0.2 |
1.80E-04 |
PRKCE,
OPRD1,
SAT1 |
TRAM-dependent toll-like receptor 4 signaling pathway [BP],
positive regulation of cellular glucuronidation [BP],
enkephalin receptor activity [MF],
spermidine binding [MF] |
| CG_adsipsc_promoter_p_RM_12_373_11 |
 |
 |
6 |
0.6 |
3.22E-04 |
CXADR,
OCLN |
apicolateral plasma membrane [CC] |
| CG_adsipsc_promoter_p_RM_14_90_7 |
 |
 |
4 |
0.4 |
3.25E-04 |
TMCO3 |
solute:hydrogen antiporter activity [MF] |
| CG_adsipsc_promoter_p_RM_12_386_8 |
 |
 |
5 |
0.8 |
4.33E-04 |
SDC2,
IL6,
SALL3,
PLA2G4B,
MAFF,
GLIS2 |
response to caffeine [BP],
parturition [BP],
negative regulation of smoothened signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_388_7 |
 |
 |
4 |
0.6 |
2.40E-04 |
CNNM2,
TPM1,
CTNNA1,
DACT1,
PTPRJ,
ZDHHC17 |
delta-catenin binding [MF],
gamma-catenin binding [MF],
magnesium ion transport [BP],
negative regulation of cell migration [BP],
regulation of Wnt receptor signaling pathway, planar cell polarity pathway [BP] |
| CG_adsipsc_promoter_p_RM_20_7_3 |
 |
 |
1 |
0.2 |
2.65E-04 |
CRHR1,
GPI |
corticotropin-releasing hormone receptor activity [MF],
corticotropin-releasing hormone binding [MF],
corticotrophin-releasing factor receptor activity [MF],
glucose-6-phosphate isomerase activity [MF],
methylglyoxal biosynthetic process [BP],
negative regulation of neuron death [BP] |
| CG_adsipsc_promoter_p_RM_14_231_7 |
 |
 |
2 |
0.4 |
2.69E-04 |
CHD7,
TALDO1,
NPY5R,
HES1,
GRIN1,
ICT1 |
cranial nerve development [BP],
N-box binding [MF],
negative regulation of stomach neuroendocrine cell differentiation [BP],
negative regulation of pancreatic A cell differentiation [BP],
heart morphogenesis [BP],
lateral inhibition [BP],
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF],
artery morphogenesis [BP],
translation release factor activity, codon nonspecific [MF],
outflow tract morphogenesis [BP],
mitochondrial translational termination [BP],
positive regulation of mitotic cell cycle, embryonic [BP],
propylene metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_14_92_6 |
 |
 |
3 |
0.2 |
3.49E-04 |
CA2,
CDK5R1,
LRFN3 |
axon [CC] |
| CG_adsipsc_promoter_p_RM_20_14_2 |
 |
 |
1 |
0.2 |
4.16E-04 |
CLIC6 |
D4 dopamine receptor binding [MF],
D3 dopamine receptor binding [MF],
D2 dopamine receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_12_427_11 |
 |
 |
5 |
0.6 |
1.41E-04 |
NLGN1,
MAF1,
ILK,
AGRN,
PALM,
FST,
SEPT11,
MYRIP |
positive regulation of dendritic spine development [BP],
receptor clustering [BP],
synapse [CC],
positive regulation of synapse assembly [BP],
protein heterooligomerization [BP],
heparan sulfate proteoglycan binding [MF],
dendrite [CC],
positive regulation of filopodium assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_56_16 |
 |
 |
3 |
0.6 |
2.71E-04 |
SLC38A3,
DAO |
asparagine transport [BP],
histidine transport [BP],
D-serine catabolic process [BP],
D-alanine catabolic process [BP] |
| CG_adsipsc_promoter_p_RM_12_304_8 |
 |
 |
7 |
1.0 |
4.39E-04 |
KDM1A,
RBM4,
RAB33B,
STK11,
ACTL6A,
DOK5,
AGO4,
IKZF1,
ERBB2 |
granulocyte differentiation [BP],
regulation of autophagic vacuole assembly [BP],
gland development [BP],
autophagy [BP],
negative regulation of translation involved in gene silencing by miRNA [BP],
nervous system development [BP] |
| CG_adsipsc_promoter_p_RM_20_12_2 |
 |
 |
1 |
0.2 |
8.33E-04 |
HIST1H2AH,
HIST1H2AC,
HIST2H4B |
nucleosome assembly [BP],
chromatin organization [BP],
negative regulation of megakaryocyte differentiation [BP],
nucleosome [CC],
protein heterodimerization activity [MF] |
| CG_adsipsc_promoter_p_RM_20_3_1 |
 |
 |
1 |
0.2 |
2.99E-04 |
MPG |
DNA-7-methylguanine glycosylase activity [MF],
DNA-7-methyladenine glycosylase activity [MF],
DNA-3-methylguanine glycosylase activity [MF],
DNA-3-methyladenine glycosylase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_312_6 |
 |
 |
1 |
0.2 |
2.00E-04 |
DNAAF1,
ATP7A,
DBI |
regulation of cilium beat frequency [BP],
skin development [BP],
copper ion export [BP],
detoxification of copper ion [BP],
negative regulation of metalloenzyme activity [BP] |
| CG_adsipsc_promoter_p_RM_12_452_6 |
 |
 |
3 |
0.6 |
2.73E-04 |
CENPF,
NCAN,
RALB,
IST1,
LAYN |
midbody [CC],
hyaluronic acid binding [MF] |
| CG_adsipsc_promoter_p_RM_12_478_16 |
 |
 |
5 |
1.0 |
3.09E-04 |
FGFR3,
SHROOM2,
SOX11 |
epithelial cell fate commitment [BP],
lens morphogenesis in camera-type eye [BP] |
| CG_adsipsc_promoter_p_RM_16_5_3 |
 |
 |
3 |
0.4 |
5.04E-04 |
SOX11,
TACC3,
STIM2,
TCF7L2,
GRM7,
CUL1,
FGFRL1 |
calcium channel regulator activity [MF],
regulation of cell cycle [BP],
cell cycle arrest [BP],
embryonic digestive tract morphogenesis [BP],
ventricular septum morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_173_7 |
 |
 |
2 |
0.2 |
2.30E-04 |
GSTZ1,
GNAS,
EDN3 |
maleylacetoacetate isomerase activity [MF],
post-embryonic body morphogenesis [BP],
peptide hormone secretion [BP] |
| CG_adsipsc_promoter_p_RM_14_272_7 |
 |
 |
4 |
0.4 |
3.38E-04 |
FARP1 |
extrinsic to membrane [CC] |
| CG_adsipsc_promoter_p_RM_12_107_14 |
 |
 |
5 |
0.6 |
1.97E-04 |
KIAA1967,
PLEKHO1,
RNASEH2A,
ARIH2,
RALY,
ZNF7,
ESCO2,
NFE2L1,
ZBTB18,
PPP4R2,
ELMOD1,
CDC14A,
ZNF778,
TEX19,
PRDM2,
DPP3,
NOL3,
TBL3,
WNT3A |
RNA splicing [BP],
hematopoietic stem cell proliferation [BP],
nucleus [CC] |
| CG_adsipsc_promoter_p_RM_14_270_8 |
 |
 |
2 |
0.2 |
3.28E-04 |
IQSEC3,
PLEKHN1,
SNX18,
ZFYVE9 |
endocytosis [BP],
phospholipid binding [MF] |
| CG_adsipsc_promoter_p_RM_12_88_20 |
 |
 |
5 |
0.8 |
1.65E-04 |
BMPR1A,
ADCYAP1R1,
IFNAR2 |
type I interferon binding [MF],
caveola [CC],
paraxial mesoderm structural organization [BP],
neural plate mediolateral regionalization [BP] |
| CG_adsipsc_promoter_p_RM_14_321_15 |
 |
 |
4 |
0.6 |
4.06E-04 |
EPB41,
BCL2L11,
SHROOM2,
PDE3B,
MYLIP |
cortical actin cytoskeleton [CC],
extrinsic to membrane [CC],
cortical cytoskeleton [CC],
negative regulation of cell adhesion mediated by integrin [BP] |
| CG_adsipsc_promoter_p_RM_12_454_5 |
 |
 |
4 |
0.8 |
2.43E-04 |
UTS2R,
OPRL1,
ACOT4 |
unsaturated monocarboxylic acid metabolic process [BP],
saturated monocarboxylic acid metabolic process [BP],
succinyl-CoA hydrolase activity [MF],
urotensin II receptor activity [MF],
nociceptin receptor activity [MF] |
| CG_adsipsc_promoter_p_RM_16_7_4 |
 |
 |
3 |
0.2 |
3.21E-04 |
RNF5,
ADORA2A |
response to caffeine [BP],
ER-associated misfolded protein catabolic process [BP] |
| CG_adsipsc_promoter_p_RM_12_106_8 |
 |
 |
3 |
0.4 |
3.42E-04 |
CTNND1 |
morphogenesis of a polarized epithelium [BP] |
| CG_adsipsc_promoter_p_RM_12_272_21 |
 |
 |
5 |
0.8 |
3.26E-04 |
MTHFD2,
CA2,
ZIC1,
DUSP5,
DUSP14,
MAT2A |
MAP kinase tyrosine/serine/threonine phosphatase activity [MF],
inner ear morphogenesis [BP],
one-carbon metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_16_43_3 |
 |
 |
2 |
0.2 |
4.69E-04 |
VIL1,
NR2F2,
EGR1,
LRP5,
HSD3B7 |
cytoplasmic actin-based contraction involved in cell motility [BP],
cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF],
lysophosphatidic acid binding [MF],
radial pattern formation [BP],
positive regulation of glomerular metanephric mesangial cell proliferation [BP],
anterior/posterior pattern specification [BP] |
| CG_adsipsc_promoter_p_RM_14_181_6 |
 |
 |
2 |
0.2 |
4.84E-04 |
TGM4 |
protein polyamination [BP] |
| CG_adsipsc_promoter_p_RM_14_291_10 |
 |
 |
7 |
1.0 |
3.84E-04 |
PKN3,
FOXQ1 |
cysteine-type endopeptidase regulator activity involved in apoptotic process [MF],
epithelial cell migration [BP] |
| CG_adsipsc_promoter_p_RM_14_29_3 |
 |
 |
2 |
0.2 |
4.39E-04 |
EGFR |
Shc-EGFR complex [CC],
activation of phospholipase A2 activity by calcium-mediated signaling [BP] |
| CG_adsipsc_promoter_p_RM_12_211_10 |
 |
 |
7 |
0.8 |
3.70E-04 |
CHD1L,
CHD7,
DR1,
USP1,
SMC2,
VIM,
UBA52,
UPF1,
NF1,
FOXC1,
CHEK1,
PHF16 |
astrocyte development [BP],
DNA repair [BP],
histone H3 acetylation [BP],
artery morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_287_10 |
 |
 |
3 |
0.6 |
3.71E-04 |
PDE1B |
calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_34_13 |
 |
 |
3 |
0.2 |
3.43E-04 |
UAP1,
ULK1 |
radial glia guided migration of cerebellar granule cell [BP],
UDP-N-acetylglucosamine diphosphorylase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_255_6 |
 |
 |
2 |
0.2 |
3.42E-04 |
FAM20C,
C9orf96,
ACR |
acrosome matrix dispersal [BP],
protein kinase activity [MF],
amidase activity [MF],
dentinogenesis [BP],
osteoclast maturation [BP] |
| CG_adsipsc_promoter_p_RM_14_316_7 |
 |
 |
2 |
0.2 |
3.51E-04 |
ARHGAP5,
H6PD,
CDK1,
SMO |
otolith morphogenesis [BP],
pronuclear fusion [BP],
detection of cell density by contact stimulus involved in contact inhibition [BP],
positive regulation of mesenchymal cell proliferation [BP],
mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP],
response to alcohol [BP],
ventral midline determination [BP] |
| CG_adsipsc_promoter_p_RM_12_461_14 |
 |
 |
4 |
0.6 |
2.40E-04 |
LTB4R |
leukotriene B4 receptor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_450_7 |
 |
 |
3 |
0.6 |
2.72E-04 |
RIMKLA |
acid-amino acid ligase activity [MF] |
| CG_adsipsc_promoter_p_RM_16_45_6 |
 |
 |
11 |
1.0 |
4.05E-04 |
ADM,
SETD1B,
MLL5,
ARNTL |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity [MF],
hormone secretion [BP],
histone methyltransferase activity (H3-K4 specific) [MF] |
| CG_adsipsc_promoter_p_RM_14_215_9 |
 |
 |
2 |
0.2 |
2.32E-04 |
GPT |
cellular amino acid biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_14_257_2 |
 |
 |
1 |
0.2 |
4.80E-04 |
LYN |
alpha2-beta1 integrin complex [CC],
positive regulation of dendritic cell apoptotic process [BP],
negative regulation of mast cell proliferation [BP],
positive regulation of oligodendrocyte progenitor proliferation [BP] |
| CG_adsipsc_promoter_p_RM_16_3_8 |
 |
 |
9 |
1.0 |
5.62E-04 |
PSMD11,
POMP |
proteasome assembly [BP] |
| CG_adsipsc_promoter_p_RM_14_376_8 |
 |
 |
2 |
0.2 |
2.78E-04 |
RBPMS,
SPEN |
nucleotide binding [MF] |
| CG_adsipsc_promoter_p_RM_14_189_10 |
 |
 |
2 |
0.4 |
3.51E-04 |
SMC3,
MLL,
EPB41,
SMAD6,
SPTBN4,
SKI,
TADA2B,
CENPF |
dynein binding [MF],
spectrin [CC],
spectrin binding [MF],
protein complex assembly [BP],
chromatin binding [MF] |
| CG_adsipsc_promoter_p_RM_12_248_18 |
 |
 |
6 |
1.0 |
3.43E-04 |
INHBB,
FOXC1,
INHA |
ovarian follicle development [BP],
negative regulation of follicle-stimulating hormone secretion [BP],
positive regulation of follicle-stimulating hormone secretion [BP] |
| CG_adsipsc_promoter_p_RM_14_25_5 |
 |
 |
3 |
0.2 |
3.69E-04 |
IKBKB |
IkappaB kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_18_4_5 |
 |
 |
2 |
0.2 |
4.78E-04 |
NT5M,
CTPS1,
CMPK1 |
pyrimidine ribonucleotide biosynthetic process [BP],
CDP biosynthetic process [BP],
dUMP catabolic process [BP],
nucleobase-containing small molecule interconversion [BP],
dCDP biosynthetic process [BP],
UDP biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_14_126_11 |
 |
 |
2 |
0.2 |
4.40E-04 |
PPARA,
ZFPM1 |
negative regulation of protein binding [BP] |
| CG_adsipsc_promoter_p_RM_12_306_18 |
 |
 |
7 |
0.8 |
2.34E-04 |
MAPK8IP2 |
regulation of JNK cascade [BP] |
| CG_adsipsc_promoter_p_RM_14_211_7 |
 |
 |
3 |
0.4 |
3.10E-04 |
SOD1,
PRKCB,
PPARD,
ITGA6,
PPIL2,
PDPK1,
DGKE,
EPHB2 |
blood coagulation [BP],
regulation of body fluid levels [BP],
wound healing [BP],
transmission of nerve impulse [BP] |
| CG_adsipsc_promoter_p_RM_12_50_14 |
 |
 |
5 |
1.0 |
3.48E-04 |
EPHA8,
NPAS3,
CSF1,
ITGAV,
RXRA,
PTEN,
ZIC2,
GNAS |
regulation of cell adhesion [BP],
maternal behavior [BP],
chromatin DNA binding [MF],
positive regulation of osteoclast differentiation [BP],
social behavior [BP],
axon guidance [BP],
developmental process involved in reproduction [BP],
regulation of macrophage derived foam cell differentiation [BP],
cell-matrix adhesion [BP] |
| CG_adsipsc_promoter_p_RM_12_221_6 |
 |
 |
2 |
0.4 |
2.93E-04 |
KIF19,
SWSAP1,
RARA |
Shu complex [CC],
plus-end specific microtubule depolymerization [BP],
Sertoli cell fate commitment [BP],
axonemal microtubule depolymerization [BP] |
| CG_adsipsc_promoter_p_RM_14_295_11 |
 |
 |
13 |
1.0 |
4.91E-04 |
YY1,
PTK7,
IPO13,
TCEB3,
ATF7IP,
RCOR1,
UHRF1BP1,
NOL3,
SMARCA4,
NCOA3,
SDHAF2,
UBAP2L,
MST4,
CACNA1B,
PIM1,
SNX18,
BIRC7,
ZIC2,
SLIT2,
FOXF2,
GSG2,
KCNIP3,
CUL1,
CUL9,
SUV420H2,
IGF1R,
GREM1,
POMP,
FZD1,
ARPC2,
SP2,
NR4A1,
SLC25A5,
IGFBP2,
CCP110,
ARNT2,
PEX3,
TPCN1,
ARID1A,
PSMD11,
TLX1,
PDCD6IP,
RUNX2,
SAE1,
POLE4,
IPO9,
BUD31,
AGO4,
MAP3K1 |
protein binding [MF],
positive regulation of transcription, DNA-dependent [BP],
establishment of planar polarity [BP],
establishment of planar polarity of embryonic epithelium [BP],
insulin-like growth factor I binding [MF],
positive regulation of steroid hormone biosynthetic process [BP],
cell migration involved in sprouting angiogenesis [BP],
negative regulation of monocyte chemotaxis [BP],
negative regulation of gene expression [BP],
proteasome assembly [BP],
transcription from RNA polymerase II promoter [BP],
negative regulation of leukocyte chemotaxis [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_14_292_8 |
 |
 |
4 |
0.6 |
3.78E-04 |
GPC5,
WNT1 |
proteinaceous extracellular matrix [CC] |
| CG_adsipsc_promoter_p_RM_16_8_2 |
 |
 |
3 |
0.2 |
6.31E-04 |
ERBB2IP,
ADAP2 |
basal protein localization [BP],
inositol 1,3,4,5 tetrakisphosphate binding [MF] |
| CG_adsipsc_promoter_p_RM_12_226_15 |
 |
 |
5 |
0.8 |
3.22E-04 |
DYRK2,
FMN2,
IRAK3 |
negative regulation of protein catabolic process [BP],
ubiquitin binding [MF] |
| CG_adsipsc_promoter_p_RM_14_318_4 |
 |
 |
2 |
0.2 |
2.05E-04 |
DAK |
FAD-AMP lyase (cyclizing) activity [MF],
glycerone kinase activity [MF],
triokinase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_337_6 |
 |
 |
2 |
0.2 |
2.08E-04 |
ENOPH1,
ZIC3,
PRKCG,
PRMT7,
AGPHD1 |
[myelin basic protein]-arginine N-methyltransferase activity [MF],
hydroxylysine kinase activity [MF],
positive regulation of mismatch repair [BP],
acireductone synthase activity [MF],
determination of left/right asymmetry in nervous system [BP] |
| CG_adsipsc_promoter_p_RM_14_387_10 |
 |
 |
2 |
0.2 |
2.56E-04 |
GREM1,
SOX8,
ID1,
SMO,
NIPBL,
FBXL15,
PDPK1,
ZNF143 |
mesenchymal to epithelial transition involved in metanephros morphogenesis [BP],
renal system development [BP],
regulation of hair cycle [BP],
cellular protein localization [BP],
embryonic digestive tract morphogenesis [BP],
BMP signaling pathway [BP],
embryonic viscerocranium morphogenesis [BP],
positive regulation of branching involved in ureteric bud morphogenesis [BP],
branching involved in ureteric bud morphogenesis [BP],
metanephros development [BP],
dorsal/ventral pattern formation [BP],
cardioblast differentiation [BP],
type B pancreatic cell development [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_14_372_5 |
 |
 |
4 |
0.4 |
3.77E-04 |
COASY,
UTP3,
AKIRIN1,
SLC16A3,
DYRK2,
STK4,
PTCHD2,
CDK5R1,
PHF2,
UBE4B |
nuclear membrane [CC],
protein serine/threonine kinase activator activity [MF],
nucleus [CC] |
| CG_adsipsc_promoter_p_RM_14_329_5 |
 |
 |
1 |
0.2 |
1.36E-04 |
YY1,
DOLPP1 |
dolichyldiphosphatase activity [MF],
response to prostaglandin F stimulus [BP] |
| CG_adsipsc_promoter_p_RM_14_21_6 |
 |
 |
2 |
0.2 |
2.48E-04 |
PRKCA |
positive regulation of dense core granule biogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_28_14 |
 |
 |
5 |
1.0 |
5.63E-04 |
NLGN2,
MAF1 |
inhibitory synapse [CC] |
| CG_adsipsc_promoter_p_RM_12_414_16 |
 |
 |
4 |
0.8 |
1.77E-04 |
AK7,
DNAI1 |
epithelial cilium movement [BP] |
| CG_adsipsc_promoter_p_RM_12_153_14 |
 |
 |
4 |
0.8 |
9.71E-05 |
TPGS1,
MGAT5B,
PKD2,
SHROOM2 |
microtubule basal body [CC],
filamentous actin [CC],
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [MF],
metanephric cortex development [BP],
eye pigment granule organization [BP],
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP],
calcium-induced calcium release activity [MF],
renal artery morphogenesis [BP],
metanephric cortical collecting duct development [BP],
renal tubule morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_389_10 |
 |
 |
3 |
0.4 |
2.98E-04 |
GATA3,
NFKB1 |
T cell receptor signaling pathway [BP],
regulation of cytokine biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_179_15 |
 |
 |
2 |
0.4 |
2.84E-04 |
EGR1 |
response to norepinephrine stimulus [BP] |
| CG_adsipsc_promoter_p_RM_14_208_4 |
 |
 |
2 |
0.2 |
2.86E-04 |
GAB1,
DBNL |
activation of JUN kinase activity [BP] |
| CG_adsipsc_promoter_p_RM_18_6_2 |
 |
 |
4 |
0.4 |
5.30E-04 |
PKNOX1,
FOXF2,
ZFPM1 |
negative regulation of interleukin-4 biosynthetic process [BP],
transcription factor complex [CC],
erythrocyte differentiation [BP],
negative regulation of mast cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_342_11 |
 |
 |
6 |
0.8 |
3.10E-04 |
EXOSC4 |
maturation of 5.8S rRNA [BP] |
| CG_adsipsc_promoter_p_RM_12_233_12 |
 |
 |
4 |
0.8 |
4.25E-04 |
FEM1B,
FGF2,
LRRK2,
SHBG |
substantia nigra development [BP],
external side of mitochondrial outer membrane [CC],
regulation of DNA damage checkpoint [BP],
negative regulation of neuron maturation [BP],
primary spermatocyte growth [BP],
activation of MAPKK activity [BP],
GTP-dependent protein kinase activity [MF],
negative regulation of branching morphogenesis of a nerve [BP] |
| CG_adsipsc_promoter_p_RM_20_11_1 |
 |
 |
1 |
0.2 |
1.54E-04 |
RBPJ,
ACTN2 |
FATZ binding [MF],
blood vessel endothelial cell fate specification [BP],
positive regulation of potassium ion transmembrane transporter activity [BP],
titin Z domain binding [MF],
negative regulation of potassium ion transmembrane transporter activity [BP],
blood vessel lumenization [BP],
MAML1-RBP-Jkappa- ICN1 complex [CC],
recombinase activity [MF],
positive regulation of ephrin receptor signaling pathway [BP],
microspike assembly [BP],
atrioventricular canal development [BP] |
| CG_adsipsc_promoter_p_RM_18_8_2 |
 |
 |
1 |
0.2 |
2.12E-04 |
TPGS1 |
sperm axoneme assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_39_11 |
 |
 |
4 |
0.6 |
3.05E-04 |
SYNGAP1,
SLC39A14,
AGRN,
STAT5A,
SLC30A5,
KLF13 |
zinc ion transport [BP],
negative regulation of erythrocyte differentiation [BP],
zinc ion transmembrane transporter activity [MF],
receptor clustering [BP],
zinc ion transmembrane transport [BP],
cellular zinc ion homeostasis [BP] |
| CG_adsipsc_promoter_p_RM_16_47_34 |
 |
 |
11 |
1.0 |
5.59E-04 |
SETD1B,
POLR2A,
MLL5,
MNAT1 |
histone methyltransferase activity (H3-K4 specific) [MF],
histone H3-K4 methylation [BP],
7-methylguanosine mRNA capping [BP] |
| CG_adsipsc_promoter_p_RM_14_235_6 |
 |
 |
4 |
0.6 |
4.28E-04 |
MTAP |
S-methyl-5-thioadenosine phosphorylase activity [MF] |
| CG_adsipsc_promoter_p_RM_16_25_4 |
 |
 |
2 |
0.4 |
3.58E-05 |
TPGS1 |
sperm axoneme assembly [BP] |
| CG_adsipsc_promoter_p_RM_14_333_5 |
 |
 |
2 |
0.2 |
3.44E-04 |
GDF7 |
roof plate formation [BP],
positive regulation of tendon cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_220_11 |
 |
 |
4 |
0.8 |
3.63E-04 |
SPEN,
SHROOM2,
FOXF1,
NKX2-3,
TGIF1,
FOXD3 |
embryonic ectodermal digestive tract morphogenesis [BP],
mesenchyme migration [BP],
negative regulation of transcription from RNA polymerase II promoter [BP],
post-embryonic digestive tract morphogenesis [BP],
cell migration [BP],
detection of wounding [BP],
eye pigment granule organization [BP],
pattern specification process [BP],
branching involved in open tracheal system development [BP],
right lung morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_293_10 |
 |
 |
2 |
0.4 |
3.65E-04 |
MAG,
PTEN |
Schmidt-Lanterman incisure [CC] |
| CG_adsipsc_promoter_p_RM_12_401_14 |
 |
 |
3 |
0.6 |
2.32E-04 |
RBM4,
ATXN2L |
cytoplasmic stress granule [CC] |
| CG_adsipsc_promoter_p_RM_14_331_3 |
 |
 |
1 |
0.2 |
2.93E-04 |
OPRL1,
MLYCD |
malonyl-CoA catabolic process [BP],
nociceptin receptor activity [MF],
malonyl-CoA decarboxylase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_12_16 |
 |
 |
7 |
1.0 |
2.33E-04 |
DIO3,
KDM1B |
histone demethylase activity (H3-monomethyl-K4 specific) [MF],
thyroxine 5-deiodinase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_187_10 |
 |
 |
4 |
0.4 |
3.60E-04 |
GADD45B,
NPY2R,
FOXF1,
TRAF7,
PKN1 |
cardiac left ventricle morphogenesis [BP],
hyperosmotic response [BP],
activation of MAPKKK activity [BP] |
| CG_adsipsc_promoter_p_RM_12_378_24 |
 |
 |
3 |
0.6 |
2.15E-04 |
CRABP1,
BMP1,
MACF1,
PRKCE,
IL6R,
VENTX,
ADRA1B |
regulation of epithelial cell migration [BP],
positive regulation of MAPK cascade [BP],
multicellular organismal development [BP],
intracellular protein kinase cascade [BP],
response to morphine [BP] |
| CG_adsipsc_promoter_p_RM_12_276_9 |
 |
 |
5 |
0.6 |
3.43E-04 |
HINFP,
TRIM71,
PRPF31,
EMX2,
ZFP1,
PCNT,
FOXL1,
WEE1,
SPIN1,
GRHL1,
DDX20 |
Cajal body [CC],
assembly of spliceosomal tri-snRNP [BP],
DNA binding [MF],
neural precursor cell proliferation [BP],
G1/S transition of mitotic cell cycle [BP] |
| CG_adsipsc_promoter_p_RM_16_29_2 |
 |
 |
1 |
0.2 |
5.00E-04 |
SOX8,
BMPR1B |
osteoblast differentiation [BP],
retinal rod cell differentiation [BP],
ovarian cumulus expansion [BP],
retina development in camera-type eye [BP] |
| CG_adsipsc_promoter_p_RM_14_296_9 |
 |
 |
13 |
1.0 |
4.07E-04 |
ZBTB18,
FOXK2,
STUB1,
RPS27A,
SOX1,
FOXF1,
REST,
NR2F2,
ONECUT3,
EN2,
MAFK,
MLL,
SLC5A7,
GMEB1,
LEMD3,
POU2F3,
PEG10,
HIC1,
SLC44A1 |
negative regulation of transforming growth factor beta receptor signaling pathway [BP],
choline transmembrane transporter activity [MF],
sequence-specific DNA binding [MF],
regulation of glucocorticoid metabolic process [BP],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_228_21 |
 |
 |
3 |
0.6 |
2.50E-04 |
SOX17,
PRDX5 |
inner cell mass cellular morphogenesis [BP],
regulation of apoptosis involved in tissue homeostasis [BP],
peroxynitrite reductase activity [MF],
cardiogenic plate morphogenesis [BP],
regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification [BP] |
| CG_adsipsc_promoter_p_RM_14_218_12 |
 |
 |
3 |
0.4 |
2.74E-04 |
IGF1R,
UBC,
ERBB2 |
JNK cascade [BP],
stress-activated MAPK cascade [BP],
positive regulation of MAPK cascade [BP],
phosphatidylinositol 3-kinase cascade [BP] |
| CG_adsipsc_promoter_p_RM_12_160_9 |
 |
 |
2 |
0.4 |
2.62E-04 |
NF2,
NT5E |
AMP catabolic process [BP],
negative regulation of tyrosine phosphorylation of Stat5 protein [BP],
adenosine biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_14_43_7 |
 |
 |
2 |
0.2 |
2.22E-04 |
NOG,
NR2E1,
KIF1B,
MAPK8IP3,
HOXD11 |
negative regulation of astrocyte differentiation [BP],
kinesin binding [MF],
embryonic skeletal joint morphogenesis [BP],
forebrain development [BP] |
| CG_adsipsc_promoter_p_RM_14_216_9 |
 |
 |
2 |
0.2 |
1.65E-04 |
ADORA2B |
cellular response to extracellular stimulus [BP] |
| CG_adsipsc_promoter_p_RM_12_270_9 |
 |
 |
4 |
0.6 |
3.09E-04 |
MPG,
HINFP,
STUB1 |
DNA-7-methylguanine glycosylase activity [MF],
DNA-7-methyladenine glycosylase activity [MF],
positive regulation of chaperone-mediated protein complex assembly [BP],
DNA-3-methylguanine glycosylase activity [MF],
DNA-3-methyladenine glycosylase activity [MF],
DNA repair [BP] |
| CG_adsipsc_promoter_p_RM_12_190_13 |
 |
 |
3 |
0.6 |
3.63E-04 |
WWP1,
ZNF75A,
RPS27A,
XIAP,
RPS3,
IKBKG,
CDKN1B,
SWAP70,
ZNF74,
SLC25A10,
SRSF6,
CHD1L,
PPM1A,
ZIC2,
NOD2,
MSX1,
POLH,
ZNF282,
DIP2A,
POU3F3,
GREM1,
BUB3,
EPN1,
ZNF22,
ZNF48,
POLR2A,
FOXL1,
MGA,
PTMA,
CD3EAP,
CCNY,
HTT,
ZKSCAN5,
ZNF276,
ZMIZ1,
AASDHPPT,
RBM4 |
nucleotide-binding oligomerization domain containing signaling pathway [BP],
regulation of sequence-specific DNA binding transcription factor activity [BP],
macromolecule biosynthetic process [BP],
transcription, DNA-dependent [BP],
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [BP],
positive regulation of NF-kappaB transcription factor activity [BP],
cellular nitrogen compound metabolic process [BP],
nucleus [CC] |
| CG_adsipsc_promoter_p_RM_14_335_9 |
 |
 |
3 |
0.4 |
9.85E-05 |
ADCK5,
STK17A,
WEE1 |
protein serine/threonine kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_375_22 |
 |
 |
4 |
0.6 |
2.48E-04 |
NEURL,
TPGS1 |
sperm axoneme assembly [BP] |
| CG_adsipsc_promoter_p_RM_14_381_12 |
 |
 |
3 |
0.4 |
2.29E-04 |
UHRF2 |
nuclear heterochromatin [CC] |
| CG_adsipsc_promoter_p_RM_20_1_10 |
 |
 |
1 |
0.2 |
4.75E-04 |
FOXA3,
BMPR2,
ZIC3,
KCNIP3,
PKNOX1,
TRIM24 |
neural plate anterior/posterior regionalization [BP],
transcription from RNA polymerase II promoter [BP],
anterior/posterior pattern specification [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_12_219_11 |
 |
 |
3 |
0.6 |
3.78E-04 |
ADRA2C,
PAPPA,
NPB,
GNAS,
MOCS3 |
G-protein coupled receptor binding [MF],
female pregnancy [BP],
enzyme active site formation via L-cysteine persulfide [BP],
post-embryonic body morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_403_16 |
 |
 |
4 |
0.8 |
2.24E-04 |
CCNE1 |
DNA replication initiation [BP] |
| CG_adsipsc_promoter_p_RM_12_81_6 |
 |
 |
7 |
1.0 |
2.71E-04 |
SPHK1,
HSPB1,
TPM1,
MAPK14,
FGF18,
VEGFA,
PANX1,
FGF17,
COL15A1 |
angiogenesis [BP],
endothelial cell chemotaxis [BP],
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [BP],
type 1 fibroblast growth factor receptor binding [MF],
regulation of interleukin-1 beta production [BP],
vascular endothelial growth factor receptor signaling pathway [BP],
striated muscle cell differentiation [BP],
cellular response to vascular endothelial growth factor stimulus [BP],
bleb [CC],
positive regulation of endothelial cell chemotaxis [BP],
type 2 fibroblast growth factor receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_12_439_8 |
 |
 |
5 |
1.0 |
3.18E-04 |
PIAS4,
RASD2 |
positive regulation of protein sumoylation [BP] |
| CG_adsipsc_promoter_p_RM_14_175_12 |
 |
 |
4 |
0.6 |
4.13E-04 |
CAPN2,
NEO1 |
myoblast fusion [BP] |
| CG_adsipsc_promoter_p_RM_14_87_3 |
 |
 |
2 |
0.4 |
1.79E-04 |
NUP85 |
macrophage chemotaxis [BP] |
| CG_adsipsc_promoter_p_RM_14_309_6 |
 |
 |
3 |
0.4 |
3.00E-04 |
SLC6A8 |
creatine transport [BP] |
| CG_adsipsc_promoter_p_RM_14_315_5 |
 |
 |
2 |
0.2 |
3.35E-04 |
MEIS1,
SKIL,
BDP1,
PDPK1,
CIDEA,
JARID2 |
negative regulation of transforming growth factor beta receptor signaling pathway [BP],
chromatin binding [MF],
transforming growth factor beta receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_311_16 |
 |
 |
6 |
0.8 |
3.18E-04 |
EMX2,
GPX4,
PI4K2A,
DUSP22 |
multicellular organismal development [BP],
phospholipid-hydroperoxide glutathione peroxidase activity [MF],
host cell presynaptic membrane [CC],
AP-3 adaptor complex binding [MF] |
| CG_adsipsc_promoter_p_RM_12_89_13 |
 |
 |
4 |
0.6 |
4.07E-04 |
PFAS,
FNTB,
GLYCTK |
protein farnesyltransferase complex [CC],
phosphoribosylformylglycinamidine synthase activity [MF],
glycerate kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_339_9 |
 |
 |
5 |
0.8 |
3.96E-04 |
GNAS |
mu-type opioid receptor binding [MF],
post-embryonic body morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_266_11 |
 |
 |
3 |
0.2 |
2.72E-04 |
SIVA1,
FEN1 |
CD27 receptor binding [MF],
double-stranded DNA specific exodeoxyribonuclease activity [MF] |
| CG_adsipsc_promoter_p_RM_14_184_7 |
 |
 |
3 |
0.4 |
2.73E-04 |
FAM21C,
FAM21B,
NPL |
retrograde transport, endosome to Golgi [BP],
WASH complex [CC],
N-acetylneuraminate lyase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_112_15 |
 |
 |
5 |
1.0 |
3.09E-04 |
CBX2,
EHMT1,
AMH,
ZBTB16,
GSX2,
SOX17,
ZNF783,
ZIC2,
MED15,
DLX4,
SNRNP70,
TRIM24,
COL19A1,
HMGA1,
PPARD,
SMYD2,
NFIC,
WDTC1,
WHSC1,
RNF187,
F2R,
ZNF276,
ZNF462,
HES3,
CTCF,
ILK |
peptidyl-lysine monomethylation [BP],
peptidyl-lysine dimethylation [BP],
positive regulation of transcription, DNA-dependent [BP],
negative regulation of transcription from RNA polymerase II promoter [BP],
regulation of transcription, DNA-dependent [BP],
transcription, DNA-dependent [BP],
p53 binding [MF],
negative regulation of transcription, DNA-dependent [BP],
histone-lysine N-methyltransferase activity [MF],
skeletal muscle tissue development [BP],
protein-lysine N-methyltransferase activity [MF],
gene expression [BP],
positive regulation of gene expression [BP] |
| CG_adsipsc_promoter_p_RM_12_444_14 |
 |
 |
3 |
0.6 |
4.47E-04 |
RPS6KB2,
TSC2,
REPS2,
AP2M1 |
epidermal growth factor receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_14_317_7 |
 |
 |
2 |
0.4 |
2.15E-04 |
USP3,
EVX1,
HINFP,
NPM1 |
histone binding [MF],
embryo development ending in birth or egg hatching [BP] |
| CG_adsipsc_promoter_p_RM_14_412_11 |
 |
 |
2 |
0.4 |
4.62E-04 |
YAP1,
SPATA18,
CCNK,
FBXO45 |
response to DNA damage stimulus [BP],
regulation of stem cell proliferation [BP] |
| CG_adsipsc_promoter_p_RM_14_48_10 |
 |
 |
1 |
0.2 |
2.58E-04 |
INHBB,
NFKB1 |
negative regulation of interleukin-12 biosynthetic process [BP],
negative regulation of hepatocyte growth factor biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_397_11 |
 |
 |
5 |
0.8 |
5.40E-04 |
DAND5,
TNKS2 |
sequestering of nodal from receptor via nodal binding [BP],
protein auto-ADP-ribosylation [BP],
negative regulation of nodal signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_14_354_28 |
 |
 |
9 |
1.0 |
1.97E-04 |
RPS6KB2,
RPS6KA4 |
ribosomal protein S6 kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_186_8 |
 |
 |
3 |
0.6 |
3.21E-04 |
TUBB4B,
CCT7,
KIF26B,
SHROOM2,
CNTNAP1 |
cytoskeleton organization [BP],
microtubule [CC],
cellular component movement [BP],
protein domain specific binding [MF] |
| CG_adsipsc_promoter_p_RM_14_22_19 |
 |
 |
7 |
1.0 |
3.74E-04 |
EP400,
NRTN,
RUVBL2,
HTT |
histone H4 acetylation [BP],
vesicle transport along microtubule [BP],
nerve development [BP],
histone H2A acetylation [BP],
NuA4 histone acetyltransferase complex [CC] |
| CG_adsipsc_promoter_p_RM_12_41_14 |
 |
 |
4 |
0.8 |
2.60E-04 |
JMY,
EGLN2,
UBE2D2,
PKNOX1,
CUX1,
GATA6,
FGF2,
FOXC1,
SIM2 |
organ formation [BP],
transcription from RNA polymerase II promoter [BP],
cardiac muscle cell proliferation [BP],
lung development [BP],
cellular response to hypoxia [BP],
lung saccule development [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_14_180_5 |
 |
 |
2 |
0.4 |
3.89E-04 |
SOX17,
MKL2,
AK4,
HES1 |
rostrocaudal neural tube patterning [BP],
liver development [BP],
common bile duct development [BP],
heart formation [BP],
positive regulation of striated muscle tissue development [BP] |
| CG_adsipsc_promoter_p_RM_14_319_6 |
 |
 |
4 |
0.6 |
2.84E-04 |
GATA3,
NIPBL |
enhancer sequence-specific DNA binding [MF],
uterus development [BP],
fat cell differentiation [BP],
cellular response to X-ray [BP] |
| CG_adsipsc_promoter_p_RM_14_182_9 |
 |
 |
2 |
0.4 |
1.42E-04 |
LLGL1,
CHD7,
ATP2A2,
PAX2,
SLC7A6 |
maintenance of apical/basal cell polarity [BP],
cranial nerve development [BP],
negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [BP],
negative regulation of apoptotic process involved in metanephric nephron tubule development [BP],
optic nerve structural organization [BP],
vestibulocochlear nerve formation [BP],
negative regulation of mesenchymal cell apoptotic process involved in metanephros development [BP],
positive regulation of optic nerve formation [BP],
optic chiasma development [BP],
transport [BP],
inner ear morphogenesis [BP],
pronephric field specification [BP],
positive regulation of metanephric DCT cell differentiation [BP],
regulation of metanephros size [BP],
calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF],
negative regulation of apoptotic process involved in metanephric collecting duct development [BP] |
| CG_adsipsc_promoter_p_RM_14_67_5 |
 |
 |
2 |
0.2 |
2.17E-04 |
CDKN1B,
CCNI2,
ACAT1,
HEY2 |
tricuspid valve morphogenesis [BP],
umbilical cord morphogenesis [BP],
enzyme binding [MF],
negative regulation of transcription initiation from RNA polymerase II promoter [BP],
negative regulation of cardiac vascular smooth muscle cell differentiation [BP],
regulation of cyclin-dependent protein kinase activity [BP],
tricuspid valve formation [BP],
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [BP],
metanephric proximal convoluted tubule development [BP] |
| CG_adsipsc_promoter_p_RM_14_370_11 |
 |
 |
8 |
1.0 |
3.33E-04 |
ZFPM1,
INPP5D,
OCRL |
phosphatidylinositol phosphorylation [BP],
granulocyte differentiation [BP],
inositol phosphate phosphatase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_37_17 |
 |
 |
3 |
0.4 |
2.46E-04 |
SQSTM1 |
pre-autophagosomal structure [CC] |
| CG_adsipsc_promoter_p_RM_12_468_11 |
 |
 |
3 |
0.4 |
2.78E-04 |
POGLUT1,
DTX1,
PPARA,
PNPLA3 |
regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP],
diolein transacylation activity [MF],
regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP],
negative regulation of neuron differentiation [BP],
regulation of Notch signaling pathway [BP],
mono-olein transacylation activity [MF] |
| CG_adsipsc_promoter_p_RM_12_371_17 |
 |
 |
2 |
0.4 |
3.07E-04 |
VLDLR,
ID2,
SMAD6,
BBX,
ALG6,
CLIC4,
EPB41,
PINK1,
SKI,
PTEN,
GYG1,
SMC3,
NTRK1,
SS18L1,
VIL1,
DNM1L,
HNRNPAB,
ZNHIT1,
BNIP3L,
RBL2,
MLL,
PPARA,
TLE4,
ARNT2,
SETD6,
ARID1B,
BBS5,
MET,
C1orf94,
CYLD,
ATF4,
INSIG1,
RNF115 |
protein binding [MF],
cell death [BP],
positive regulation of transcription, DNA-dependent [BP],
regulation of transcription, DNA-dependent [BP],
transcription, DNA-dependent [BP],
repressing transcription factor binding [MF],
flagellum assembly [BP],
glucosyltransferase activity [MF],
regulation of neuron projection development [BP] |
| CG_adsipsc_promoter_p_RM_12_278_15 |
 |
 |
4 |
0.6 |
3.44E-04 |
LEP |
central nervous system neuron development [BP] |
| CG_adsipsc_promoter_p_RM_12_75_12 |
 |
 |
3 |
0.4 |
2.25E-04 |
HCRTR1 |
peptide hormone binding [MF] |
| CG_adsipsc_promoter_p_RM_18_2_13 |
 |
 |
4 |
0.4 |
4.32E-04 |
PRMT8,
CELSR2,
TSPYL2,
EHMT1 |
rDNA binding [MF],
histone methylation [BP],
neural plate anterior/posterior regionalization [BP] |
| CG_adsipsc_promoter_p_RM_12_295_23 |
 |
 |
6 |
0.8 |
3.04E-04 |
HTRA2,
PPIF |
pentacyclic triterpenoid metabolic process [BP],
regulation of proton-transporting ATPase activity, rotational mechanism [BP] |
| CG_adsipsc_promoter_p_RM_12_405_11 |
 |
 |
2 |
0.4 |
1.79E-04 |
SLIT2,
SALL3,
HTRA2,
SMAD6 |
ureteric bud development [BP],
cellular response to growth factor stimulus [BP],
olfactory bulb interneuron development [BP] |
| CG_adsipsc_promoter_p_RM_12_71_24 |
 |
 |
4 |
0.6 |
5.26E-04 |
NAGS,
GRIN1 |
acetyl-CoA:L-glutamate N-acetyltransferase activity [MF],
propylene metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_12_290_16 |
 |
 |
5 |
0.8 |
3.06E-04 |
FGF2,
SOX1,
ONECUT3,
KCNIP3,
WWC1,
JDP2,
KCNH8,
FLI1,
LIN28B,
NFKBIZ,
BHLHE40,
LZTR1,
FBXL15,
HES3,
ZNF358,
CNOT6,
PRDM16 |
transcription, DNA-dependent [BP],
dorsal/ventral pattern formation [BP],
positive regulation of cell fate specification [BP],
RNA metabolic process [BP],
regulation of transcription, DNA-dependent [BP] |
| CG_adsipsc_promoter_p_RM_14_57_10 |
 |
 |
3 |
0.4 |
3.61E-04 |
TRIM32 |
response to tumor necrosis factor [BP] |
| CG_adsipsc_promoter_p_RM_20_15_2 |
 |
 |
1 |
0.2 |
6.43E-04 |
PCDHA13,
PCDHA5,
PCDHA10 |
homophilic cell adhesion [BP],
calcium ion binding [MF],
cell adhesion [BP] |
| CG_adsipsc_promoter_p_RM_14_142_7 |
 |
 |
1 |
0.2 |
3.47E-04 |
CHRNB2,
CDT1,
P2RY11,
DRD4 |
response to cocaine [BP],
regulation of synaptic transmission, dopaminergic [BP],
neurotransmitter receptor activity [MF],
social behavior [BP],
regulation of dopamine metabolic process [BP],
regulation of S phase of mitotic cell cycle [BP],
dopamine metabolic process [BP],
synaptic transmission, dopaminergic [BP] |
| CG_adsipsc_promoter_p_RM_12_360_16 |
 |
 |
2 |
0.4 |
9.53E-05 |
AATF,
BACE2 |
negative regulation of amyloid precursor protein biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_313_14 |
 |
 |
5 |
0.8 |
2.97E-04 |
VRK1,
SHROOM2,
WNK2,
TNFAIP3,
ADCK1,
MARK4,
CLDN9,
PVRL3,
CTNNA2,
SQSTM1 |
apical junction complex [CC],
cell-cell junction organization [BP],
protein serine/threonine kinase activity [MF],
cell-cell adherens junction [CC],
ubiquitin binding [MF] |
| CG_adsipsc_promoter_p_RM_20_13_2 |
 |
 |
1 |
0.2 |
4.28E-04 |
ANG |
angiogenin-PRI complex [CC] |
| CG_adsipsc_promoter_p_RM_18_15_2 |
 |
 |
1 |
0.2 |
2.70E-04 |
MLL5,
GNAS,
CNTN2 |
positive regulation of adenosine receptor signaling pathway [BP],
mu-type opioid receptor binding [MF],
establishment of protein localization to juxtaparanode region of axon [BP],
post-embryonic body morphogenesis [BP],
DNA methylation [BP] |
| CG_adsipsc_promoter_p_RM_14_123_9 |
 |
 |
3 |
0.2 |
2.79E-04 |
DRAP1,
ESRRA,
AFF1,
LMX1B,
HSF1 |
sequence-specific DNA binding [MF],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_14_273_4 |
 |
 |
2 |
0.2 |
3.38E-04 |
FXN,
GLRX5 |
regulation of ferrochelatase activity [BP],
2 iron, 2 sulfur cluster binding [MF],
iron chaperone activity [MF] |
| CG_adsipsc_promoter_p_RM_12_1_12 |
 |
 |
1 |
0.2 |
3.12E-04 |
DES,
PSEN1,
SYNGR3,
LHX2 |
dorsal/ventral pattern formation [BP],
neuromuscular junction [CC] |
| CG_adsipsc_promoter_p_RM_12_457_11 |
 |
 |
4 |
0.8 |
3.33E-04 |
STAT5A,
KLF13 |
negative regulation of erythrocyte differentiation [BP] |
| CG_adsipsc_promoter_p_RM_14_144_7 |
 |
 |
2 |
0.2 |
3.05E-04 |
CHST13,
CHST12,
SOCS6 |
chondroitin sulfate biosynthetic process [BP],
negative regulation of T cell activation [BP],
chondroitin 4-sulfotransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_313_2 |
 |
 |
4 |
0.6 |
3.92E-04 |
ITGB4,
NTRK1,
CARNS1,
TRIM67,
UGCG |
carnosine biosynthetic process [BP],
carnosine synthase activity [MF],
ceramide glucosyltransferase activity [MF],
neurotrophin p75 receptor binding [MF],
positive regulation of neuron projection development [BP],
filopodium assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_431_11 |
 |
 |
3 |
0.6 |
3.42E-04 |
LRWD1,
ING1,
PGAP2 |
GPI anchor biosynthetic process [BP],
methylated histone residue binding [MF] |
| CG_adsipsc_promoter_p_RM_14_121_3 |
 |
 |
1 |
0.2 |
4.43E-04 |
RAC3,
SHROOM2 |
establishment of melanosome localization [BP],
neuronal cell body [CC],
filamentous actin [CC] |
| CG_adsipsc_promoter_p_RM_14_252_7 |
 |
 |
5 |
0.8 |
3.53E-04 |
SOD1,
ARPC2,
ARPC4,
SREBF2,
INSIG1,
CYP1A2 |
negative regulation of steroid biosynthetic process [BP],
SREBP signaling pathway [BP],
hydrogen peroxide biosynthetic process [BP],
Arp2/3 protein complex [CC],
SREBP-SCAP-Insig complex [CC],
cholesterol metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_14_310_13 |
 |
 |
4 |
0.6 |
4.78E-04 |
TCF21,
ACE,
FGFRL1 |
regulation of smooth muscle cell migration [BP],
diaphragm development [BP] |
| CG_adsipsc_promoter_p_RM_14_146_6 |
 |
 |
4 |
0.6 |
2.67E-04 |
TMSB4X,
MIB2,
MPRIP,
MYO9B,
GABRA5,
IQGAP2,
MDK |
behavioral fear response [BP],
actin binding [MF] |
| CG_adsipsc_promoter_p_RM_12_300_7 |
 |
 |
5 |
1.0 |
2.61E-05 |
NIPBL,
MPG |
DNA-7-methylguanine glycosylase activity [MF],
DNA-7-methyladenine glycosylase activity [MF],
DNA-3-methylguanine glycosylase activity [MF],
DNA-3-methyladenine glycosylase activity [MF],
external genitalia morphogenesis [BP],
SMC loading complex [CC] |
| CG_adsipsc_promoter_p_RM_12_174_17 |
 |
 |
3 |
0.4 |
3.44E-04 |
PDE8B |
phosphorelay response regulator activity [MF] |
| CG_adsipsc_promoter_p_RM_14_62_7 |
 |
 |
2 |
0.2 |
2.46E-04 |
MAP2K1,
SLC5A3,
SHROOM2 |
establishment of melanosome localization [BP],
eye pigment granule organization [BP],
myo-inositol:sodium symporter activity [MF],
receptor signaling protein tyrosine phosphatase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_161_17 |
 |
 |
4 |
0.8 |
2.26E-04 |
SKIV2L2,
PBX3,
CA2 |
dorsal spinal cord development [BP],
response to pH [BP],
exosome (RNase complex) [CC] |
| CG_adsipsc_promoter_p_RM_14_250_11 |
 |
 |
13 |
1.0 |
4.57E-04 |
SOX12,
EVX1,
PBX3,
SLC12A2,
ELF3,
ZNF71,
NAB1,
TFAP2C,
MXD1,
TRIM24 |
spinal cord development [BP],
sequence-specific DNA binding [MF],
sequence-specific DNA binding transcription factor activity [MF],
transcription cofactor activity [MF],
Schwann cell differentiation [BP],
branching involved in mammary gland duct morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_278_13 |
 |
 |
6 |
0.6 |
2.80E-04 |
NT5E,
NT5M,
GNAS,
CDK13 |
cellular response to catecholamine stimulus [BP],
5'-nucleotidase activity [MF],
nuclear cyclin-dependent protein kinase holoenzyme complex [CC] |
| CG_adsipsc_promoter_p_RM_14_256_5 |
 |
 |
3 |
0.4 |
1.83E-04 |
GDI1,
BAG3 |
neuron projection [CC] |
| CG_adsipsc_promoter_p_RM_12_209_16 |
 |
 |
6 |
1.0 |
2.07E-04 |
FOXB1,
IFIT5,
RARS,
CCND1 |
midbrain development [BP],
mammary gland alveolus development [BP],
tRNA binding [MF],
lactation [BP],
mammary gland lobule development [BP] |
| CG_adsipsc_promoter_p_RM_14_26_5 |
 |
 |
3 |
0.4 |
1.33E-04 |
GAPDH,
ZFPM1 |
peptidyl-cysteine S-nitrosylase activity [MF],
peptidyl-cysteine S-trans-nitrosylation [BP],
negative regulation of interleukin-4 biosynthetic process [BP],
negative regulation of mast cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_14_8_7 |
 |
 |
2 |
0.2 |
2.89E-04 |
SMAD6,
CCNY,
SMAD1,
SUFU,
PKD2 |
cytoplasmic sequestering of transcription factor [BP],
co-SMAD binding [MF],
positive regulation of cyclin-dependent protein kinase activity [BP],
I-SMAD binding [MF],
SMAD protein complex assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_362_10 |
 |
 |
5 |
0.8 |
3.65E-04 |
LIMK1,
STK11,
DNM2,
RREB1,
ZBTB18,
ARF6,
NPAS1,
POLR2H,
AP2M1,
IRX5,
IRX6,
VPS13A,
MTA1,
HHEX,
EPN1,
HMGA1,
BARX2,
CUX1,
EP300,
FTL,
TAF5,
SRRM1,
ID2,
BUD31,
NFIX,
ONECUT3 |
protein complex [CC],
cellular membrane organization [BP],
sequence-specific DNA binding transcription factor activity [MF],
embryonic organ development [BP],
vesicle-mediated transport [BP],
transcription from RNA polymerase II promoter [BP],
nervous system development [BP] |
| CG_adsipsc_promoter_p_RM_12_65_4 |
 |
 |
3 |
0.6 |
2.39E-04 |
CC2D1A,
GABPA |
RNA polymerase II core promoter proximal region sequence-specific DNA binding [MF] |
| CG_adsipsc_promoter_p_RM_14_51_11 |
 |
 |
3 |
0.6 |
3.52E-04 |
ETV6,
ZBTB18,
LMO4,
MEIS1,
USF2,
AATF,
AEBP1,
TEAD1,
IRX6,
PRDM16 |
sequence-specific DNA binding [MF],
negative regulation of myeloid cell differentiation [BP],
definitive hemopoiesis [BP],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_14_28_8 |
 |
 |
2 |
0.2 |
2.29E-04 |
CHRNB2,
OPRL1,
NTRK1,
PIK3CA |
lateral geniculate nucleus development [BP],
response to nicotine [BP],
nociceptin receptor activity [MF],
hypomethylation of CpG island [BP],
neurotrophin p75 receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_12_377_13 |
 |
 |
5 |
1.0 |
2.35E-04 |
IGF1R,
PTPRU,
FGF9,
FZD7,
TCF7 |
canonical Wnt receptor signaling pathway [BP],
male sex determination [BP] |
| CG_adsipsc_promoter_p_RM_12_319_20 |
 |
 |
2 |
0.4 |
2.66E-04 |
RPS9 |
rRNA binding [MF],
translation regulator activity [MF] |
| CG_adsipsc_promoter_p_RM_12_246_20 |
 |
 |
4 |
0.8 |
2.69E-04 |
NR2F1,
DLX1,
NR4A3,
F2R |
negative regulation of neuron apoptotic process [BP],
forebrain development [BP] |
| CG_adsipsc_promoter_p_RM_12_466_14 |
 |
 |
3 |
0.4 |
1.44E-04 |
KAZALD1,
MYRIP,
VWA1,
SLC1A4,
FGF18,
ATP1A1,
AACS,
FGFR3,
WNT2B |
melanosome [CC],
interstitial matrix [CC],
positive regulation of insulin secretion [BP],
lung development [BP],
endochondral ossification [BP],
chondrocyte differentiation [BP],
cell-cell signaling [BP] |
| CG_adsipsc_promoter_p_RM_14_162_6 |
 |
 |
1 |
0.2 |
4.70E-04 |
KCNK3 |
cochlea development [BP] |
| CG_adsipsc_promoter_p_RM_12_338_5 |
 |
 |
3 |
0.6 |
2.45E-04 |
GTPBP4,
WNT1,
STK4,
UBC,
FOXO3 |
negative regulation of protein ubiquitination [BP],
regulation of sequence-specific DNA binding transcription factor activity [BP],
negative regulation of cell-cell adhesion [BP],
cell morphogenesis [BP],
signal transduction in response to DNA damage [BP],
hippo signaling cascade [BP],
female gonad development [BP] |
| CG_adsipsc_promoter_p_RM_12_297_14 |
 |
 |
3 |
0.6 |
2.36E-04 |
CRHBP,
SLC18A2 |
dense core granule [CC],
cellular response to ammonium ion [BP] |
| CG_adsipsc_promoter_p_RM_12_250_9 |
 |
 |
3 |
0.6 |
2.46E-04 |
USP14 |
regulation of proteasomal protein catabolic process [BP] |
| CG_adsipsc_promoter_p_RM_14_66_4 |
 |
 |
2 |
0.2 |
3.72E-04 |
PKN2,
NANOS1 |
epithelial cell migration [BP] |
| CG_adsipsc_promoter_p_RM_14_39_13 |
 |
 |
3 |
0.4 |
3.39E-04 |
CTNNA2,
SNCAIP,
ACVR1B,
PRKCA,
GADD45B,
MELK,
STK16,
DNAJB6,
TPM1,
KIAA1804,
BICD1,
PDE4A,
PACS2,
MADD |
cell death [BP],
cellular component movement [BP],
protein serine/threonine kinase activity [MF],
protein phosphorylation [BP],
positive regulation of ATPase activity [BP],
regulation of apoptotic process [BP],
protein autophosphorylation [BP],
apoptotic process [BP],
enzyme binding [MF],
structural constituent of cytoskeleton [MF],
perinuclear region of cytoplasm [CC] |
| CG_adsipsc_promoter_p_RM_14_254_5 |
 |
 |
2 |
0.2 |
1.96E-04 |
PLEKHG6,
FSD1 |
cleavage furrow [CC] |
| CG_adsipsc_promoter_p_RM_14_382_8 |
 |
 |
1 |
0.2 |
3.25E-04 |
HMGA1,
RPS3,
ADRA2C,
PDPK1 |
activation of protein kinase B activity [BP],
DNA-(apurinic or apyrimidinic site) lyase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_160_7 |
 |
 |
2 |
0.2 |
3.95E-04 |
LRP5,
LMX1B,
HMGB3 |
multicellular organismal development [BP],
embryonic camera-type eye morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_256_7 |
 |
 |
4 |
0.6 |
3.23E-04 |
CD4 |
maintenance of protein location in cell [BP] |
| CG_adsipsc_promoter_p_RM_12_165_11 |
 |
 |
2 |
0.4 |
2.84E-04 |
RPS7,
HOXD8,
FZD1,
EPC2,
FGF2,
FOXO3,
HOXC12,
ZBTB48,
NFIX,
FGFR3,
ZNF771,
EHMT1 |
substantia nigra development [BP],
positive regulation of phosphatidylinositol 3-kinase activity [BP],
negative regulation of transcription from RNA polymerase II promoter [BP],
transcription, DNA-dependent [BP],
negative regulation of transcription, DNA-dependent [BP],
fibroblast growth factor binding [MF],
RNA metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_14_60_2 |
 |
 |
2 |
0.2 |
3.38E-04 |
TCF7L1,
PAFAH1B1 |
astral microtubule [CC],
positive regulation of transcription from RNA polymerase II promoter during mitosis [BP],
establishment of centrosome localization [BP] |
| CG_adsipsc_promoter_p_RM_14_129_4 |
 |
 |
2 |
0.2 |
2.06E-04 |
MAP3K1,
CDC42,
KIAA1804 |
MAP kinase kinase kinase activity [MF],
regulation of filopodium assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_490_12 |
 |
 |
2 |
0.2 |
2.10E-04 |
BMP2,
BMP1,
UBE2V2 |
DNA double-strand break processing [BP],
positive regulation of cartilage development [BP] |
| CG_adsipsc_promoter_p_RM_14_165_3 |
 |
 |
3 |
0.4 |
3.94E-04 |
INHBB,
PBX3,
WNT1 |
dorsal spinal cord development [BP],
oocyte development [BP],
host cell surface receptor binding [MF],
embryonic axis specification [BP],
anterior compartment pattern formation [BP],
midbrain-hindbrain boundary maturation during brain development [BP],
negative regulation of DNA damage checkpoint [BP],
cerebellum formation [BP],
negative regulation of hepatocyte growth factor biosynthetic process [BP],
posterior compartment specification [BP] |
| CG_adsipsc_promoter_p_RM_12_157_5 |
 |
 |
2 |
0.2 |
1.67E-04 |
ADD1,
CD3E,
PTPRJ |
immunological synapse [CC],
T cell receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_12_142_7 |
 |
 |
5 |
0.6 |
3.20E-04 |
BCL2L11,
FER,
NAB2,
SMO |
otolith morphogenesis [BP],
ventral midline determination [BP],
BIM-BCL-xl complex [CC],
detection of cell density by contact stimulus involved in contact inhibition [BP],
odontogenesis of dentin-containing tooth [BP],
diapedesis [BP],
mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP],
BIM-BCL-2 complex [CC],
Fc-epsilon receptor signaling pathway [BP],
regulation of epidermis development [BP] |
| CG_adsipsc_promoter_p_RM_12_101_18 |
 |
 |
2 |
0.4 |
2.91E-04 |
DHX9,
IGF2BP1 |
CRD-mediated mRNA stabilization [BP],
CRD-mediated mRNA stability complex [CC] |
| CG_adsipsc_promoter_p_RM_14_241_17 |
 |
 |
2 |
0.2 |
3.35E-04 |
FGFR3,
SHROOM2,
SOX11 |
epithelial cell fate commitment [BP],
lens morphogenesis in camera-type eye [BP] |
| CG_adsipsc_promoter_p_RM_16_53_2 |
 |
 |
1 |
0.2 |
4.09E-04 |
SLC5A5,
ZFPM1 |
negative regulation of interleukin-4 biosynthetic process [BP],
sodium:iodide symporter activity [MF],
negative regulation of mast cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_14_230_5 |
 |
 |
3 |
0.4 |
3.61E-04 |
SIVA1,
COL9A3,
ACR,
NEO1,
CDK5R1,
COL4A2,
MYO6,
EBAG9 |
cadherin binding [MF],
neuron projection development [BP],
minus-end directed microfilament motor activity [MF],
CD27 receptor binding [MF],
acrosome matrix dispersal [BP],
axon guidance [BP],
apoptotic protease activator activity [MF],
amidase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_379_10 |
 |
 |
4 |
0.8 |
1.66E-04 |
PPP2R1A,
SPHK1,
DMRT3,
RRAGA,
TAB1,
RIPK1,
IKZF1,
ALX1,
CAV1,
ARNTL |
MAPK cascade [BP],
inactivation of MAPK activity [BP],
positive regulation of NF-kappaB transcription factor activity [BP],
regulation of transcription, DNA-dependent [BP],
protein heterodimerization activity [MF],
positive regulation of extrinsic apoptotic signaling pathway [BP],
negative regulation of JAK-STAT cascade [BP] |
| CG_adsipsc_promoter_p_RM_12_215_21 |
 |
 |
7 |
1.0 |
2.65E-04 |
GADD45G,
GADD45B |
activation of MAPKKK activity [BP] |
| CG_adsipsc_promoter_p_RM_12_392_4 |
 |
 |
2 |
0.4 |
3.21E-04 |
PDXK |
lithium ion binding [MF],
pyridoxal phosphate biosynthetic process [BP],
pyridoxal 5'-phosphate salvage [BP],
pyridoxal kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_399_22 |
 |
 |
6 |
1.0 |
3.38E-04 |
TOMM40L,
PLEKHG4,
TIRAP,
RXRA,
MIF,
EIF2AK4,
VDAC3,
RARA |
positive regulation of chemokine (C-X-C motif) ligand 2 production [BP],
retinoic acid-responsive element binding [MF],
intracellular [CC],
retinoic acid receptor activity [MF],
porin activity [MF] |
| CG_adsipsc_promoter_p_RM_14_274_15 |
 |
 |
4 |
0.4 |
2.19E-04 |
FGF2,
TCF23,
GPC1 |
muscle organ development [BP],
fibroblast growth factor binding [MF] |
| CG_adsipsc_promoter_p_RM_14_294_22 |
 |
 |
3 |
0.4 |
4.24E-04 |
IGF1R,
EPB41L5,
SIRT1,
MAP3K10 |
cellular response to transforming growth factor beta stimulus [BP],
bHLH transcription factor binding [MF],
negative regulation of protein kinase B signaling cascade [BP] |
| CG_adsipsc_promoter_p_RM_12_43_8 |
 |
 |
4 |
0.8 |
3.32E-04 |
BHLHE40,
EP300,
PLK1 |
RNA polymerase II activating transcription factor binding [MF],
regulation of protein binding [BP] |
| CG_adsipsc_promoter_p_RM_14_168_7 |
 |
 |
1 |
0.2 |
2.89E-04 |
PHF16,
OGFOD1,
HLA-A,
PLOD1,
HLA-E,
IFNAR2,
PHF15 |
MHC class I receptor activity [MF],
histone H4-K12 acetylation [BP],
L-ascorbic acid binding [MF],
MHC class I protein complex [CC],
histone H4-K5 acetylation [BP],
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP],
histone H4-K8 acetylation [BP],
type I interferon-mediated signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_68_9 |
 |
 |
4 |
0.6 |
1.36E-04 |
PDE3B,
GATA4 |
cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [MF],
lung lobe formation [BP],
cell-cell signaling [BP],
atrial septum secundum morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_61_10 |
 |
 |
2 |
0.4 |
3.31E-04 |
CTCF,
TOP1,
ABHD12B,
FAAH |
acylglycerol lipase activity [MF],
chromosome segregation [BP] |
| CG_adsipsc_promoter_p_RM_14_70_24 |
 |
 |
3 |
0.4 |
4.28E-04 |
HOXC5,
ARID2,
NOG,
UNCX,
BMI1,
RING1,
BMPR2,
FOXL1,
FOXC1,
BPTF |
lymphangiogenesis [BP],
PRC1 complex [CC],
chromatin modification [BP],
anterior/posterior pattern specification [BP],
pattern specification process [BP],
mesoderm formation [BP] |
| CG_adsipsc_promoter_p_RM_12_332_4 |
 |
 |
8 |
1.0 |
2.70E-04 |
MET,
BSND,
PKD2,
GATA4,
LDLRAP1,
WHSC1 |
basolateral plasma membrane [CC],
atrial septum secundum morphogenesis [BP],
basal plasma membrane [CC],
atrial septum primum morphogenesis [BP],
atrial septum morphogenesis [BP],
ventricular septum development [BP] |
| CG_adsipsc_promoter_p_RM_12_152_14 |
 |
 |
5 |
0.8 |
2.08E-04 |
RABEP1 |
apoptotic process [BP] |
| CG_adsipsc_promoter_p_RM_12_163_10 |
 |
 |
4 |
0.8 |
2.76E-04 |
ABT1 |
spinal cord motor neuron differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_109_11 |
 |
 |
3 |
0.4 |
2.33E-04 |
WNT9B,
ASB1 |
male genitalia development [BP] |
| CG_adsipsc_promoter_p_RM_12_139_5 |
 |
 |
2 |
0.4 |
2.12E-04 |
ATP6V0E1,
RAN,
ATP6V0B |
proton-transporting V-type ATPase, V0 domain [CC],
transferrin transport [BP],
interaction with host [BP],
chromatin [CC],
ATP hydrolysis coupled proton transport [BP] |
| CG_adsipsc_promoter_p_RM_14_389_7 |
 |
 |
4 |
0.2 |
2.71E-04 |
SH3GLB1,
RUNX2,
NR2E1,
SALL3,
GNPAT,
PLOD1 |
amygdala development [BP],
negative regulation of smoothened signaling pathway [BP],
phosphatidic acid biosynthetic process [BP],
hydroxylysine biosynthetic process [BP],
olfactory bulb development [BP],
glycerone-phosphate O-acyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_86_9 |
 |
 |
3 |
0.4 |
2.53E-04 |
PLD2,
TAB2,
GRK4,
PLK5,
MAPK14,
OPRD1,
HES1,
GRM1,
HTRA2,
HHEX |
common bile duct development [BP],
cellular response to growth factor stimulus [BP],
activation of MAPK activity [BP],
cell surface receptor signaling pathway [BP],
G-protein coupled receptor internalization [BP] |
| CG_adsipsc_promoter_p_RM_14_297_7 |
 |
 |
13 |
1.0 |
4.23E-04 |
COQ7,
EPB41L5,
FOXF1,
UBR3 |
in utero embryonic development [BP],
embryonic foregut morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_269_44 |
 |
 |
5 |
1.0 |
3.15E-04 |
CHD7,
BTAF1 |
helicase activity [MF],
genitalia development [BP],
female genitalia development [BP] |
| CG_adsipsc_promoter_p_RM_14_276_13 |
 |
 |
2 |
0.2 |
3.78E-04 |
ID2,
INSIG1,
NTMT1,
HHEX |
positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
N-terminal peptidyl-proline dimethylation [BP],
N-terminal peptidyl-serine dimethylation [BP],
hepatic duct development [BP],
N-terminal peptidyl-alanine trimethylation [BP],
embryonic organ development [BP],
negative regulation of cargo loading into COPII-coated vesicle [BP],
repressing transcription factor binding [MF],
N-terminal peptidyl-serine trimethylation [BP] |
| CG_adsipsc_promoter_p_RM_14_176_9 |
 |
 |
4 |
0.6 |
3.09E-04 |
ARIH2,
UBE2D4 |
protein K63-linked ubiquitination [BP] |
| CG_adsipsc_promoter_p_RM_14_134_11 |
 |
 |
2 |
0.2 |
2.33E-04 |
FXYD5,
CSK,
BAIAP2,
CXADR |
cell adhesion molecule binding [MF],
filopodium [CC],
proline-rich region binding [MF],
negative regulation of calcium-dependent cell-cell adhesion [BP] |
| CG_adsipsc_promoter_p_RM_12_59_22 |
 |
 |
4 |
0.8 |
2.53E-04 |
LHX2,
TSC2,
SOX11 |
protein import into nucleus [BP],
negative regulation of transcription regulatory region DNA binding [BP] |
| CG_adsipsc_promoter_p_RM_14_89_6 |
 |
 |
1 |
0.2 |
3.23E-04 |
PLCB1,
RPS6KA4,
AGRN |
G-protein coupled acetylcholine receptor signaling pathway [BP],
interleukin-1-mediated signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_14_385_9 |
 |
 |
4 |
0.2 |
3.65E-04 |
POU3F3 |
metanephric macula densa development [BP] |
| CG_adsipsc_promoter_p_RM_14_109_9 |
 |
 |
5 |
0.6 |
3.21E-04 |
KLF2,
RIPK1 |
cellular response to tumor necrosis factor [BP],
response to tumor necrosis factor [BP] |
| CG_adsipsc_promoter_p_RM_14_27_19 |
 |
 |
3 |
0.4 |
3.00E-04 |
ARHGEF16,
NDEL1,
KIF5A |
kinesin complex [CC],
activation of Cdc42 GTPase activity [BP] |
| CG_adsipsc_promoter_p_RM_12_23_13 |
 |
 |
5 |
1.0 |
2.97E-04 |
ITGB3,
FGF18,
AGAP3,
AGAP1 |
ARF GTPase activator activity [MF],
positive regulation of vascular endothelial growth factor receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_14_46_7 |
 |
 |
2 |
0.2 |
2.75E-04 |
LHX2,
TRIM71,
PAX2,
ADORA2A |
regulation of norepinephrine secretion [BP],
negative regulation of alpha-beta T cell activation [BP],
neural tube closure [BP] |
| CG_adsipsc_promoter_p_RM_12_429_22 |
 |
 |
4 |
0.6 |
3.48E-04 |
DOCK1,
ITGA6,
CTNNB1,
PLCG1,
NCLN,
SOX14,
NTRK2,
FGF2,
DRAXIN,
RAP2A,
FGFR3,
HEY2,
PBX3,
TCAP,
CD274,
ID1,
ARHGAP33,
HUNK,
PPDPF,
PTPRM,
PAK2,
FOXP4 |
positive regulation of phosphorylation [BP],
substantia nigra development [BP],
MAPK cascade [BP],
regulation of angiogenesis [BP],
neuron projection development [BP],
cellular protein localization [BP],
regulation of signal transduction [BP],
cardiac muscle hypertrophy in response to stress [BP],
forebrain development [BP],
neuron differentiation [BP],
signal transduction [BP],
negative regulation of transcription by transcription factor localization [BP],
neuron development [BP],
pattern specification process [BP],
regulation of MAPK cascade [BP],
cell differentiation [BP],
nervous system development [BP] |
| CG_adsipsc_promoter_p_RM_14_183_13 |
 |
 |
2 |
0.2 |
3.35E-04 |
HOXD8,
SOX11,
MLLT10,
PBX3,
SLC2A4RG,
WNT5B,
GATA4,
LMX1B,
PKNOX1,
TAF5 |
RNA polymerase II transcription factor binding transcription factor activity [MF],
nucleic acid binding transcription factor activity [MF],
embryonic digestive tract morphogenesis [BP],
anterior/posterior pattern specification [BP],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_459_17 |
 |
 |
2 |
0.4 |
2.48E-04 |
UNG |
somatic recombination of immunoglobulin gene segments [BP] |
| CG_adsipsc_promoter_p_RM_16_39_2 |
 |
 |
3 |
0.4 |
4.42E-04 |
BASP1,
TALDO1,
TAS1R3 |
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF],
positive regulation of metanephric ureteric bud development [BP],
thorax and anterior abdomen determination [BP],
detection of chemical stimulus involved in sensory perception of sweet taste [BP],
xylulose biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_14_85_2 |
 |
 |
1 |
0.2 |
2.75E-04 |
COL14A1,
PLP1,
HES1 |
N-box binding [MF],
negative regulation of stomach neuroendocrine cell differentiation [BP],
negative regulation of pancreatic A cell differentiation [BP],
lateral inhibition [BP],
cell morphogenesis involved in neuron differentiation [BP],
cell maturation [BP],
collagen type XIV [CC],
positive regulation of mitotic cell cycle, embryonic [BP] |
| CG_adsipsc_promoter_p_RM_16_40_5 |
 |
 |
2 |
0.2 |
3.82E-04 |
CMPK1,
EGR1,
SRD5A3 |
positive regulation of glomerular metanephric mesangial cell proliferation [BP],
dCDP biosynthetic process [BP],
CDP biosynthetic process [BP],
polyprenol catabolic process [BP],
UDP biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_170_19 |
 |
 |
4 |
0.6 |
2.49E-04 |
TTC3,
UBE2D4 |
protein K48-linked ubiquitination [BP] |
| CG_adsipsc_promoter_p_RM_14_125_10 |
 |
 |
2 |
0.2 |
3.34E-04 |
MIF,
GSN,
PML |
aging [BP],
cell aging [BP] |
| CG_adsipsc_promoter_p_RM_16_50_3 |
 |
 |
2 |
0.4 |
3.82E-04 |
SLC6A8,
CCNY,
PKD2 |
metanephric cortex development [BP],
creatine transport [BP],
creatine:sodium symporter activity [MF],
creatine transmembrane transporter activity [MF],
positive regulation of cyclin-dependent protein kinase activity [BP],
polycystin complex [CC],
cytoplasmic cyclin-dependent protein kinase holoenzyme complex [CC],
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP],
renal artery morphogenesis [BP],
metanephric cortical collecting duct development [BP],
basal cortex [CC] |
| CG_adsipsc_promoter_p_RM_12_121_21 |
 |
 |
2 |
0.4 |
2.58E-04 |
ZDHHC14 |
transferase activity, transferring acyl groups [MF] |
| CG_adsipsc_promoter_p_RM_12_232_12 |
 |
 |
3 |
0.4 |
3.19E-04 |
PI4K2A,
ST3GAL3 |
N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF],
host cell presynaptic membrane [CC],
basophil degranulation [BP],
AP-3 adaptor complex binding [MF] |
| CG_adsipsc_promoter_p_RM_16_15_5 |
 |
 |
2 |
0.2 |
6.28E-04 |
MLL,
ADHFE1 |
molecular hydrogen transport [BP],
positive regulation of cellular response to drug [BP],
hydroxyacid-oxoacid transhydrogenase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_365_5 |
 |
 |
2 |
0.2 |
4.50E-04 |
PTPN6,
B3GNT5 |
beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [MF],
negative regulation of peptidyl-tyrosine phosphorylation [BP],
lipopolysaccharide N-acetylglucosaminyltransferase activity [MF],
lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_267_22 |
 |
 |
7 |
1.0 |
3.49E-04 |
KIF19 |
plus-end specific microtubule depolymerization [BP],
axonemal microtubule depolymerization [BP] |
| CG_adsipsc_promoter_p_RM_14_83_3 |
 |
 |
2 |
0.2 |
1.60E-04 |
CREBRF,
NR1D2,
PBX3,
LMX1B,
PCYOX1 |
sequence-specific DNA binding [MF],
chloride-transporting ATPase activity [MF],
prenylcysteine oxidase activity [MF],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_20_8_2 |
 |
 |
1 |
0.2 |
8.16E-04 |
PCDHA11,
PCDHA12,
PCDHA13,
PCDHA7,
PCDHA10 |
homophilic cell adhesion [BP],
calcium ion binding [MF],
cell adhesion [BP] |
| CG_adsipsc_promoter_p_RM_12_49_11 |
 |
 |
6 |
1.0 |
3.52E-04 |
PKIA,
PKIG |
cAMP-dependent protein kinase inhibitor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_42_5 |
 |
 |
2 |
0.4 |
3.57E-04 |
TAF8,
MORC3 |
maintenance of protein location in nucleus [BP] |
| CG_adsipsc_promoter_p_RM_14_298_31 |
 |
 |
13 |
1.0 |
4.74E-04 |
CPE,
ATF7IP,
MOCS3,
TNRC6A,
CAPNS1,
PRPF3,
LEMD3,
AXL,
CERS6,
RPF2,
MAP3K1,
SPOPL,
NTRK2,
RING1,
KDM2A,
ZIC2,
MTMR3,
CUL1,
MED15,
IGF1R,
RAB5A,
COG3,
SP2,
SLC25A5,
SERPINB8,
URI1,
PCGF5,
ARID1A,
AKAP9,
CNOT6,
CCNF,
EID3,
ATMIN,
GATAD1,
CTCF,
NRSN1,
COPS4,
YTHDF3,
SLAIN2,
UHRF1BP1,
EP400,
DNM3,
SEPT7,
KLHDC2,
SDHAF2,
UBAP2L,
MST4,
USP47,
EN2,
CDK5R1,
ZIC1,
B4GALT7,
SIRT1,
TSPYL2,
UNC5B,
ARPC2,
UBE2E1,
HOXC12,
ZMIZ1,
ING2,
SUPT6H,
CAMSAP2,
PSMD11,
CDC14A,
ERCC6L2,
POLE4,
IPO9,
AGO4,
CLK3,
GGNBP2,
YY1,
RFC5,
SMAD1,
SDCBP,
RCOR1,
ZNF839,
FZD1,
NOTCH2NL,
BMP2K,
DUSP9,
ARNT2,
MATN2,
FBXO45,
TRIO,
POMP,
GSG2,
RABEPK,
GMEB1,
NOL3,
MAPK8IP3,
TACC3,
LMO4,
MEGF8,
WTIP,
ANTXR1,
PTK7,
BIRC7,
DIP2B,
BMPR1B,
CNTNAP2,
BMPER,
AEBP2,
SMARCA4,
DMBX1,
UBQLN2,
PXK,
GAL,
SLIT2,
GLI4,
CABLES1,
MTA1,
GREM1,
PIM1,
HOOK3,
NR4A1,
ONECUT3,
CASC3,
POU4F2,
RTF1,
SUV420H2,
TAB2,
RNF169,
TLX1,
SAE1,
C1orf94,
KAT6B,
HSF1 |
brain development [BP],
retinal ganglion cell axon guidance [BP],
nuclear chromatin [CC],
gene silencing by miRNA [BP],
nuclear speck [CC],
multicellular organismal development [BP],
nervous system development [BP],
chromatin modification [BP],
sequence-specific DNA binding transcription factor activity [MF],
chromosome organization [BP],
nucleus [CC],
neurogenesis [BP],
protein binding [MF],
axonogenesis [BP],
micro-ribonucleoprotein complex [CC],
PcG protein complex [CC],
chromosome [CC],
BMP signaling pathway [BP],
central nervous system development [BP],
cell morphogenesis [BP],
cerebral cortex development [BP],
negative regulation of monocyte chemotaxis [BP],
chromatin binding [MF],
negative regulation of gene expression [BP],
substrate adhesion-dependent cell spreading [BP],
neuron development [BP],
negative regulation of BMP signaling pathway [BP],
protein complex [CC],
intracellular [CC],
regulation of gene expression, epigenetic [BP],
neuron projection development [BP],
transcription corepressor activity [MF],
cellular protein modification process [BP],
sequence-specific DNA binding [MF],
nucleoplasm [CC],
regulation of gene expression [BP],
cytoplasmic microtubule organization [BP],
intracellular membrane-bounded organelle [CC] |
| CG_adsipsc_promoter_p_RM_16_38_13 |
 |
 |
5 |
0.6 |
4.11E-04 |
TEAD1,
JUNB,
TRIM28,
GTF2I,
NR4A3 |
transcription initiation from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_14_106_5 |
 |
 |
5 |
0.8 |
3.59E-04 |
FOXK1,
WNT1,
MSX1,
WEE1,
ID4,
PDXK |
muscle organ development [BP],
midbrain development [BP],
negative regulation of fat cell differentiation [BP],
anterior/posterior pattern specification [BP],
pyridoxal 5'-phosphate salvage [BP],
magnesium ion binding [MF],
embryonic axis specification [BP],
midbrain-hindbrain boundary maturation during brain development [BP],
negative regulation of DNA damage checkpoint [BP],
cerebellum formation [BP],
pyridoxal phosphate biosynthetic process [BP],
pattern specification process [BP] |
| CG_adsipsc_promoter_p_RM_14_81_4 |
 |
 |
1 |
0.2 |
4.93E-04 |
ATP2C1,
KLF2,
CSK,
GPX4,
ADPRHL2 |
manganese-transporting ATPase activity [MF],
cellular manganese ion homeostasis [BP],
Golgi calcium ion homeostasis [BP],
Golgi calcium ion transport [BP],
phospholipid-hydroperoxide glutathione peroxidase activity [MF],
negative regulation of interleukin-6 production [BP],
poly(ADP-ribose) glycohydrolase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_102_6 |
 |
 |
3 |
0.4 |
2.12E-04 |
DPYSL2,
EGR1 |
response to amphetamine [BP] |
| CG_adsipsc_promoter_p_RM_14_49_9 |
 |
 |
3 |
0.4 |
4.28E-04 |
ATP2A2,
AANAT |
calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF],
aralkylamine N-acetyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_217_22 |
 |
 |
4 |
0.6 |
2.93E-04 |
CACNG7,
NLGN1,
NRG3 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity [BP],
intracellular protein kinase cascade [BP] |
| CG_adsipsc_promoter_p_RM_14_44_13 |
 |
 |
4 |
0.4 |
3.32E-04 |
ONECUT3,
PTF1A,
HOXC5,
EMX1,
JPH3,
VENTX,
FOXC1,
LHX4 |
sequence-specific DNA binding [MF],
calcium-release channel activity [MF] |
| CG_adsipsc_promoter_p_RM_12_460_9 |
 |
 |
3 |
0.6 |
2.23E-04 |
DACT1 |
regulation of Wnt receptor signaling pathway, planar cell polarity pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_279_7 |
 |
 |
4 |
0.6 |
1.25E-04 |
SDHAF1,
CLIC4,
HLX,
PDIA3,
LAP3,
NEURL,
PRKCE,
USP13,
IQCE,
SFXN1,
ARMC10,
TPGS1,
SLC25A10,
SEMA4B,
IREB2,
IDH3A |
positive regulation of organ growth [BP],
cysteine-type endopeptidase activity [MF],
sperm axoneme assembly [BP],
cell differentiation [BP],
mitochondrion [CC] |
| CG_adsipsc_promoter_p_RM_12_370_6 |
 |
 |
4 |
0.6 |
1.85E-04 |
LYN,
NKD2,
HGS,
TRIB2,
IL1R1 |
platelet-derived growth factor receptor binding [MF],
positive regulation of oligodendrocyte progenitor proliferation [BP],
alpha2-beta1 integrin complex [CC],
ubiquitin protein ligase binding [MF],
positive regulation of dendritic cell apoptotic process [BP],
negative regulation of mast cell proliferation [BP],
negative regulation of interleukin-10 biosynthetic process [BP],
positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
regulation of protein catabolic process [BP] |
| CG_adsipsc_promoter_p_RM_12_3_8 |
 |
 |
2 |
0.2 |
1.90E-04 |
SNED1,
PLCB3,
AGRN |
positive regulation of synaptic growth at neuromuscular junction [BP],
calcium ion binding [MF],
chondroitin sulfate binding [MF] |
| CG_adsipsc_promoter_p_RM_12_398_41 |
 |
 |
5 |
1.0 |
1.15E-04 |
MAP2K1 |
receptor signaling protein tyrosine phosphatase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_353_20 |
 |
 |
9 |
1.0 |
3.48E-04 |
WASF3,
FGD2,
PALM,
LIMD1,
NCMAP,
MYH14 |
regulation of cell shape [BP],
positive regulation of myelination [BP] |
| CG_adsipsc_promoter_p_RM_14_299_10 |
 |
 |
3 |
0.4 |
5.02E-04 |
ACVR2B,
DMBX1,
FOXP4,
DR1,
ARID2,
SOX12,
ZNF710,
IGF1R,
EN2,
ZNF696,
HABP4,
STAT5A,
ZIC2,
PKNOX2,
FOSL2,
TMEM57,
EP300,
SUV420H2,
FOXO3 |
regulation of transcription, DNA-dependent [BP],
prostate gland epithelium morphogenesis [BP],
central nervous system development [BP],
sequence-specific DNA binding [MF],
brain development [BP],
regulation of transcription from RNA polymerase II promoter [BP],
embryonic foregut morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_259_7 |
 |
 |
2 |
0.4 |
3.19E-04 |
ASPSCR1,
FOXO3 |
pattern specification process [BP],
glucose homeostasis [BP] |
| CG_adsipsc_promoter_p_RM_12_188_11 |
 |
 |
4 |
0.8 |
2.39E-04 |
SMARCA5,
TTLL3,
RNF111,
SKIL |
protein-glycine ligase activity [MF],
protein polyglycylation [BP],
protein-glycine ligase activity, initiating [MF],
SMAD binding [MF],
DNA-dependent transcription, initiation [BP] |
| CG_adsipsc_promoter_p_RM_12_361_12 |
 |
 |
2 |
0.4 |
2.06E-04 |
MPST,
MOCS3 |
thiosulfate sulfurtransferase activity [MF],
sulfurtransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_213_3 |
 |
 |
2 |
0.2 |
2.40E-04 |
PTPN11,
IST1 |
negative regulation of growth hormone secretion [BP],
virus budding from nuclear membrane by viral capsid re-envelopment [BP],
negative regulation of cortisol secretion [BP] |
| CG_adsipsc_promoter_p_RM_12_455_14 |
 |
 |
4 |
0.6 |
2.73E-04 |
MLLT10,
POU4F2,
ADAP2,
HES1,
ARNTL2,
GATA3,
YAP1,
HHEX |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity [MF],
transcription regulatory region DNA binding [MF],
otic vesicle development [BP],
embryonic organ development [BP],
pharyngeal system development [BP],
positive regulation of transcription from RNA polymerase II promoter [BP],
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF],
embryonic heart tube development [BP],
common bile duct development [BP],
heart development [BP],
HMG box domain binding [MF] |
| CG_adsipsc_promoter_p_RM_14_100_6 |
 |
 |
3 |
0.2 |
4.21E-04 |
RNASE2,
RNASE3 |
lysosome [CC],
pancreatic ribonuclease activity [MF] |
| CG_adsipsc_promoter_p_RM_12_426_10 |
 |
 |
2 |
0.4 |
1.20E-04 |
TFAP2C,
PDPK1 |
3-phosphoinositide-dependent protein kinase activity [MF],
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_183_14 |
 |
 |
3 |
0.4 |
2.96E-04 |
IKZF1,
IGF1R |
positive regulation of neutrophil differentiation [BP],
inactivation of MAPKK activity [BP] |
| CG_adsipsc_promoter_p_RM_16_31_2 |
 |
 |
1 |
0.2 |
4.01E-04 |
ZNF440,
ZNF441,
ZNF844,
ZNF267,
HIST1H2BN,
HIST1H2BO,
ZNF136,
ZNF720 |
nucleosome [CC],
nucleic acid binding [MF],
DNA binding [MF] |
| CG_adsipsc_promoter_p_RM_16_11_8 |
 |
 |
9 |
0.8 |
2.17E-04 |
ILK,
KHDRBS3,
SYNGAP1,
SETD1B,
P2RX2,
SLC27A1,
RBM38,
SKI |
protein domain specific binding [MF],
dendritic shaft [CC],
skeletal muscle fiber development [BP],
nucleotide binding [MF],
regulation of action potential in neuron [BP],
SH3 domain binding [MF] |
| CG_adsipsc_promoter_p_RM_12_198_20 |
 |
 |
8 |
1.0 |
6.33E-05 |
NKD1,
CD46,
NT5M,
AMOTL1 |
establishment of cell polarity involved in ameboidal cell migration [BP],
positive regulation of non-canonical Wnt receptor signaling pathway via JNK cascade [BP],
inner acrosomal membrane [CC],
negative regulation of convergent extension involved in axis elongation [BP],
dUMP catabolic process [BP],
regulation of cell motility involved in somitogenic axis elongation [BP] |
| CG_adsipsc_promoter_p_RM_16_36_6 |
 |
 |
3 |
0.6 |
2.64E-04 |
PDXK,
HMGA1,
CD4 |
induction by virus of host cell-cell fusion [BP],
pyridoxal 5'-phosphate salvage [BP],
lithium ion binding [MF],
pyridoxal kinase activity [MF],
pyridoxal phosphate biosynthetic process [BP],
oncogene-induced senescence [BP],
protein palmitoleylation [BP] |
| CG_adsipsc_promoter_p_RM_12_141_11 |
 |
 |
6 |
1.0 |
3.25E-04 |
RIMKLB,
RNF2,
RING1,
GTPBP1 |
histone H2A monoubiquitination [BP],
acid-amino acid ligase activity [MF],
sex chromatin [CC],
cytoplasmic exosome (RNase complex) [CC],
PRC1 complex [CC] |
| CG_adsipsc_promoter_p_RM_14_320_7 |
 |
 |
4 |
0.6 |
3.51E-04 |
TGFBR1,
ATP7A,
SLC25A27,
FOXL1,
CYR61 |
extracellular structure organization [BP],
positive regulation of cell proliferation [BP],
blood vessel development [BP],
cartilage development [BP],
extracellular matrix organization [BP],
collagen fibril organization [BP],
skeletal system development [BP] |
| CG_adsipsc_promoter_p_RM_12_293_3 |
 |
 |
1 |
0.2 |
7.10E-05 |
INPP5F,
SIRT1 |
negative regulation of cAMP-dependent protein kinase activity [BP],
negative regulation of prostaglandin biosynthetic process [BP],
phosphatidylinositol catabolic process [BP],
negative regulation of cellular response to testosterone stimulus [BP],
establishment of chromatin silencing [BP] |
| CG_adsipsc_promoter_p_RM_16_30_6 |
 |
 |
1 |
0.2 |
4.59E-04 |
TBC1D25,
RBM4 |
IRES-dependent translational initiation [BP],
cap-independent translational initiation [BP],
circadian regulation of translation [BP],
regulation of autophagic vacuole maturation [BP] |
| CG_adsipsc_promoter_p_RM_14_11_12 |
 |
 |
8 |
1.0 |
4.11E-04 |
LHX2,
NPAS2,
TLX1,
SIX3,
NR2C2,
VENTX,
ZIC3,
ZNF131,
NFKB1,
LMX1B,
UBN1,
PRPF6,
ARID3A |
nucleic acid binding transcription factor activity [MF],
positive regulation of transcription from RNA polymerase II promoter [BP],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_230_15 |
 |
 |
4 |
0.6 |
3.24E-04 |
ACSL3,
CTNNB1,
RDH10,
GATA4,
CRHR1,
CTCF,
SLC27A2,
FZD1 |
primary lung bud formation [BP],
long-chain fatty acid import [BP],
gonad development [BP],
regulation of centromeric sister chromatid cohesion [BP],
apical part of cell [CC],
long-chain fatty acid-CoA ligase activity [MF],
genitalia morphogenesis [BP],
embryonic foregut morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_110_15 |
 |
 |
5 |
1.0 |
3.16E-04 |
ATP9B |
establishment of protein localization to Golgi [BP] |
| CG_adsipsc_promoter_p_RM_12_194_10 |
 |
 |
2 |
0.4 |
3.59E-04 |
BMP2,
EIF5A,
EEFSEC |
cardiac epithelial to mesenchymal transition [BP],
translation elongation factor activity [MF],
endocardial cushion morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_322_8 |
 |
 |
1 |
0.2 |
5.19E-04 |
NT5M,
DUT |
pyrimidine nucleobase metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_20_16_1 |
 |
 |
1 |
0.2 |
5.49E-04 |
HIST1H2AH,
HIST1H2AC,
HIST2H4B |
nucleosome assembly [BP],
chromatin organization [BP],
negative regulation of megakaryocyte differentiation [BP],
nucleosome [CC],
protein heterodimerization activity [MF] |
| CG_adsipsc_promoter_p_RM_14_355_13 |
 |
 |
6 |
0.6 |
2.61E-04 |
KNSTRN,
CDC42,
KLHL10 |
regulation of attachment of spindle microtubules to kinetochore [BP],
mitotic spindle [CC],
cell morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_324_7 |
 |
 |
3 |
0.4 |
1.07E-04 |
WWC1 |
positive regulation of MAPK cascade [BP] |
| CG_adsipsc_promoter_p_RM_14_413_9 |
 |
 |
2 |
0.4 |
3.05E-04 |
INHBB,
ATP6AP2,
PDE8B,
ID1,
MET |
hepatocyte growth factor-activated receptor activity [MF],
positive regulation of glucose transport [BP],
negative regulation of insulin secretion [BP],
host cell surface receptor binding [MF],
regulation of MAPK cascade [BP] |
| CG_adsipsc_promoter_p_RM_14_145_8 |
 |
 |
1 |
0.2 |
2.92E-04 |
SDHAF1 |
mitochondrial respiratory chain complex II assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_358_17 |
 |
 |
2 |
0.4 |
2.80E-04 |
TBL1X,
DRD4,
TIPARP,
DVL3,
TBX1,
AATF,
ABLIM3,
ATF4,
SQSTM1 |
face morphogenesis [BP],
positive regulation of transcription, DNA-dependent [BP],
cochlea morphogenesis [BP],
social behavior [BP],
positive regulation of transcription from RNA polymerase II promoter [BP],
positive regulation of protein phosphorylation [BP],
outflow tract septum morphogenesis [BP],
positive regulation of kinase activity [BP] |
| CG_adsipsc_promoter_p_RM_14_341_6 |
 |
 |
2 |
0.2 |
2.51E-04 |
STAG3,
SYCE1L,
FES,
SLAIN2 |
synaptonemal complex assembly [BP],
positive regulation of microtubule polymerization [BP] |
| CG_adsipsc_promoter_p_RM_14_202_6 |
 |
 |
1 |
0.2 |
1.27E-04 |
ARFGEF2,
FNTB,
ACSF3 |
symmetric synapse [CC],
malonate catabolic process [BP],
protein farnesyltransferase complex [CC],
malonyl-CoA synthetase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_411_7 |
 |
 |
2 |
0.2 |
3.46E-04 |
YY1 |
RNA localization [BP] |
| CG_adsipsc_promoter_p_RM_16_34_3 |
 |
 |
1 |
0.2 |
2.64E-04 |
IGF1R |
regulation of JNK cascade [BP],
inactivation of MAPKK activity [BP] |
| CG_adsipsc_promoter_p_RM_14_147_4 |
 |
 |
2 |
0.2 |
2.35E-04 |
CARM1,
RPIA |
histone H3-R17 methylation [BP],
histone methyltransferase activity (H3-R17 specific) [MF],
ribose-5-phosphate isomerase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_326_5 |
 |
 |
1 |
0.2 |
2.38E-04 |
CDT1,
CDC45 |
regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
DNA replication checkpoint [BP],
DNA replication initiation [BP] |
| CG_adsipsc_promoter_p_RM_12_257_9 |
 |
 |
6 |
1.0 |
3.01E-04 |
PARK7,
CAPN10,
CAPN7 |
calcium-dependent cysteine-type endopeptidase activity [MF],
membrane hyperpolarization [BP] |
| CG_adsipsc_promoter_p_RM_14_307_9 |
 |
 |
3 |
0.4 |
2.19E-04 |
FLAD1,
TGFBR2 |
positive regulation of tolerance induction to self antigen [BP],
bronchus morphogenesis [BP],
FAD biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_14_124_8 |
 |
 |
3 |
0.2 |
3.04E-04 |
FSTL3,
CTNNB1 |
negative regulation of osteoclast differentiation [BP] |
| CG_adsipsc_promoter_p_RM_16_13_3 |
 |
 |
2 |
0.2 |
3.02E-04 |
SETMAR,
NAT8L |
positive regulation of double-strand break repair via nonhomologous end joining [BP],
aspartate N-acetyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_147_18 |
 |
 |
5 |
0.8 |
2.18E-04 |
EDNRA,
TSC2,
EPAS1,
LEP |
response to hypoxia [BP] |
| CG_adsipsc_promoter_p_RM_14_347_2 |
 |
 |
1 |
0.2 |
2.33E-04 |
NIPBL |
positive regulation of ossification [BP] |
| CG_adsipsc_promoter_p_RM_12_5_2 |
 |
 |
4 |
0.6 |
2.08E-04 |
CHP1,
ATAD3A,
ENGASE,
DNAJA3 |
protein stabilization [BP],
mitochondrial nucleoid [CC],
membrane docking [BP],
mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [MF],
negative regulation of NF-kappaB transcription factor activity [BP] |
| CG_adsipsc_promoter_p_RM_12_464_14 |
 |
 |
4 |
0.6 |
2.59E-04 |
ALPPL2,
ALPP |
alkaline phosphatase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_62_8 |
 |
 |
2 |
0.4 |
2.32E-04 |
FANCD2,
YAP1,
DCPS |
response to gamma radiation [BP],
negative regulation of programmed cell death [BP],
regulation of keratinocyte proliferation [BP] |
| CG_adsipsc_promoter_p_RM_14_345_2 |
 |
 |
7 |
0.8 |
8.66E-05 |
IDNK,
PRKCB |
histone H3-T6 phosphorylation [BP],
D-gluconate catabolic process [BP],
gluconokinase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_35_10 |
 |
 |
4 |
0.8 |
4.31E-04 |
PCSK9,
BMP2,
THRA,
SLC6A2 |
positive regulation of Wnt receptor signaling pathway by BMP signaling pathway [BP],
neuron differentiation [BP],
regulation of thyroid hormone mediated signaling pathway [BP],
norepinephrine:sodium symporter activity [MF],
steroid receptor RNA activator RNA binding [MF] |
| CG_adsipsc_promoter_p_RM_14_290_10 |
 |
 |
2 |
0.2 |
3.51E-04 |
ARID1A |
nucleosome mobilization [BP] |
| CG_adsipsc_promoter_p_RM_12_222_15 |
 |
 |
3 |
0.6 |
3.02E-04 |
VIL1 |
positive regulation of actin filament bundle assembly [BP] |
| CG_adsipsc_promoter_p_RM_14_2_6 |
 |
 |
3 |
0.4 |
4.28E-04 |
VEGFA,
PPCDC |
basophil chemotaxis [BP],
phosphopantothenoylcysteine decarboxylase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_253_8 |
 |
 |
6 |
1.0 |
2.58E-04 |
SQSTM1,
VPS16,
HOXD10,
FOXL1,
HOXC10 |
forelimb morphogenesis [BP],
late endosome [CC],
spinal cord motor neuron cell fate specification [BP],
proximal/distal pattern formation [BP] |
| CG_adsipsc_promoter_p_RM_14_61_9 |
 |
 |
1 |
0.2 |
3.29E-04 |
ASL,
PRKCE |
TRAM-dependent toll-like receptor 4 signaling pathway [BP],
positive regulation of cellular glucuronidation [BP],
arginine biosynthetic process via ornithine [BP],
argininosuccinate lyase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_171_28 |
 |
 |
4 |
0.8 |
3.12E-04 |
NOG,
EGFR,
NR2E1,
IL11RA |
negative regulation of astrocyte differentiation [BP],
head development [BP],
olfactory bulb development [BP],
cerebral cortex cell migration [BP],
morphogenesis of an epithelial fold [BP] |
| CG_adsipsc_promoter_p_RM_12_227_13 |
 |
 |
4 |
0.6 |
2.02E-04 |
CEBPG,
TRIM28,
NFKB1,
FOXL1,
AHR |
positive regulation of DNA repair [BP],
sequence-specific DNA binding [MF],
cartilage development [BP],
double-stranded DNA binding [MF],
regulation of Wnt receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_66_7 |
 |
 |
1 |
0.2 |
2.69E-04 |
MAP2K1 |
receptor signaling protein tyrosine phosphatase activity [MF],
activation of MAPK activity [BP],
regulation of stress-activated MAPK cascade [BP] |
| CG_adsipsc_promoter_p_RM_12_132_9 |
 |
 |
3 |
0.6 |
2.81E-04 |
SOX17,
DACT1,
TPM1,
CDC73,
SHROOM2 |
beta-catenin binding [MF],
filamentous actin [CC],
negative regulation of G1/S transition of mitotic cell cycle [BP],
endodermal cell fate commitment [BP],
protein destabilization [BP] |
| CG_adsipsc_promoter_p_RM_14_260_5 |
 |
 |
1 |
0.2 |
2.47E-04 |
FLVCR1 |
head morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_116_6 |
 |
 |
2 |
0.2 |
1.99E-04 |
MDK |
defecation [BP] |
| CG_adsipsc_promoter_p_RM_12_143_15 |
 |
 |
5 |
0.8 |
1.72E-04 |
PBX3 |
anterior compartment pattern formation [BP],
posterior compartment specification [BP] |
| CG_adsipsc_promoter_p_RM_12_225_15 |
 |
 |
4 |
0.6 |
2.94E-04 |
RCC1,
FZD3,
ESRRA,
FOXE1,
WNT1,
STK11,
OTX1,
CTHRC1,
LMNB1,
CCRN4L,
PSMD14,
APCDD1,
GATA4,
ZNF473,
HIF3A |
midbrain development [BP],
Wnt receptor signaling pathway [BP],
Wnt-protein binding [MF],
inner ear morphogenesis [BP],
nucleoplasm [CC],
embryonic organ morphogenesis [BP],
canonical Wnt receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_285_17 |
 |
 |
4 |
0.4 |
2.38E-04 |
PAK2 |
protein tyrosine kinase activator activity [MF] |
| CG_adsipsc_promoter_p_RM_12_24_6 |
 |
 |
4 |
0.8 |
2.96E-04 |
PTK2B,
ROMO1,
IQGAP1,
GNAO1 |
positive regulation of reactive oxygen species metabolic process [BP],
positive regulation of GTPase activity [BP] |
| CG_adsipsc_promoter_p_RM_16_54_9 |
 |
 |
3 |
0.4 |
2.03E-04 |
PDXK,
EGR1,
COMT,
CMPK1 |
lithium ion binding [MF],
pyridoxal 5'-phosphate salvage [BP],
CDP biosynthetic process [BP],
positive regulation of homocysteine metabolic process [BP],
positive regulation of glomerular metanephric mesangial cell proliferation [BP],
pyridoxal kinase activity [MF],
pyridoxal phosphate biosynthetic process [BP],
dCDP biosynthetic process [BP],
UDP biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_14_209_4 |
 |
 |
2 |
0.2 |
2.74E-04 |
RASD2 |
regulation of cAMP-mediated signaling [BP] |
| CG_adsipsc_promoter_p_RM_18_13_1 |
 |
 |
2 |
0.4 |
7.10E-04 |
HIST1H2AC,
HIST1H2AH |
nucleosome assembly [BP],
nucleosome [CC],
protein heterodimerization activity [MF] |
| CG_adsipsc_promoter_p_RM_14_328_8 |
 |
 |
2 |
0.2 |
3.27E-04 |
TTC19,
SGPP2,
EPHX1 |
cis-stilbene-oxide hydrolase activity [MF],
mitochondrial respiratory chain complex III assembly [BP],
sphingosine-1-phosphate phosphatase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_79_11 |
 |
 |
3 |
0.4 |
3.13E-04 |
HNRNPM,
YEATS4,
UHRF1,
PKN1 |
nuclear matrix [CC],
hyperosmotic response [BP] |
| CG_adsipsc_promoter_p_RM_14_6_4 |
 |
 |
2 |
0.2 |
3.65E-04 |
PKD2,
RBM24,
MOG,
RBM38,
MOCS3 |
regulation of myotube differentiation [BP],
metanephric cortex development [BP],
positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP],
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP],
enzyme active site formation via L-cysteine persulfide [BP],
renal artery morphogenesis [BP],
regulation of mRNA stability [BP],
metanephric cortical collecting duct development [BP],
mRNA 3'-UTR binding [MF] |
| CG_adsipsc_promoter_p_RM_12_491_8 |
 |
 |
3 |
0.4 |
3.88E-04 |
ZRANB1,
SQSTM1 |
K63-linked polyubiquitin binding [MF] |
| CG_adsipsc_promoter_p_RM_12_424_9 |
 |
 |
8 |
1.0 |
2.78E-04 |
LFNG,
KAT2B,
ITCH,
CPLX3 |
compartment pattern specification [BP],
neurotransmitter transporter activity [MF],
Notch signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_136_9 |
 |
 |
2 |
0.4 |
2.08E-04 |
JMY,
AGRN |
'de novo' actin filament nucleation [BP],
positive regulation of synaptic growth at neuromuscular junction [BP] |
| CG_adsipsc_promoter_p_RM_16_52_6 |
 |
 |
2 |
0.2 |
3.36E-04 |
HES3,
GDF7,
OPRL1,
MGAT2 |
midbrain development [BP],
roof plate formation [BP],
nociceptin receptor activity [MF],
alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF],
positive regulation of tendon cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_473_19 |
 |
 |
3 |
0.4 |
3.32E-04 |
PTH1R,
LHX2,
SREBF2,
MSL3,
TFAP2E,
IRF9,
TSHZ1,
PIK3CD,
HOXD1,
NR2F2,
CUL4A,
STAT5A,
FOSL2,
PRRX2,
SMAD6,
KLF13 |
positive regulation of inositol phosphate biosynthetic process [BP],
negative regulation of erythrocyte differentiation [BP],
adenylate cyclase-modulating G-protein coupled receptor signaling pathway [BP],
sequence-specific DNA binding transcription factor activity [MF],
mast cell differentiation [BP],
transcription from RNA polymerase II promoter [BP],
positive regulation of S phase of mitotic cell cycle [BP] |
| CG_adsipsc_promoter_p_RM_14_238_13 |
 |
 |
3 |
0.4 |
4.18E-04 |
RAB7A,
PAX2,
HOOK3 |
centriolar satellite [CC],
early endosome to late endosome transport [BP] |
| CG_adsipsc_promoter_p_RM_12_367_13 |
 |
 |
5 |
1.0 |
3.07E-04 |
MSX2,
RUNX2 |
osteoblast development [BP],
chondrocyte development [BP] |
| CG_adsipsc_promoter_p_RM_14_169_2 |
 |
 |
2 |
0.2 |
4.64E-04 |
KLF2,
ACVR1B,
LMX1B |
in utero embryonic development [BP] |
| CG_adsipsc_promoter_p_RM_12_442_16 |
 |
 |
6 |
1.0 |
1.92E-04 |
EYA4,
HES3,
SMAD1,
TBX1 |
midbrain development [BP],
middle ear morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_18_11_1 |
 |
 |
3 |
0.4 |
8.42E-04 |
COASY,
IGF1R |
inactivation of MAPKK activity [BP],
dephospho-CoA kinase activity [MF],
pantetheine-phosphate adenylyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_482_13 |
 |
 |
7 |
0.8 |
3.43E-04 |
ESPN,
TGFBR1 |
positive regulation of filopodium assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_70_12 |
 |
 |
3 |
0.6 |
6.66E-05 |
SOCS2,
PKD2 |
metanephric smooth muscle tissue development [BP],
detection of nodal flow [BP],
metanephric cortex development [BP],
polycystin complex [CC],
JAK pathway signal transduction adaptor activity [MF],
cellular response to hydrostatic pressure [BP],
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP],
calcium-induced calcium release activity [MF],
renal artery morphogenesis [BP],
metanephric cortical collecting duct development [BP],
JAK-STAT cascade [BP],
basal cortex [CC] |
| CG_adsipsc_promoter_p_RM_14_388_7 |
 |
 |
4 |
0.2 |
1.22E-04 |
LPIN1 |
regulation of fat cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_341_15 |
 |
 |
3 |
0.6 |
3.86E-04 |
BAIAP2,
CSK,
PRPS1,
WNK2 |
proline-rich region binding [MF],
kinase activity [MF],
negative regulation of ERK1 and ERK2 cascade [BP] |
| CG_adsipsc_promoter_p_RM_12_258_14 |
 |
 |
6 |
1.0 |
2.55E-04 |
ARID1A,
CARM1,
POU4F2 |
intracellular estrogen receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_16_32_3 |
 |
 |
3 |
0.6 |
5.57E-04 |
GRIN1,
CNTNAP2,
GPR6,
MMP24 |
integral to plasma membrane [CC],
superior temporal gyrus development [BP],
propylene metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_12_418_14 |
 |
 |
6 |
1.0 |
2.73E-04 |
DNAJC3,
EDEM1,
PLA2G4B |
activation of signaling protein activity involved in unfolded protein response [BP],
misfolded protein binding [MF],
endoplasmic reticulum unfolded protein response [BP] |
| CG_adsipsc_promoter_p_RM_12_145_14 |
 |
 |
6 |
0.8 |
3.78E-04 |
TRIM71,
HSPA4,
ZAR1,
SOX11,
TELO2,
TACC3,
GLYCTK,
WNK4,
STXBP1,
ZIC2,
CAPRIN1,
HNRNPAB,
PHF7,
FGFR4,
SEPT2,
EIF3B,
SLC25A10,
BCL2L11 |
tube formation [BP],
protein complex scaffold [MF],
cytoplasm [CC],
dicarboxylic acid transport [BP],
stem cell proliferation [BP] |
| CG_adsipsc_promoter_p_RM_16_14_3 |
 |
 |
2 |
0.2 |
2.96E-04 |
PDPK1,
SNTG2,
ARNT2,
PRKAR2B |
central nervous system development [BP],
3-phosphoinositide-dependent protein kinase activity [MF],
response to antipsychotic drug [BP] |
| CG_adsipsc_promoter_p_RM_12_93_12 |
 |
 |
2 |
0.4 |
2.48E-04 |
SOX2 |
glial cell fate commitment [BP] |
| CG_adsipsc_promoter_p_RM_14_197_9 |
 |
 |
3 |
0.4 |
2.74E-04 |
CNTROB,
ITM2B,
PDXP,
PTPRM,
MAPK8IP2,
PIK3CA |
cytokinesis [BP],
lamellipodium [CC],
beta-amyloid binding [MF] |
| CG_adsipsc_promoter_p_RM_14_384_4 |
 |
 |
2 |
0.2 |
2.55E-04 |
RXRA |
chromatin DNA binding [MF] |
| CG_adsipsc_promoter_p_RM_12_448_7 |
 |
 |
2 |
0.4 |
1.94E-04 |
SLC12A9,
ADD1,
SPTAN1 |
spectrin binding [MF],
cation:chloride symporter activity [MF] |
| CG_adsipsc_promoter_p_RM_14_32_17 |
 |
 |
4 |
0.8 |
2.56E-04 |
PLCB3,
MAF1,
PRDX5,
PDIA3,
PLCG1,
HTT,
MAPK8IP2,
CLN8,
FGFRL1 |
RNA polymerase III regulatory region DNA binding [MF],
social behavior [BP],
heart valve morphogenesis [BP],
negative regulation of transcription from RNA polymerase III promoter [BP],
L-glutamate import [BP],
phospholipase C activity [MF] |
| CG_adsipsc_promoter_p_RM_14_392_10 |
 |
 |
7 |
1.0 |
4.57E-04 |
SPHK1,
ZRANB1,
FOXP4,
RAD23A,
MSH3,
CPE,
UBR3,
SETD1B,
SEPT7,
LEMD3,
CEP164,
CHD7,
PPP4C,
ZNF341,
CAMTA1,
ZC3H18,
ZNF559-ZNF177,
CBLC,
MIER1,
HOXC11,
POU4F2,
IGHMBP2,
SALL3,
LASP1,
PHLPP1,
TSPO,
POLR2H,
WDTC1,
ARID1B,
SYAP1,
ADAM9,
RBM27,
ZBTB42,
UTRN,
CXXC5,
ZNF114,
PPIA,
ZMYM2 |
response to manganese ion [BP],
zinc ion binding [MF],
DNA binding [MF],
nucleus [CC] |
| CG_adsipsc_promoter_p_RM_14_84_2 |
 |
 |
1 |
0.2 |
4.66E-04 |
SOX2,
INHBB,
PML |
negative regulation of translation in response to oxidative stress [BP],
negative regulation of hepatocyte growth factor biosynthetic process [BP],
extrinsic to endoplasmic reticulum membrane [CC],
host cell surface receptor binding [MF],
detection of mechanical stimulus involved in equilibrioception [BP] |
| CG_adsipsc_promoter_p_RM_12_186_17 |
 |
 |
5 |
0.6 |
3.28E-04 |
NDOR1,
GUCY2D,
CXADR,
HIF1AN,
PLOD1,
STK4,
CYP26A1,
HOOK3,
SKP2,
FADS2,
FGF21,
SQSTM1 |
endocardium development [BP],
identical protein binding [MF],
regulation of low-density lipoprotein particle clearance [BP],
iron ion binding [MF] |
| CG_adsipsc_promoter_p_RM_14_340_5 |
 |
 |
1 |
0.2 |
3.26E-04 |
EPO |
erythropoietin receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_14_195_4 |
 |
 |
3 |
0.6 |
2.84E-04 |
GSTZ1,
DCPS |
m7G(5')pppN diphosphatase activity [MF],
cellular response to menadione [BP],
maleylacetoacetate isomerase activity [MF],
RNA 7-methylguanosine cap binding [MF] |
| CG_adsipsc_promoter_p_RM_12_318_6 |
 |
 |
4 |
0.8 |
3.19E-04 |
CRTAP,
E2F4 |
peptidyl-proline hydroxylation to 3-hydroxy-L-proline [BP],
protein domain specific binding [MF] |
| CG_adsipsc_promoter_p_RM_14_227_3 |
 |
 |
4 |
0.4 |
3.69E-04 |
SOX1 |
forebrain neuron development [BP] |
| CG_adsipsc_promoter_p_RM_14_386_14 |
 |
 |
4 |
0.2 |
4.06E-04 |
ADHFE1,
EGLN2 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [MF],
hydroxyacid-oxoacid transhydrogenase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_420_9 |
 |
 |
2 |
0.4 |
2.66E-04 |
PARK7 |
positive regulation of oxidative phosphorylation uncoupler activity [BP] |
| CG_adsipsc_promoter_p_RM_12_469_7 |
 |
 |
4 |
0.8 |
3.35E-04 |
ID4,
LTBP4,
FGF9,
BMPR1A |
regulation of timing of cell differentiation [BP],
transforming growth factor beta-activated receptor activity [MF],
lung development [BP],
cerebral cortex neuron differentiation [BP],
transmembrane receptor protein serine/threonine kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_141_7 |
 |
 |
2 |
0.2 |
3.34E-04 |
UBE2Q2,
ARIH2,
WNT2B |
protein K48-linked ubiquitination [BP],
hematopoietic stem cell proliferation [BP] |
| CG_adsipsc_promoter_p_RM_14_223_5 |
 |
 |
3 |
0.2 |
1.98E-04 |
SYNM,
SPHK1 |
sphingoid catabolic process [BP],
adherens junction [CC] |
| CG_adsipsc_promoter_p_RM_12_421_26 |
 |
 |
5 |
0.8 |
2.31E-04 |
CEP135,
PRKCA,
SFI1,
PRKCD,
FOXD3,
TYMS,
STARD9,
TSSK2,
HOXD3,
ESRRA |
regulation of platelet aggregation [BP],
centriole [CC],
negative regulation of glial cell apoptotic process [BP],
cartilage development [BP] |
| CG_adsipsc_promoter_p_RM_14_167_3 |
 |
 |
1 |
0.2 |
4.46E-04 |
CHRNB2,
FGF2,
BMP8A,
HOXD11,
URI1 |
cellular response to growth factor stimulus [BP],
regulation of synapse assembly [BP],
organ induction [BP],
growth [BP],
cartilage development [BP] |
| CG_adsipsc_promoter_p_RM_18_1_17 |
 |
 |
4 |
0.4 |
4.57E-04 |
BPTF,
PRMT8,
BRSK1,
SLC44A1,
TRIM24,
SLC6A8,
ID2,
BRPF1,
SPEN,
EPO,
FOXA3,
CDK5R1,
KLF2,
MLL5,
PKNOX1,
USP21,
EHMT1 |
positive regulation of transcription, DNA-dependent [BP],
histone methylation [BP],
neural plate anterior/posterior regionalization [BP],
neuron differentiation [BP],
choline transmembrane transporter activity [MF],
erythrocyte differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_314_7 |
 |
 |
3 |
0.6 |
1.27E-04 |
ENOPH1,
KMO |
acireductone synthase activity [MF],
kynurenine 3-monooxygenase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_433_10 |
 |
 |
3 |
0.6 |
2.81E-04 |
CDK12,
NPR3,
CDK5R1,
HIF1A,
EPHB2 |
axonal fasciculation [BP],
positive regulation of nitric-oxide synthase activity [BP],
nuclear cyclin-dependent protein kinase holoenzyme complex [CC] |
| CG_adsipsc_promoter_p_RM_14_82_3 |
 |
 |
2 |
0.2 |
3.11E-04 |
SMYD2 |
protein-lysine N-methyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_479_15 |
 |
 |
5 |
0.8 |
2.93E-04 |
COL5A1 |
proteoglycan binding [MF] |
| CG_adsipsc_promoter_p_RM_14_221_7 |
 |
 |
1 |
0.2 |
2.70E-04 |
IRAK3,
LRP3,
ITSN1 |
positive regulation of macrophage tolerance induction [BP],
coated pit [CC] |
| CG_adsipsc_promoter_p_RM_16_18_7 |
 |
 |
9 |
0.8 |
2.34E-04 |
AP1AR,
PPARD |
linoleic acid binding [MF],
regulation of Arp2/3 complex-mediated actin nucleation [BP] |
| CG_adsipsc_promoter_p_RM_12_231_8 |
 |
 |
3 |
0.6 |
2.24E-04 |
HMGXB4,
SPRTN,
BHLHA15,
FAM171B,
ZNF276,
ENDOG,
ZNF570,
NOM1,
FOXF1,
ZNF805,
ZNF107,
AGFG1,
ZFX |
DNA binding [MF],
nucleic acid binding [MF] |
| CG_adsipsc_promoter_p_RM_14_410_3 |
 |
 |
2 |
0.4 |
3.16E-04 |
NYNRIN,
RLF |
DNA integration [BP] |
| CG_adsipsc_promoter_p_RM_14_366_6 |
 |
 |
2 |
0.2 |
3.67E-04 |
CASP7,
PML |
response to gamma radiation [BP],
negative regulation of translation in response to oxidative stress [BP],
extrinsic to endoplasmic reticulum membrane [CC],
cysteine-type endopeptidase activity [MF] |
| CG_adsipsc_promoter_p_RM_16_51_2 |
 |
 |
2 |
0.2 |
1.76E-04 |
KLF11,
TGIF1,
MSL3,
POU3F2 |
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_14_362_6 |
 |
 |
2 |
0.2 |
1.98E-04 |
ZIC2,
COQ7,
FPGS,
FSTL3,
SKI |
negative regulation of activin receptor signaling pathway [BP],
neural tube formation [BP],
brain development [BP] |
| CG_adsipsc_promoter_p_RM_12_284_11 |
 |
 |
4 |
0.8 |
1.56E-04 |
INHBB,
DRAXIN,
PDPK1 |
3-phosphoinositide-dependent protein kinase activity [MF],
negative regulation of hepatocyte growth factor biosynthetic process [BP],
commissural neuron differentiation in spinal cord [BP],
host cell surface receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_16_16_2 |
 |
 |
3 |
0.2 |
5.13E-04 |
CAD,
SOX8 |
aspartate binding [MF],
aspartate carbamoyltransferase activity [MF],
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [MF],
retinal rod cell differentiation [BP],
carbamoyl phosphate biosynthetic process [BP],
dihydroorotase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_148_22 |
 |
 |
5 |
0.8 |
2.92E-04 |
DUOX1 |
thyroid hormone generation [BP] |
| CG_adsipsc_promoter_p_RM_12_336_17 |
 |
 |
5 |
0.8 |
3.67E-04 |
SLC22A3,
ABCG1 |
toxin transporter activity [MF] |
| CG_adsipsc_promoter_p_RM_12_347_18 |
 |
 |
5 |
0.8 |
2.18E-04 |
ID2,
FOXB1 |
mammary gland alveolus development [BP],
mammary gland lobule development [BP],
entrainment of circadian clock [BP],
epithelial cell differentiation involved in mammary gland alveolus development [BP] |
| CG_adsipsc_promoter_p_RM_14_364_4 |
 |
 |
3 |
0.4 |
3.56E-04 |
BCL2L11,
PKD2 |
BIM-BCL-xl complex [CC],
metanephric cortex development [BP],
BIM-BCL-2 complex [CC],
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP],
renal artery morphogenesis [BP],
metanephric cortical collecting duct development [BP] |
| CG_adsipsc_promoter_p_RM_14_16_7 |
 |
 |
2 |
0.4 |
3.10E-04 |
SMARCA4,
CDC73,
FOXO4 |
negative regulation of S phase of mitotic cell cycle [BP],
negative regulation of smooth muscle cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_294_16 |
 |
 |
4 |
0.4 |
2.36E-04 |
BMP6,
ALPL,
PTEN |
postsynaptic density assembly [BP],
negative regulation of cyclin-dependent protein kinase activity involved in G1/S [BP],
cementum mineralization [BP],
inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [MF],
endochondral ossification [BP],
negative regulation of ribosome biogenesis [BP],
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [MF],
negative regulation of synaptic vesicle clustering [BP] |
| CG_adsipsc_promoter_p_RM_14_302_11 |
 |
 |
3 |
0.2 |
3.65E-04 |
SMTNL1,
F2R |
positive regulation of vasoconstriction [BP] |
| CG_adsipsc_promoter_p_RM_14_198_9 |
 |
 |
4 |
0.4 |
3.05E-04 |
HCN2,
PRKAR1A,
HTR2C,
ACR |
cAMP binding [MF],
drug binding [MF] |
| CG_adsipsc_promoter_p_RM_12_349_29 |
 |
 |
5 |
0.8 |
4.03E-04 |
CNKSR2 |
regulation of signal transduction [BP] |
| CG_adsipsc_promoter_p_RM_12_162_13 |
 |
 |
2 |
0.4 |
2.74E-04 |
HOXD8,
PPM1A,
ESR1,
MAFK,
FOXD2,
FGF2,
FOXO3,
HOXC12,
VEGFA,
IKBKG,
NFIX,
FGFR3,
ZNF771,
FZD1 |
positive regulation of blood vessel endothelial cell migration [BP],
transcription, DNA-dependent [BP],
negative regulation of transcription, DNA-dependent [BP],
regulation of sequence-specific DNA binding transcription factor activity [BP],
substantia nigra development [BP],
ovarian follicle development [BP],
negative regulation of transcription from RNA polymerase II promoter [BP],
gonad development [BP],
positive regulation of endothelial cell proliferation [BP],
antral ovarian follicle growth [BP],
insulin receptor signaling pathway [BP],
lung development [BP],
epithelial cell differentiation [BP],
branching involved in ureteric bud morphogenesis [BP],
positive regulation of sequence-specific DNA binding transcription factor activity [BP],
mammary gland alveolus development [BP],
morphogenesis of an epithelium [BP],
negative regulation of gene expression [BP],
branching morphogenesis of an epithelial tube [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_16_12_5 |
 |
 |
3 |
0.4 |
1.17E-04 |
NDEL1,
TCF7L1 |
oligopeptidase activity [MF],
positive regulation of transcription from RNA polymerase II promoter during mitosis [BP] |
| CG_adsipsc_promoter_p_RM_12_355_6 |
 |
 |
3 |
0.6 |
1.29E-04 |
WRN,
DRD4,
SLC12A5,
NDFIP1,
SWAP70,
XPOT |
DNA recombination [BP],
negative regulation of transporter activity [BP],
tRNA export from nucleus [BP],
olfactory learning [BP],
isotype switching [BP],
thermosensory behavior [BP] |
| CG_adsipsc_promoter_p_RM_14_323_5 |
 |
 |
2 |
0.2 |
3.35E-04 |
SKI,
ADPRHL2,
FOXL1,
RNF146 |
Wnt receptor signaling pathway [BP],
visceral mesoderm-endoderm interaction involved in midgut development [BP],
poly-ADP-D-ribose binding [MF],
positive regulation of Wnt receptor signaling pathway [BP],
poly(ADP-ribose) glycohydrolase activity [MF],
regulation of Wnt receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_18_16_4 |
 |
 |
1 |
0.2 |
2.61E-04 |
ARPC1B,
ARPC5L,
ILK,
TMSB10,
TRIP10,
AGTRAP,
SKI,
P2RX2 |
regulation of actin filament polymerization [BP],
regulation of actin cytoskeleton organization [BP],
actin cytoskeleton organization [BP],
skeletal muscle fiber development [BP],
positive regulation of calcium ion transport into cytosol [BP],
terminal bouton [CC],
regulation of action potential in neuron [BP],
regulation of blood pressure [BP] |
| CG_adsipsc_promoter_p_RM_12_113_14 |
 |
 |
4 |
0.6 |
2.97E-04 |
CAV1,
RND2 |
acrosomal membrane [CC] |
| CG_adsipsc_promoter_p_RM_12_116_9 |
 |
 |
4 |
0.6 |
3.12E-04 |
ARFGAP1,
HTT |
retrograde vesicle-mediated transport, Golgi to ER [BP] |
| CG_adsipsc_promoter_p_RM_14_380_9 |
 |
 |
2 |
0.2 |
3.43E-04 |
HIPK1,
FAM20C,
EIF2AK4,
RABEP1,
PAK4 |
protein serine/threonine kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_16_33_2 |
 |
 |
2 |
0.4 |
4.22E-04 |
HIST3H2BB,
ACO2,
HIST1H2BO |
nucleosome assembly [BP],
3 iron, 4 sulfur cluster binding [MF],
citrate hydro-lyase (cis-aconitate-forming) activity [MF],
nucleosome [CC],
isocitrate hydro-lyase (cis-aconitate-forming) activity [MF] |
| CG_adsipsc_promoter_p_RM_14_14_7 |
 |
 |
3 |
0.4 |
2.24E-04 |
BACH1 |
regulation of transcription involved in G2/M-phase of mitotic cell cycle [BP] |
| CG_adsipsc_promoter_p_RM_12_176_20 |
 |
 |
3 |
0.6 |
4.21E-04 |
IGF1R,
GGPS1,
GATA6 |
negative regulation of transforming growth factor beta2 production [BP],
inactivation of MAPKK activity [BP],
geranylgeranyl diphosphate biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_16_10_6 |
 |
 |
3 |
0.2 |
3.69E-04 |
MRPL23,
ICT1 |
mitochondrial large ribosomal subunit [CC] |
| CG_adsipsc_promoter_p_RM_12_430_20 |
 |
 |
4 |
0.6 |
2.32E-04 |
SMAD6,
NOG,
PTCHD2,
PTCHD1,
TGIF1,
TGFBR1 |
hedgehog receptor activity [MF],
SMAD binding [MF],
co-SMAD binding [MF],
negative regulation of pathway-restricted SMAD protein phosphorylation [BP],
pathway-restricted SMAD protein phosphorylation [BP],
I-SMAD binding [MF] |
| CG_adsipsc_promoter_p_RM_12_385_12 |
 |
 |
7 |
1.0 |
2.95E-04 |
FAS,
VEGFA,
INSIG1,
FOXB1,
MSX2,
TCF21,
MINK1 |
negative thymic T cell selection [BP],
gland development [BP],
cranial suture morphogenesis [BP],
mammary gland lobule development [BP],
mammary gland alveolus development [BP],
embryo development [BP] |
| CG_adsipsc_promoter_p_RM_14_245_4 |
 |
 |
2 |
0.2 |
4.16E-04 |
PLEKHF1,
LIMK1,
CAMTA1,
UTRN,
NDEL1,
ZC3H18,
MNAT1,
TRAF4,
HHEX |
central nervous system neuron axonogenesis [BP],
nucleus [CC],
positive regulation of axon extension [BP] |
| CG_adsipsc_promoter_p_RM_16_35_4 |
 |
 |
1 |
0.2 |
4.41E-04 |
ZFYVE27,
TPM1,
GNAS,
IGF2BP1 |
positive regulation of heart rate by epinephrine [BP],
dendrite [CC],
post-embryonic body morphogenesis [BP],
regulation of mRNA stability involved in response to stress [BP] |
| CG_adsipsc_promoter_p_RM_14_53_7 |
 |
 |
5 |
0.6 |
2.90E-04 |
SLC22A5,
UAP1,
NR2E1,
NRF1,
PLXNA3 |
positive regulation of intestinal epithelial structure maintenance [BP],
amygdala development [BP],
UDP-N-acetylglucosamine diphosphorylase activity [MF],
hippocampus development [BP],
forebrain generation of neurons [BP],
sodium-dependent organic cation transport [BP],
quorum sensing involved in interaction with host [BP],
mitochondrion organization [BP] |
| CG_adsipsc_promoter_p_RM_14_88_6 |
 |
 |
1 |
0.2 |
3.26E-04 |
TSSK3,
CCND2,
CTCF,
MAP2K4,
MNAT1,
ADRBK2,
RPS6KA4 |
regulation of cyclin-dependent protein kinase activity [BP],
protein serine/threonine kinase activity [MF],
positive regulation of cyclin-dependent protein kinase activity [BP],
regulation of histone acetylation [BP],
protein kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_18_13 |
 |
 |
6 |
1.0 |
2.79E-04 |
SLC6A1,
OXT |
response to sucrose stimulus [BP] |
| CG_adsipsc_promoter_p_RM_14_10_6 |
 |
 |
8 |
1.0 |
3.76E-04 |
GNAS,
CTCF |
regulation of gene expression, epigenetic [BP],
genetic imprinting [BP] |
| CG_adsipsc_promoter_p_RM_12_411_14 |
 |
 |
2 |
0.4 |
3.31E-04 |
ANAPC11,
UBE2A |
protein K11-linked ubiquitination [BP] |
| CG_adsipsc_promoter_p_RM_12_216_19 |
 |
 |
3 |
0.6 |
1.90E-04 |
SMAD4,
CDK10,
TLX1,
SIX3,
SMO,
PDX1,
RNF187,
BAI1 |
transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [MF],
protein import into nucleus [BP],
endocrine pancreas development [BP],
otolith morphogenesis [BP],
protein localization to nucleus [BP],
cell fate commitment [BP],
cell proliferation [BP],
ventral midline determination [BP],
detection of cell density by contact stimulus involved in contact inhibition [BP],
mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP],
type B pancreatic cell differentiation [BP],
neuron differentiation [BP],
neuron fate commitment [BP],
negative regulation of cell proliferation [BP],
positive regulation of transcription, DNA-dependent [BP],
regulation of binding [BP],
exocrine pancreas development [BP],
organ morphogenesis [BP],
branching involved in ureteric bud morphogenesis [BP],
positive regulation of transcription from RNA polymerase II promoter [BP],
regulation of hair follicle development [BP],
positive regulation of gene expression [BP] |
| CG_adsipsc_promoter_p_RM_12_9_16 |
 |
 |
6 |
1.0 |
3.48E-04 |
TLX1,
CTNNB1,
TBX1,
SOX1,
FOXC1,
TGFBR1 |
artery morphogenesis [BP],
parathyroid gland development [BP],
cell fate commitment [BP],
lens development in camera-type eye [BP],
lens morphogenesis in camera-type eye [BP] |
| CG_adsipsc_promoter_p_RM_16_37_3 |
 |
 |
5 |
0.6 |
2.32E-04 |
FNTA |
positive regulation of tubulin deacetylation [BP] |
| CG_adsipsc_promoter_p_RM_12_277_14 |
 |
 |
5 |
0.6 |
2.28E-04 |
NEK7,
RMDN2,
CCNE1,
CDT1,
SKA1,
MAP2K1,
THEMIS2,
NDE1,
DNAI1,
MICB,
MICA,
CENPP,
MAEA |
spindle pole [CC],
mitotic prometaphase [BP],
vesicle transport along microtubule [BP],
cell adhesion [BP],
MHC class I protein complex [CC],
natural killer cell lectin-like receptor binding [MF],
microtubule [CC],
gamma-delta T cell activation [BP],
spindle [CC],
mitotic cell cycle [BP],
cell division [BP] |
| CG_adsipsc_promoter_p_RM_12_99_8 |
 |
 |
5 |
0.8 |
2.26E-04 |
PKN3,
PRKCA |
protein kinase C activity [MF] |
| CG_adsipsc_promoter_p_RM_14_207_7 |
 |
 |
3 |
0.2 |
4.40E-04 |
TGFBR1,
FZD1 |
canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation [BP],
autocrine signaling [BP],
canonical Wnt receptor signaling pathway involved in osteoblast differentiation [BP],
palate development [BP] |
| CG_adsipsc_promoter_p_RM_14_249_4 |
 |
 |
5 |
0.8 |
3.30E-04 |
ADRA2C,
OPRD1 |
regulation of sensory perception of pain [BP] |
| CG_adsipsc_promoter_p_RM_14_325_6 |
 |
 |
2 |
0.2 |
2.87E-04 |
PCNT |
olfactory bulb development [BP] |
| CG_adsipsc_promoter_p_RM_12_343_12 |
 |
 |
5 |
0.8 |
3.53E-04 |
NLGN1,
GABARAPL2,
MCU |
positive regulation of synaptic vesicle endocytosis [BP],
uniporter activity [MF],
intra-Golgi vesicle-mediated transport [BP],
protein complex oligomerization [BP],
cytoskeletal matrix organization at active zone [BP],
positive regulation of synaptic vesicle exocytosis [BP],
neurexin clustering [BP] |
| CG_adsipsc_promoter_p_RM_12_91_12 |
 |
 |
7 |
1.0 |
2.44E-04 |
PIK3CD,
STAT5A |
mast cell differentiation [BP],
natural killer cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_14_15_5 |
 |
 |
3 |
0.4 |
1.98E-04 |
SLC5A5,
MPST |
sodium:iodide symporter activity [MF],
3-mercaptopyruvate sulfurtransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_199_10 |
 |
 |
3 |
0.4 |
2.32E-04 |
ID4,
SLC5A3,
SMAD5 |
myo-inositol:sodium symporter activity [MF],
positive regulation of osteoblast differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_372_12 |
 |
 |
3 |
0.6 |
4.01E-04 |
FLNB,
ARIH1,
IFITM2 |
cytokine-mediated signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_204_7 |
 |
 |
2 |
0.4 |
2.50E-04 |
PKN3,
NQO2,
MET,
IFRD1,
ARHGAP10,
BRSK2,
ARFGEF2 |
symmetric synapse [CC],
dihydronicotinamide riboside quinone reductase activity [MF],
adult somatic muscle development [BP],
hepatocyte growth factor-activated receptor activity [MF],
perinuclear region of cytoplasm [CC] |
| CG_adsipsc_promoter_p_RM_12_212_15 |
 |
 |
3 |
0.6 |
3.05E-04 |
UHRF1 |
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [BP],
hemi-methylated DNA-binding [MF] |
| CG_adsipsc_promoter_p_RM_14_282_4 |
 |
 |
1 |
0.2 |
4.28E-04 |
SIRT1,
YY1,
POLI,
GNAS,
HCK |
mu-type opioid receptor binding [MF],
negative regulation of prostaglandin biosynthetic process [BP],
post-embryonic body morphogenesis [BP],
PcG protein complex [CC],
negative regulation of cellular response to testosterone stimulus [BP],
establishment of chromatin silencing [BP],
respiratory burst after phagocytosis [BP],
DNA repair [BP],
response to prostaglandin F stimulus [BP],
negative regulation of cAMP-dependent protein kinase activity [BP],
extrinsic to internal side of plasma membrane [CC],
positive regulation of cAMP-dependent protein kinase activity [BP],
leukocyte migration involved in immune response [BP] |
| CG_adsipsc_promoter_p_RM_14_327_9 |
 |
 |
3 |
0.4 |
2.01E-04 |
SKI |
olfactory bulb development [BP] |
| CG_adsipsc_promoter_p_RM_14_127_2 |
 |
 |
2 |
0.4 |
2.70E-04 |
MYO6,
ACTN3 |
minus-end directed microfilament motor activity [MF],
actin filament [CC] |
| CG_adsipsc_promoter_p_RM_14_23_12 |
 |
 |
3 |
0.2 |
1.55E-04 |
PFAS,
PALM |
D3 dopamine receptor binding [MF],
phosphoribosylformylglycinamidine synthase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_55_4 |
 |
 |
2 |
0.2 |
2.44E-04 |
CYR61,
PLOD1 |
hydroxylysine biosynthetic process [BP],
intussusceptive angiogenesis [BP],
positive regulation of protein kinase activity [BP],
extracellular matrix binding [MF] |
| CG_adsipsc_promoter_p_RM_12_396_13 |
 |
 |
3 |
0.4 |
2.84E-04 |
TRAF2,
GREM1,
SLC22A18,
S1PR1,
SKI,
RSAD2,
ACTN2 |
negative regulation of BMP signaling pathway [BP],
regulation of ossification [BP],
sphingolipid binding [MF],
protein homotrimerization [BP],
ubiquitin protein ligase binding [MF],
focal adhesion assembly [BP],
positive regulation of T cell cytokine production [BP],
regulation of focal adhesion assembly [BP],
transmission of nerve impulse [BP] |
| CG_adsipsc_promoter_p_RM_12_407_9 |
 |
 |
4 |
0.6 |
2.55E-04 |
CAPRIN1,
SMAD1 |
positive regulation of dendrite morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_298_22 |
 |
 |
4 |
0.8 |
2.70E-04 |
SMPD2 |
ceramide biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_425_12 |
 |
 |
8 |
1.0 |
3.41E-04 |
CNTNAP1,
PKN1,
RASSF3,
RPS6KB2,
IGFBP2,
OXT,
ARHGAP33,
SNX25,
BAI1 |
cell communication [BP],
signal transduction [BP] |
| CG_adsipsc_promoter_p_RM_12_417_10 |
 |
 |
2 |
0.4 |
2.38E-04 |
GTF3C4,
CTNS |
compound eye corneal lens development [BP],
transcription from RNA polymerase III promoter [BP] |
| CG_adsipsc_promoter_p_RM_12_245_11 |
 |
 |
5 |
0.8 |
2.14E-04 |
PTPN11,
RNF8,
GAPDHS,
ING2,
LEP |
peptide hormone receptor binding [MF],
spermatid development [BP],
multicellular organismal reproductive process [BP],
regulation of response to DNA damage stimulus [BP] |
| CG_adsipsc_promoter_p_RM_12_55_14 |
 |
 |
3 |
0.6 |
1.79E-04 |
PDK2,
ADD1,
RET,
LEP |
cellular response to retinoic acid [BP],
regulation of gluconeogenesis [BP],
cellular response to nutrient [BP] |
| CG_adsipsc_promoter_p_RM_12_202_18 |
 |
 |
5 |
0.8 |
3.12E-04 |
GIGYF2,
WNT1 |
negative regulation of cell-cell adhesion [BP],
midbrain-hindbrain boundary maturation during brain development [BP],
insulin-like growth factor receptor signaling pathway [BP],
cerebellum formation [BP],
negative regulation of DNA damage checkpoint [BP] |
| CG_adsipsc_promoter_p_RM_12_244_14 |
 |
 |
5 |
1.0 |
4.32E-04 |
GSX2,
UNCX,
LMO4,
RB1,
BHLHE40,
RCC1 |
dorsal spinal cord development [BP],
RNA polymerase II activating transcription factor binding [MF],
spinal cord association neuron differentiation [BP],
olfactory bulb interneuron differentiation [BP],
regulation of S phase of mitotic cell cycle [BP] |
| CG_adsipsc_promoter_p_RM_12_13_13 |
 |
 |
7 |
1.0 |
2.00E-04 |
WDYHV1,
DIO3,
PPP4R4 |
regulation of protein serine/threonine phosphatase activity [BP],
thyroxine 5-deiodinase activity [MF],
protein-N-terminal glutamine amidohydrolase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_30_4 |
 |
 |
2 |
0.2 |
3.45E-04 |
OPRL1,
ATP2A2,
CMPK1 |
calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF],
dCDP biosynthetic process [BP],
CDP biosynthetic process [BP],
UDP biosynthetic process [BP],
nociceptin receptor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_475_25 |
 |
 |
5 |
1.0 |
1.76E-04 |
RAB12,
NLGN1,
SC5DL,
KDM3A,
RAB40C,
MAPK8IP2,
TAF1B |
positive regulation of synaptic vesicle exocytosis [BP],
neurexin clustering [BP],
positive regulation of synaptic vesicle endocytosis [BP],
regulation of excitatory postsynaptic membrane potential [BP],
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity [BP],
RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [BP],
GDP binding [MF],
RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity [MF],
lathosterol oxidase activity [MF],
formaldehyde biosynthetic process [BP],
core promoter binding [MF],
RNA polymerase I CORE element sequence-specific DNA binding [MF],
cholesterol biosynthetic process via lathosterol [BP],
cytoskeletal matrix organization at active zone [BP],
RNA polymerase I core factor complex [CC],
regulation of synaptic transmission, glutamatergic [BP],
regulation of N-methyl-D-aspartate selective glutamate receptor activity [BP],
histone H3-K9 dimethylation [BP] |
| CG_adsipsc_promoter_p_RM_14_397_5 |
 |
 |
1 |
0.2 |
5.21E-04 |
ZNF628,
TWIST2,
RXRA,
LCOR,
DOT1L,
TFDP1,
MYB |
negative regulation of transcription from RNA polymerase II promoter [BP],
histone lysine methylation [BP],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_288_11 |
 |
 |
3 |
0.4 |
4.71E-04 |
PPARA,
PARPBP |
regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP],
negative regulation of double-strand break repair via homologous recombination [BP],
regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_14_348_8 |
 |
 |
7 |
0.8 |
2.59E-04 |
STRADB,
TGFBR1 |
cell cycle arrest [BP] |
| CG_adsipsc_promoter_p_RM_14_237_10 |
 |
 |
3 |
0.4 |
5.71E-04 |
APLP1 |
cellular response to norepinephrine stimulus [BP],
alpha-2B adrenergic receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_14_346_4 |
 |
 |
2 |
0.2 |
3.15E-04 |
ARHGEF4,
BAIAP2 |
filopodium assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_20_12 |
 |
 |
5 |
0.8 |
1.74E-04 |
AFMID,
CDKN1A |
arylformamidase activity [MF],
cyclin-dependent protein kinase activating kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_288_4 |
 |
 |
1 |
0.2 |
2.62E-04 |
ZFPM1,
JPH3,
TGFBR2 |
positive regulation of tolerance induction to self antigen [BP],
bronchus morphogenesis [BP],
embryonic hemopoiesis [BP],
negative regulation of mast cell differentiation [BP],
negative regulation of interleukin-4 biosynthetic process [BP],
regulation of neuronal synaptic plasticity [BP] |
| CG_adsipsc_promoter_p_RM_12_196_8 |
 |
 |
2 |
0.4 |
3.15E-04 |
RALBP1,
OCRL |
Rac GTPase activator activity [MF] |
| CG_adsipsc_promoter_p_RM_12_29_12 |
 |
 |
4 |
0.6 |
5.20E-04 |
CDK13,
MNAT1,
ID1,
SMO |
central nervous system neuron differentiation [BP],
heart development [BP],
RNA polymerase II carboxy-terminal domain kinase activity [MF],
negative regulation of DNA binding [BP] |
| CG_adsipsc_promoter_p_RM_12_268_19 |
 |
 |
3 |
0.6 |
3.28E-04 |
ACVR2B,
SCARA3,
EMID1,
HOXC11,
FOXF1,
PAX2,
COL6A2,
GATA3,
SMO |
embryonic digestive tract morphogenesis [BP],
mesonephros development [BP],
pancreas development [BP],
mesenchymal to epithelial transition [BP],
embryonic foregut morphogenesis [BP],
mammary gland epithelial cell differentiation [BP],
ureter development [BP],
regulation of nephron tubule epithelial cell differentiation [BP],
nephric duct morphogenesis [BP],
positive regulation of branching involved in ureteric bud morphogenesis [BP],
venous blood vessel development [BP],
renal system development [BP],
kidney development [BP],
ureter maturation [BP],
midgut development [BP],
mesenchymal to epithelial transition involved in metanephros morphogenesis [BP],
regulation of stem cell maintenance [BP],
determination of left/right symmetry [BP],
collagen [CC],
mesoderm development [BP],
nephric duct formation [BP],
metanephros development [BP],
urogenital system development [BP] |
| CG_adsipsc_promoter_p_RM_14_117_12 |
 |
 |
2 |
0.2 |
3.46E-04 |
PAQR8,
KL,
SAP30,
MINK1,
GNAS,
ARID1B,
ESR1,
SUDS3,
IRX5,
CBFB,
KLF2,
MLL5,
ZNF660,
ZNF2,
HOXD11,
NAB1,
IDUA,
CTCF,
ZNF587B,
BMP6 |
skeletal system morphogenesis [BP],
regulation of transcription, DNA-dependent [BP],
steroid binding [MF],
DNA methylation [BP],
transcription, DNA-dependent [BP],
endochondral ossification [BP],
cell maturation [BP],
multicellular organismal development [BP],
regulation of gene expression, epigenetic [BP],
vitamin D binding [MF],
skeletal system development [BP] |
| CG_adsipsc_promoter_p_RM_14_38_6 |
 |
 |
4 |
0.4 |
3.07E-04 |
SLC2A4,
DAG1,
SGCG |
sarcolemma [CC],
dystroglycan complex [CC],
dystrophin-associated glycoprotein complex [CC] |
| CG_adsipsc_promoter_p_RM_12_57_18 |
 |
 |
3 |
0.6 |
2.60E-04 |
KIAA0232,
EPHB6,
CAMK1D,
SLC11A1,
PKN1,
RDH12,
CCNE1,
PRKCD,
WRNIP1,
HSD3B7,
MERTK,
WEE1,
DGKE,
SQSTM1 |
kinase activity [MF],
protein tyrosine kinase activity [MF],
protein phosphorylation [BP],
protein serine/threonine kinase activity [MF],
protein kinase activity [MF],
respiratory burst [BP],
protein kinase C activity [MF],
nucleotide binding [MF],
positive regulation of phagocytosis [BP],
phagocytosis [BP],
ATP binding [MF] |
| CG_adsipsc_promoter_p_RM_12_326_15 |
 |
 |
4 |
0.6 |
3.39E-04 |
MT2A,
SMAD4,
FOSB,
TCHP,
EGFR,
FOXO3,
PPFIA3,
RAN,
RBPJ,
CDH1,
FOXQ1,
IGF1R,
BMP8A,
SUV39H1,
PKN3,
PCNT,
GATA4,
GYPC,
TARDBP,
SNAP25,
CHAMP1,
RSRC1,
TFG,
RNF182,
POLE4,
POU3F3 |
protein binding [MF],
SMAD protein signal transduction [BP],
sequence-specific DNA binding [MF],
developmental growth [BP],
nucleocytoplasmic transport [BP],
epithelial cell fate commitment [BP],
in utero embryonic development [BP],
growth [BP],
tissue development [BP],
positive regulation of BMP signaling pathway [BP],
embryo development [BP],
double-stranded DNA binding [MF] |
| CG_adsipsc_promoter_p_RM_14_398_10 |
 |
 |
2 |
0.2 |
1.68E-04 |
SMAD4,
SLC12A9,
HTR6 |
negative regulation of gamma-aminobutyric acid secretion [BP],
transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [MF],
negative regulation of acetylcholine secretion [BP],
cation:chloride symporter activity [MF] |
| CG_adsipsc_promoter_p_RM_12_404_17 |
 |
 |
5 |
0.8 |
6.31E-04 |
GNAS,
RALA |
Edg-2 lysophosphatidic acid receptor binding [MF],
mu-type opioid receptor binding [MF],
post-embryonic body morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_374_11 |
 |
 |
4 |
0.6 |
2.95E-04 |
SMARCB1,
TRRAP,
PRDM16 |
transcription coactivator activity [MF] |
| CG_adsipsc_promoter_p_RM_14_73_6 |
 |
 |
2 |
0.2 |
2.65E-04 |
GCGR,
NPR1 |
peptide hormone binding [MF] |
| CG_adsipsc_promoter_p_RM_12_423_9 |
 |
 |
5 |
1.0 |
2.20E-04 |
B3GNT2,
B3GALT6 |
UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [MF],
UDP-galactosyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_36_9 |
 |
 |
2 |
0.2 |
1.38E-04 |
TCF7L1,
CSGALNACT2 |
dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [BP],
positive regulation of transcription from RNA polymerase II promoter during mitosis [BP] |
| CG_adsipsc_promoter_p_RM_12_365_8 |
 |
 |
5 |
1.0 |
2.35E-04 |
SLC22A3,
SPCS1 |
regulation of appetite [BP],
quaternary ammonium group transmembrane transporter activity [MF],
peptidase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_284_7 |
 |
 |
2 |
0.2 |
2.56E-04 |
ONECUT3,
BACH1,
AK7,
MED12L,
SHROOM2,
EN2,
POU3F2 |
eye pigment granule organization [BP],
sequence-specific DNA binding [MF],
beta-catenin binding [MF],
brain development [BP],
RNA polymerase II transcription cofactor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_352_10 |
 |
 |
5 |
1.0 |
2.15E-04 |
KAT8,
PKP4,
FOXF1,
YAP1,
NSD1 |
lateral mesoderm development [BP],
positive regulation of gene expression [BP],
positive regulation of transcription, DNA-dependent [BP] |
| CG_adsipsc_promoter_p_RM_14_75_10 |
 |
 |
7 |
1.0 |
2.50E-04 |
AQP6 |
nitrate transmembrane transporter activity [MF] |
| CG_adsipsc_promoter_p_RM_14_201_6 |
 |
 |
4 |
0.6 |
2.75E-04 |
ADRA2A,
TCF7L1 |
phospholipase C-activating adrenergic receptor signaling pathway [BP],
positive regulation of transcription from RNA polymerase II promoter during mitosis [BP],
adenylate cyclase-inhibiting adrenergic receptor signaling pathway [BP],
negative regulation of adrenergic receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_14_136_4 |
 |
 |
2 |
0.2 |
2.32E-04 |
INSIG1,
LSM11 |
U7 snRNA binding [MF],
negative regulation of cargo loading into COPII-coated vesicle [BP] |
| CG_adsipsc_promoter_p_RM_14_24_2 |
 |
 |
2 |
0.2 |
3.40E-04 |
MC5R,
DRAXIN,
RLF |
DNA mediated transformation [BP],
positive regulation of cAMP biosynthetic process [BP],
commissural neuron differentiation in spinal cord [BP] |
| CG_adsipsc_promoter_p_RM_12_191_14 |
 |
 |
4 |
0.6 |
3.68E-04 |
ATP9B,
CAD,
ALDH5A1 |
aspartate binding [MF],
aspartate carbamoyltransferase activity [MF],
glutamine metabolic process [BP],
cation-transporting ATPase activity [MF],
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [MF],
succinate-semialdehyde dehydrogenase (NAD+) activity [MF],
dihydroorotase activity [MF],
ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism [MF],
succinate-semialdehyde dehydrogenase [NAD(P)+] activity [MF] |
| CG_adsipsc_promoter_p_RM_12_47_31 |
 |
 |
5 |
1.0 |
2.00E-04 |
CAPRIN1,
SMAD1 |
positive regulation of dendrite morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_102_26 |
 |
 |
2 |
0.4 |
3.30E-04 |
TFAM,
MAP2K5,
NLGN1,
PRSS41,
PPARD,
RB1,
ID1,
TMPO,
MET,
CLN5,
SMAD1,
OVOL1,
CABLES1,
DYNLL1,
DLX6,
EP300,
TSC2,
UNC50,
FOXC1,
BASP1,
LHX2 |
anatomical structure morphogenesis [BP],
positive regulation of transcription, DNA-dependent [BP],
transcription regulatory region DNA binding [MF],
intracellular organelle [CC],
brain development [BP],
regulation of transcription from RNA polymerase I promoter [BP],
nuclear inner membrane [CC],
mesoderm development [BP],
skeletal system development [BP],
heart development [BP],
nervous system development [BP] |
| CG_adsipsc_promoter_p_RM_12_15_15 |
 |
 |
5 |
0.8 |
1.97E-04 |
NSD1,
SETD1B,
HDAC11 |
histone methylation [BP],
chromatin modification [BP],
histone H3-K4 methylation [BP] |
| CG_adsipsc_promoter_p_RM_14_138_5 |
 |
 |
2 |
0.4 |
3.38E-04 |
HS3ST2 |
[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity [MF] |
| CG_adsipsc_promoter_p_RM_14_65_11 |
 |
 |
7 |
1.0 |
3.29E-04 |
ARID1B,
WDR5,
USP21,
MLL5,
PRDM16 |
transcription coactivator activity [MF],
histone methyltransferase activity (H3-K4 specific) [MF] |
| CG_adsipsc_promoter_p_RM_12_82_10 |
 |
 |
5 |
0.8 |
3.44E-04 |
PTPRJ,
TSC2 |
negative regulation of protein kinase B signaling cascade [BP] |
| CG_adsipsc_promoter_p_RM_12_428_24 |
 |
 |
6 |
0.6 |
2.38E-04 |
LMNB1,
PIM3,
PIM1,
WNK2,
CLK3,
FAM20C,
PRKCB,
MAST1,
PAX2,
NARF,
MYCN |
lamin filament [CC],
nuclear lamina [CC],
protein serine/threonine kinase activity [MF],
negative regulation of reactive oxygen species metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_14_194_9 |
 |
 |
3 |
0.4 |
3.07E-04 |
PKD2,
RAP1B,
CDK5R1,
TRAPPC10,
GATA3,
MATN2 |
regulation of establishment of cell polarity [BP],
mesonephros development [BP],
sodium ion transmembrane transport [BP],
neuron migration [BP] |
| CG_adsipsc_promoter_p_RM_12_135_15 |
 |
 |
5 |
0.8 |
4.32E-04 |
KLF2 |
cellular response to interleukin-1 [BP] |
| CG_adsipsc_promoter_p_RM_12_144_13 |
 |
 |
1 |
0.2 |
4.23E-04 |
NUDT16L1,
NUDT16 |
snoRNA binding [MF] |
| CG_adsipsc_promoter_p_RM_14_280_7 |
 |
 |
2 |
0.2 |
4.74E-04 |
STRA8,
FOXL1,
PRDX5 |
regulation of apoptosis involved in tissue homeostasis [BP],
visceral mesoderm-endoderm interaction involved in midgut development [BP],
peroxynitrite reductase activity [MF],
meiotic cell cycle DNA replication checkpoint [BP] |
| CG_adsipsc_promoter_p_RM_12_301_18 |
 |
 |
5 |
0.8 |
3.42E-04 |
HEY2,
ZBTB16,
BMP1,
ZFPM1 |
atrioventricular valve development [BP],
atrial septum morphogenesis [BP],
positive regulation of cartilage development [BP],
tricuspid valve formation [BP],
tricuspid valve morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_40_15 |
 |
 |
4 |
0.4 |
1.26E-04 |
RPS7,
HSD17B4,
RPS26,
ATG10 |
autophagy in response to ER overload [BP],
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [MF],
17-beta-hydroxysteroid dehydrogenase (NAD+) activity [MF],
very long-chain fatty-acyl-CoA metabolic process [BP],
cytosolic small ribosomal subunit [CC] |
| CG_adsipsc_promoter_p_RM_12_213_9 |
 |
 |
4 |
0.6 |
1.47E-04 |
LDLRAP1 |
signaling adaptor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_436_10 |
 |
 |
5 |
0.8 |
3.10E-04 |
KLC1,
COL6A1 |
collagen type VI [CC],
stress granule disassembly [BP] |
| CG_adsipsc_promoter_p_RM_12_80_17 |
 |
 |
5 |
0.8 |
3.10E-04 |
HOXC8,
CRKL,
FOXG1,
HOXD11,
PALM,
ZIC1,
FOXB1,
NRG3,
ROBO3,
CLIC6 |
pattern specification process [BP],
axon midline choice point recognition [BP],
anterior/posterior pattern specification [BP],
D3 dopamine receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_14_79_7 |
 |
 |
2 |
0.2 |
2.42E-04 |
LMNB1,
ATP11B,
GPR124 |
nuclear inner membrane [CC],
regulation of angiogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_69_7 |
 |
 |
2 |
0.4 |
2.73E-04 |
KLC3,
TICRR,
MAPRE3,
STAT5A |
positive regulation of mast cell differentiation [BP],
cardiolipin synthase activity [MF],
cell cycle [BP] |
| CG_adsipsc_promoter_p_RM_14_86_7 |
 |
 |
2 |
0.2 |
3.40E-04 |
YY1,
RCOR1 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF] |
| CG_adsipsc_promoter_p_RM_14_130_4 |
 |
 |
1 |
0.2 |
2.12E-04 |
SMCHD1,
SGOL2,
SLC22A3,
IDUA |
L-iduronidase activity [MF],
histamine uptake [BP],
inactivation of X chromosome by DNA methylation [BP],
meiotic sister chromatid cohesion, centromeric [BP] |
| CG_adsipsc_promoter_p_RM_14_5_5 |
 |
 |
2 |
0.2 |
2.94E-04 |
SPINT1,
CD6,
ADAM23,
CDHR2 |
placenta blood vessel development [BP],
cell adhesion [BP] |
| CG_adsipsc_promoter_p_RM_14_196_4 |
 |
 |
1 |
0.2 |
2.97E-04 |
VEGFA,
MAPK7,
EHMT1 |
ovarian follicle development [BP],
positive regulation of transcription from RNA polymerase II promoter in response to stress [BP],
basophil chemotaxis [BP],
stress-activated MAPK cascade [BP],
DNA methylation [BP] |
| CG_adsipsc_promoter_p_RM_12_131_16 |
 |
 |
6 |
1.0 |
2.48E-04 |
FLVCR2,
FLVCR1,
DDX20,
NELFB,
PIAS4,
HEXIM2,
PDX1,
NFIC |
negative regulation of transcription from RNA polymerase II promoter [BP],
negative regulation of transcription, DNA-dependent [BP],
heme transport [BP],
heme transporter activity [MF] |
| CG_adsipsc_promoter_p_RM_12_58_18 |
 |
 |
5 |
1.0 |
3.09E-04 |
PKD2,
TRIOBP,
TPM1,
SIX3,
APC2 |
protein import into nucleus [BP],
actinin binding [MF],
filamentous actin [CC],
actin cytoskeleton [CC],
actin filament [CC] |
| CG_adsipsc_promoter_p_RM_14_374_8 |
 |
 |
3 |
0.4 |
3.25E-04 |
ACO2,
ALMS1,
RSAD1,
INHBB |
4 iron, 4 sulfur cluster binding [MF],
fat cell differentiation [BP],
ovulation [BP] |
| CG_adsipsc_promoter_p_RM_14_111_11 |
 |
 |
5 |
0.6 |
3.27E-04 |
GABRD,
HTT,
DOPEY2,
GABRG3 |
GABA-A receptor activity [MF],
endoplasmic reticulum organization [BP] |
| CG_adsipsc_promoter_p_RM_12_178_5 |
 |
 |
4 |
0.8 |
1.04E-04 |
NPY5R,
BIRC7 |
generation of ovulation cycle rhythm [BP],
regulation of natural killer cell apoptotic process [BP] |
| CG_adsipsc_promoter_p_RM_14_132_4 |
 |
 |
2 |
0.2 |
4.10E-04 |
FAM20C |
regulation of fibroblast growth factor receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_14_203_7 |
 |
 |
2 |
0.2 |
3.00E-04 |
SMCHD1 |
inactivation of X chromosome by DNA methylation [BP] |
| CG_adsipsc_promoter_p_RM_12_406_14 |
 |
 |
5 |
1.0 |
3.39E-04 |
DYNLL2,
DNAI1 |
dynein complex [CC] |
| CG_adsipsc_promoter_p_RM_12_305_14 |
 |
 |
7 |
1.0 |
3.24E-04 |
ID2,
CD40,
KIT,
SKI |
olfactory bulb development [BP],
positive regulation of tyrosine phosphorylation of Stat1 protein [BP] |
| CG_adsipsc_promoter_p_RM_14_226_8 |
 |
 |
4 |
0.4 |
3.84E-04 |
SMARCA4,
CHAF1A |
WINAC complex [CC] |
| CG_adsipsc_promoter_p_RM_12_312_14 |
 |
 |
6 |
0.8 |
2.62E-04 |
SUV39H1,
GADD45A,
CARM1,
DENND3,
HOOK3,
RHOB,
MAPK14 |
endosome to lysosome transport [BP],
cellular response to ionizing radiation [BP],
histone methyltransferase activity [MF],
protein methyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_440_21 |
 |
 |
6 |
1.0 |
2.52E-04 |
CRELD1,
CRHBP,
VANGL2,
HEY2,
GATA4,
CRHR1,
DRD5 |
cardiac septum development [BP],
muscular septum morphogenesis [BP],
corticotropin-releasing hormone binding [MF],
response to cocaine [BP],
ventricular septum development [BP] |
| CG_adsipsc_promoter_p_RM_12_38_9 |
 |
 |
4 |
0.6 |
4.05E-04 |
BCL2L11,
ACVRL1,
ABHD6,
DAG1,
MSN |
extrinsic to membrane [CC],
negative regulation of cell migration [BP] |
| CG_adsipsc_promoter_p_RM_14_3_4 |
 |
 |
1 |
0.2 |
1.67E-04 |
SCAMP1,
CLTA |
post-Golgi vesicle-mediated transport [BP] |
| CG_adsipsc_promoter_p_RM_12_36_8 |
 |
 |
3 |
0.4 |
2.75E-04 |
RNASEH2A,
FAM120B,
PRDX5,
CUX1,
STAT5A,
ZNF574,
LCOR,
HEY2,
RNF169,
BRD2,
PPM1D |
auditory receptor cell differentiation [BP],
nucleus [CC] |
| CG_adsipsc_promoter_p_RM_12_489_21 |
 |
 |
4 |
0.6 |
2.85E-04 |
ITGB3,
DPYSL5,
NRGN,
STUB1,
PPIL2,
VEGFA,
PAX2,
POU3F3 |
platelet-derived growth factor receptor binding [MF],
ubiquitin-ubiquitin ligase activity [MF],
metanephric distal convoluted tubule development [BP],
vascular endothelial growth factor receptor binding [MF],
tube development [BP],
vascular endothelial growth factor receptor 2 binding [MF],
metanephric DCT cell differentiation [BP],
nervous system development [BP] |
| CG_adsipsc_promoter_p_RM_14_41_13 |
 |
 |
2 |
0.4 |
3.35E-04 |
RBM38,
ADAMTSL4,
VWC2 |
regulation of myotube differentiation [BP],
interstitial matrix [CC] |
| CG_adsipsc_promoter_p_RM_14_19_6 |
 |
 |
2 |
0.2 |
1.65E-04 |
FGFRL1 |
heart valve morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_12_354_12 |
 |
 |
4 |
0.6 |
2.49E-04 |
RPIA |
ribose-5-phosphate isomerase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_353_15 |
 |
 |
4 |
0.6 |
2.74E-04 |
AGO4,
YWHAH,
TOP1,
TLX2,
CNOT3 |
negative regulation of dendrite morphogenesis [BP],
cytoplasmic mRNA processing body [CC] |
| CG_adsipsc_promoter_p_RM_12_137_15 |
 |
 |
3 |
0.6 |
4.45E-04 |
PELI2,
TRAF3 |
toll-like receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_14_363_15 |
 |
 |
8 |
1.0 |
3.23E-04 |
KAT5,
RBM38 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [BP] |
| CG_adsipsc_promoter_p_RM_12_470_16 |
 |
 |
3 |
0.4 |
3.23E-04 |
MED25,
IFI30,
CDC73,
DYNC1I1 |
condensed chromosome kinetochore [CC],
negative regulation of fibroblast proliferation [BP] |
| CG_adsipsc_promoter_p_RM_12_316_19 |
 |
 |
6 |
0.6 |
3.15E-04 |
RHOB,
ZIC2,
ISL1,
DENND3 |
endosome to lysosome transport [BP],
retinal ganglion cell axon guidance [BP] |
| CG_adsipsc_promoter_p_RM_14_164_24 |
 |
 |
3 |
0.4 |
4.51E-04 |
SQSTM1,
SPATA18,
CDC73,
ID4,
NOG,
NR2F1,
MIF,
RNF169,
SUZ12,
MSX1,
NFIX,
PSEN1,
MAPK8IP2,
CBLC |
response to DNA damage stimulus [BP],
protein ubiquitination [BP],
cerebral cortex neuron differentiation [BP],
negative regulation of astrocyte differentiation [BP],
negative regulation of transcription from RNA polymerase II promoter [BP],
regulation of receptor activity [BP],
forebrain development [BP],
negative regulation of transcription, DNA-dependent [BP],
negative regulation of cell differentiation [BP],
negative regulation of epidermal growth factor-activated receptor activity [BP],
negative regulation of gene expression [BP],
K63-linked polyubiquitin binding [MF],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_12_463_21 |
 |
 |
5 |
0.8 |
3.71E-04 |
EFNB1,
SEMA3F,
SKI,
NR2F2,
SPTBN1,
ZIC2,
FOXF1,
CLTC,
PKD2,
UBR3,
GATAD2A,
TSC2,
DRAXIN,
CACNG7,
CACNA1H |
voltage-gated calcium channel activity [MF],
neural tube closure [BP],
placenta blood vessel development [BP],
axon guidance [BP],
in utero embryonic development [BP],
embryo development [BP],
endocardial cushion development [BP] |
| CG_adsipsc_promoter_p_RM_12_327_16 |
 |
 |
4 |
0.8 |
1.72E-04 |
UTS2R,
JAM3,
NIPBL |
external genitalia morphogenesis [BP],
regulation of actin cytoskeleton organization by cell-cell adhesion [BP],
urotensin II receptor activity [MF] |
| CG_adsipsc_promoter_p_RM_16_26_3 |
 |
 |
2 |
0.4 |
3.09E-04 |
YY1,
PNRC2,
UPF1 |
deadenylation-independent decapping of nuclear-transcribed mRNA [BP],
response to prostaglandin F stimulus [BP],
cytoplasmic mRNA processing body [CC],
RNA localization [BP] |
| CG_adsipsc_promoter_p_RM_12_340_7 |
 |
 |
3 |
0.6 |
1.64E-04 |
PAFAH1B1,
FAM20C,
RB1,
NTSR1,
FOXL1,
MOG,
ACTR10 |
osteoclast development [BP],
establishment of centrosome localization [BP],
visceral mesoderm-endoderm interaction involved in midgut development [BP],
dentinogenesis [BP],
positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP],
microtubule-based movement [BP],
phosphoprotein binding [MF],
microtubule-based process [BP],
adult locomotory behavior [BP],
osteoclast maturation [BP] |
| CG_adsipsc_promoter_p_RM_12_325_13 |
 |
 |
3 |
0.6 |
3.55E-04 |
CBFB,
POU4F3,
ZIC2,
FOSL2,
UNCX |
retinal ganglion cell axon guidance [BP],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_4_10 |
 |
 |
4 |
0.6 |
3.01E-04 |
ACVRL1,
FOXC1,
HES1 |
positive regulation of BMP signaling pathway [BP],
blood vessel remodeling [BP],
lymphangiogenesis [BP],
neural crest cell development [BP],
artery development [BP] |
| CG_adsipsc_promoter_p_RM_14_151_7 |
 |
 |
1 |
0.2 |
4.76E-04 |
NEO1,
CDK5R1,
GRK4,
CNKSR2,
PTGFR |
cadherin binding [MF],
neuronal cell body [CC],
G-protein coupled receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_16_1_10 |
 |
 |
9 |
1.0 |
4.82E-04 |
CAMK1D,
RING1,
PDE1B,
DNAJC6,
MKL2,
PTEN,
ZIC2,
CDC14A,
CXXC5,
CAMTA1,
MNAT1,
HIC1,
IGF1R |
phosphoprotein phosphatase activity [MF],
cytoplasm [CC],
protein tyrosine phosphatase activity [MF],
negative regulation of protein kinase B signaling cascade [BP] |
| CG_adsipsc_promoter_p_RM_12_356_12 |
 |
 |
3 |
0.6 |
2.03E-04 |
BLM,
PCYOX1,
LIG3,
ATG10 |
negative regulation of DNA recombination [BP],
autophagy in response to ER overload [BP],
synaptonemal complex [CC],
prenylcysteine oxidase activity [MF],
chloride-transporting ATPase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_263_5 |
 |
 |
2 |
0.2 |
3.14E-04 |
APOC1,
HHEX |
repressing transcription factor binding [MF],
negative regulation of phosphatidylcholine catabolic process [BP],
hepatic duct development [BP] |
| CG_adsipsc_promoter_p_RM_14_91_6 |
 |
 |
2 |
0.2 |
2.75E-04 |
OSR2 |
osteoblast proliferation [BP] |
| CG_adsipsc_promoter_p_RM_12_229_14 |
 |
 |
4 |
0.6 |
2.74E-04 |
STK11,
CDK5R1,
CAB39,
C9orf96 |
kinase activity [MF],
protein kinase activator activity [MF],
protein kinase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_447_12 |
 |
 |
2 |
0.4 |
3.91E-04 |
PAPD5,
CDT1,
WRNIP1,
ING5 |
DNA replication [BP],
regulation of DNA-dependent DNA replication initiation [BP],
regulation of S phase of mitotic cell cycle [BP] |
| CG_adsipsc_promoter_p_RM_12_382_28 |
 |
 |
4 |
0.6 |
2.82E-04 |
RCC1,
ZNF473,
CSDC2 |
histone mRNA 3'-end processing [BP],
spindle assembly [BP] |
| CG_adsipsc_promoter_p_RM_14_156_2 |
 |
 |
1 |
0.2 |
1.86E-04 |
XRCC5,
UBE4B |
enzyme binding [MF],
Ku70:Ku80 complex [CC] |
| CG_adsipsc_promoter_p_RM_12_111_18 |
 |
 |
4 |
0.6 |
6.06E-04 |
BMP2,
ISL1 |
positive regulation of granulocyte colony-stimulating factor production [BP],
endocardial cushion morphogenesis [BP],
positive regulation of Wnt receptor signaling pathway by BMP signaling pathway [BP],
peripheral nervous system neuron axonogenesis [BP],
cardiocyte differentiation [BP],
negative regulation of cardiac muscle cell differentiation [BP],
positive regulation of macrophage colony-stimulating factor production [BP],
negative regulation of protein homodimerization activity [BP],
cardiac muscle tissue morphogenesis [BP],
pituitary gland development [BP] |
| CG_adsipsc_promoter_p_RM_12_363_16 |
 |
 |
4 |
0.6 |
2.56E-04 |
NAV2,
PAX2,
POU3F3 |
metanephric epithelium development [BP],
optic nerve development [BP],
metanephric DCT cell differentiation [BP],
metanephric distal convoluted tubule development [BP] |
| CG_adsipsc_promoter_p_RM_14_154_7 |
 |
 |
2 |
0.4 |
2.96E-04 |
MARK4,
SHROOM2,
TNFAIP3,
ADCK1,
CNTNAP1,
CLDN9,
SQSTM1,
WTIP,
AMOTL1 |
cytoskeleton organization [BP],
microtubule cytoskeleton [CC],
tight junction [CC],
protein serine/threonine kinase activity [MF],
hippo signaling cascade [BP],
ubiquitin binding [MF] |
| CG_adsipsc_promoter_p_RM_14_265_13 |
 |
 |
3 |
0.2 |
6.22E-04 |
NOG,
PI4K2A,
DOT1L |
negative regulation of cytokine activity [BP],
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
host cell presynaptic membrane [CC],
AP-3 adaptor complex binding [MF],
basophil degranulation [BP],
regulation of JAK-STAT cascade [BP] |
| CG_adsipsc_promoter_p_RM_12_238_11 |
 |
 |
2 |
0.4 |
2.85E-04 |
FOXG1,
HIF1A,
GDF11,
FOXL1,
HOXC11 |
pattern specification process [BP],
positive regulation of neuroblast proliferation [BP],
metanephros development [BP] |
| CG_adsipsc_promoter_p_RM_14_13_6 |
 |
 |
3 |
0.4 |
3.49E-04 |
PLOD1,
TACC2,
TACC3,
AACS,
NAT8L,
PRDM16 |
interkinetic nuclear migration [BP],
rough endoplasmic reticulum membrane [CC],
white fat cell differentiation [BP],
astral microtubule organization [BP] |
| CG_adsipsc_promoter_p_RM_12_208_18 |
 |
 |
5 |
0.8 |
2.36E-04 |
CHAC1,
HIF1AN |
Notch binding [MF],
negative regulation of Notch signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_14_267_4 |
 |
 |
2 |
0.2 |
2.08E-04 |
SPATA18 |
mitochondrion degradation by induced vacuole formation [BP] |
| CG_adsipsc_promoter_p_RM_12_2_15 |
 |
 |
6 |
0.8 |
4.19E-04 |
PPARD,
UPF1,
IGHMBP2 |
RNA-dependent ATPase activity [MF],
ATP-dependent RNA helicase activity [MF],
cell-substrate adhesion [BP] |
| CG_adsipsc_promoter_p_RM_14_396_6 |
 |
 |
2 |
0.2 |
3.79E-04 |
KIT,
HPS6 |
melanocyte differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_73_14 |
 |
 |
3 |
0.6 |
2.86E-04 |
LDLRAP1,
ZAP70 |
phosphotyrosine binding [MF] |
| CG_adsipsc_promoter_p_RM_20_6_2 |
 |
 |
1 |
0.2 |
3.32E-05 |
PTDSS2 |
CDP-diacylglycerol-serine O-phosphatidyltransferase activity [MF],
phosphatidylserine biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_400_11 |
 |
 |
3 |
0.6 |
3.18E-04 |
FOXC1,
OVOL1,
XRCC5 |
Ku70:Ku80 complex [CC],
mesoderm development [BP],
double-stranded DNA binding [MF] |
| CG_adsipsc_promoter_p_RM_14_404_11 |
 |
 |
5 |
0.8 |
3.05E-04 |
P2RX2,
LTB4R |
detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP],
nickel cation binding [MF],
leukotriene B4 receptor activity [MF],
mercury ion binding [MF] |
| CG_adsipsc_promoter_p_RM_14_244_6 |
 |
 |
1 |
0.2 |
3.83E-04 |
SMC3,
FAM20C,
GPR3 |
regulation of meiosis [BP],
meiosis [BP],
dentinogenesis [BP],
osteoclast maturation [BP] |
| CG_adsipsc_promoter_p_RM_12_25_14 |
 |
 |
6 |
1.0 |
3.45E-04 |
PRMT6,
INHBB,
NAT8L,
C1GALT1,
AHR |
histone methyltransferase activity (H3-R2 specific) [MF],
aspartate N-acetyltransferase activity [MF],
host cell surface receptor binding [MF],
cytosolic aryl hydrocarbon receptor complex [CC],
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [MF],
negative regulation of hepatocyte growth factor biosynthetic process [BP],
histone methyltransferase activity (H2A-R3 specific) [MF] |
| CG_adsipsc_promoter_p_RM_14_158_7 |
 |
 |
2 |
0.2 |
2.86E-04 |
PSEN2,
SLC25A4,
IFNAR2,
NRG3,
SLC6A11,
ATP2A2 |
calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF],
integral to plasma membrane [CC],
type I interferon binding [MF] |
| CG_adsipsc_promoter_p_RM_12_31_15 |
 |
 |
3 |
0.4 |
3.41E-04 |
POU4F3,
ZIC2,
APOPT1,
BCL2L11 |
positive regulation of release of cytochrome c from mitochondria [BP],
retinal ganglion cell axon guidance [BP] |
| CG_adsipsc_promoter_p_RM_14_283_2 |
 |
 |
2 |
0.2 |
1.35E-04 |
BIRC7 |
regulation of natural killer cell apoptotic process [BP] |
| CG_adsipsc_promoter_p_RM_14_97_4 |
 |
 |
2 |
0.4 |
5.32E-04 |
AGBL5 |
protein branching point deglutamylation [BP] |
| CG_adsipsc_promoter_p_RM_14_247_3 |
 |
 |
2 |
0.2 |
2.61E-04 |
DOK1,
PDPK1 |
insulin receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_12_203_6 |
 |
 |
5 |
0.8 |
9.89E-05 |
CCNT2,
ELAC1,
LRRFIP1,
ADARB1,
GATA4 |
tRNA 3'-trailer cleavage [BP],
lung lobe formation [BP],
gene expression [BP],
double-stranded RNA binding [MF] |
| CG_adsipsc_promoter_p_RM_12_206_12 |
 |
 |
2 |
0.4 |
3.63E-04 |
SRRT,
KNDC1,
PROX1,
SOX2 |
olfactory placode formation [BP],
neuronal stem cell maintenance [BP],
cerebellar granule cell differentiation [BP],
pigment biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_255_16 |
 |
 |
6 |
1.0 |
2.54E-04 |
RNF4,
FOXP4,
CRAMP1L,
TDRD3,
RBPJ,
ZFPM1,
RXRA,
SUV39H1,
PPARD,
MIXL1,
SKI,
POLR2H,
SMAD6 |
transcription factor binding [MF],
repressing transcription factor binding [MF],
transcription initiation from RNA polymerase II promoter [BP],
chromatin binding [MF],
cardiac muscle tissue morphogenesis [BP],
heart development [BP] |
| CG_adsipsc_promoter_p_RM_14_394_6 |
 |
 |
5 |
0.6 |
2.07E-04 |
SHROOM2 |
eye pigment granule organization [BP] |
| CG_adsipsc_promoter_p_RM_14_281_5 |
 |
 |
2 |
0.2 |
2.60E-04 |
ATP6V0A1,
MALT1,
DNM2,
KCNK3 |
transferrin transport [BP],
B-1 B cell differentiation [BP],
open rectifier potassium channel activity [MF] |
| CG_adsipsc_promoter_p_RM_14_174_5 |
 |
 |
2 |
0.4 |
3.91E-04 |
MVB12B,
CHMP4B,
CHMP2B |
late endosome membrane [CC] |
| CG_adsipsc_promoter_p_RM_12_348_9 |
 |
 |
4 |
0.6 |
2.32E-04 |
HK1,
G6PC3,
SPEN,
BMPR1A,
RCOR1,
RBAK,
SOX2,
VAX2 |
ectoderm development [BP],
glucose 6-phosphate metabolic process [BP],
negative regulation of transcription, DNA-dependent [BP],
dorsal/ventral axis specification [BP],
transcription regulatory region DNA binding [MF] |
| CG_adsipsc_promoter_p_RM_12_6_17 |
 |
 |
4 |
0.6 |
3.81E-04 |
FZD1,
RGS7BP,
AXL,
PTK7,
APC2 |
dendritic cell differentiation [BP],
planar cell polarity pathway involved in neural tube closure [BP],
negative regulation of catenin import into nucleus [BP],
negative regulation of signal transduction [BP] |
| CG_adsipsc_promoter_p_RM_12_175_15 |
 |
 |
5 |
0.8 |
2.78E-04 |
TFAM |
regulation of transcription from RNA polymerase I promoter [BP] |
| CG_adsipsc_promoter_p_RM_14_45_10 |
 |
 |
2 |
0.2 |
3.09E-04 |
TRIM28,
IRF5,
CUX2,
HOXC12,
MYRF,
TCF7 |
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_14_95_2 |
 |
 |
2 |
0.2 |
1.64E-04 |
GAA |
maltose metabolic process [BP],
sucrose metabolic process [BP],
diaphragm contraction [BP],
vacuolar sequestering [BP] |
| CG_adsipsc_promoter_p_RM_14_178_2 |
 |
 |
1 |
0.2 |
1.38E-04 |
SKI,
NACC1,
DDX20,
FAM20C |
transcriptional repressor complex [CC],
nuclear body [CC],
dentinogenesis [BP],
osteoclast maturation [BP] |
| CG_adsipsc_promoter_p_RM_12_296_12 |
 |
 |
5 |
0.8 |
3.08E-04 |
ELMOD2 |
regulation of defense response to virus [BP] |
| CG_adsipsc_promoter_p_RM_12_234_7 |
 |
 |
2 |
0.4 |
2.50E-04 |
RAC1,
FGFR3 |
positive regulation of phosphatidylinositol 3-kinase activity [BP],
cochlea development [BP] |
| CG_adsipsc_promoter_p_RM_12_94_22 |
 |
 |
5 |
0.6 |
2.87E-04 |
IRF5,
GGPS1,
POLR3G |
isoprenoid metabolic process [BP],
positive regulation of interferon-beta production [BP] |
| CG_adsipsc_promoter_p_RM_14_269_9 |
 |
 |
2 |
0.2 |
4.96E-04 |
NF1,
FOXC1,
ALDH1A3,
HOXC11 |
forebrain astrocyte development [BP],
eye development [BP],
artery morphogenesis [BP],
metanephros development [BP],
camera-type eye development [BP],
collagen fibril organization [BP],
nucleus accumbens development [BP] |
| CG_adsipsc_promoter_p_RM_12_90_9 |
 |
 |
5 |
0.8 |
4.05E-04 |
KLC3,
SPHK1 |
sphingoid catabolic process [BP],
cardiolipin synthase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_33_7 |
 |
 |
2 |
0.2 |
1.74E-04 |
SOX2,
ID2,
GPR3 |
regulation of meiosis [BP],
negative regulation of osteoblast differentiation [BP] |
| CG_adsipsc_promoter_p_RM_14_31_7 |
 |
 |
2 |
0.2 |
2.33E-04 |
ELAC1,
NT5M |
tRNA 3'-trailer cleavage [BP],
dUMP catabolic process [BP] |
| CG_adsipsc_promoter_p_RM_12_441_17 |
 |
 |
4 |
0.8 |
2.82E-04 |
PDP1,
PDK2,
SETD6,
EHMT1 |
peptidyl-lysine monomethylation [BP],
regulation of acetyl-CoA biosynthetic process from pyruvate [BP] |
| CG_adsipsc_promoter_p_RM_14_228_14 |
 |
 |
3 |
0.2 |
2.94E-04 |
SNRPD3,
IRF9,
CARM1,
PSMD13,
ADARB1,
CTNNB1,
MAFK,
KDM2A,
SART1,
E4F1 |
type I interferon biosynthetic process [BP],
regulation of nephron tubule epithelial cell differentiation [BP],
nucleoplasm [CC] |
| CG_adsipsc_promoter_p_RM_12_117_18 |
 |
 |
4 |
0.8 |
2.86E-04 |
PPRC1,
FOXE1,
HOXC4,
HOXC6,
UBR3,
RPS3,
SOX1,
ACVR2B,
CERS4,
CDC73,
BACH1,
CCNE1,
ZNF621,
MKL2,
AATF,
LFNG,
TGFBR1,
SMARCB1,
RPS21,
FOXD2,
ZNF684,
CCRN4L,
ZNF584,
ZNF589,
ZNF526,
KCNH3,
HLX,
ZNF740,
LMO4,
FN3KRP,
ITM2B,
LPIN1,
TGIF1,
ZNF274,
PDPK1,
TCF19,
WWC1,
TFDP1,
HINFP |
regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
organ morphogenesis [BP],
regulation of transcription, DNA-dependent [BP],
sequence-specific DNA binding transcription factor activity [MF],
transcription, DNA-dependent [BP],
negative regulation of amyloid precursor protein biosynthetic process [BP],
regulation of gene expression [BP],
kinase activity [MF],
pattern specification process [BP],
RNA metabolic process [BP],
embryo development [BP] |
| CG_adsipsc_promoter_p_RM_14_408_4 |
 |
 |
2 |
0.4 |
3.36E-04 |
USP14,
USP10 |
cysteine-type endopeptidase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_22_14 |
 |
 |
4 |
0.8 |
3.37E-04 |
PPP1R14C |
regulation of phosphorylation [BP] |
| CG_adsipsc_promoter_p_RM_12_359_11 |
 |
 |
3 |
0.4 |
2.67E-04 |
PTPN12,
SPTBN4,
SEPT11,
GRASP |
cell junction [CC],
cardiac conduction [BP] |
| CG_adsipsc_promoter_p_RM_14_93_2 |
 |
 |
1 |
0.2 |
4.37E-04 |
FGD5,
AGRN |
positive regulation of synaptic growth at neuromuscular junction [BP],
filopodium assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_465_20 |
 |
 |
7 |
1.0 |
2.58E-04 |
FOXP4,
NAA40,
DAND5,
SMO,
TBX1,
FOXL1,
TCF25,
KAT8 |
semicircular canal morphogenesis [BP],
determination of left/right asymmetry in lateral mesoderm [BP],
embryonic viscerocranium morphogenesis [BP],
acetyltransferase activity [MF],
N-acetyltransferase activity [MF],
heart development [BP] |
| CG_adsipsc_promoter_p_RM_12_242_13 |
 |
 |
4 |
0.8 |
2.96E-04 |
NTRK2,
HSPB1,
VEGFA |
endothelial cell chemotaxis [BP],
positive regulation of endothelial cell chemotaxis [BP],
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [BP],
central nervous system neuron development [BP] |
| CG_adsipsc_promoter_p_RM_12_140_10 |
 |
 |
3 |
0.6 |
2.60E-04 |
TAF5,
YY1,
HOXD4,
KLF11,
NR2C2,
CTCF,
MAP3K10,
ZSCAN22,
HOXC11 |
transcription corepressor activity [MF],
sequence-specific DNA binding transcription factor activity [MF] |
| CG_adsipsc_promoter_p_RM_12_54_6 |
 |
 |
3 |
0.4 |
2.97E-04 |
ADRB1,
TERF2IP,
DKC1,
RAI1 |
telomere maintenance via telomerase [BP],
negative regulation of multicellular organism growth [BP] |
| CG_adsipsc_promoter_p_RM_12_197_6 |
 |
 |
2 |
0.4 |
3.75E-04 |
KLHL10,
BMP2,
MSH2,
FGFR3,
GADD45B,
MYO9B,
RDH12,
GATA3,
ATP5C1 |
regulation of cell cycle [BP],
ADP binding [MF],
cellular response to BMP stimulus [BP],
negative regulation of cell cycle [BP],
response to X-ray [BP],
bone maturation [BP],
male gonad development [BP],
ATP catabolic process [BP],
retinol dehydrogenase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_289_16 |
 |
 |
4 |
0.8 |
3.46E-04 |
TYMS |
tetrahydrofolate metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_12_395_17 |
 |
 |
6 |
1.0 |
2.39E-04 |
NOG,
HOXD3,
PVRL3,
NPY5R,
FOXF1,
LIMD1,
LRP5 |
cardiac left ventricle morphogenesis [BP],
morphogenesis of a branching structure [BP],
negative regulation of osteoblast differentiation [BP],
retina morphogenesis in camera-type eye [BP],
anterior/posterior pattern specification [BP] |
| CG_adsipsc_promoter_p_RM_12_78_19 |
 |
 |
4 |
0.8 |
3.39E-04 |
CNTNAP1,
TMPO,
SBK1,
VAX2,
SQSTM1,
WNK2,
NARF,
NEFH,
GNAZ,
RPS6KB2,
MARK4,
JAK2,
KLF2,
PPP2R5D,
PSKH1,
ADCK1,
PKNOX1,
CTNNA2,
VLDLR,
GNAI1 |
axonogenesis [BP],
G-protein coupled serotonin receptor binding [MF],
protein serine/threonine kinase activity [MF],
neuron projection morphogenesis [BP],
protein kinase activity [MF],
cell morphogenesis [BP],
lamin binding [MF],
erythrocyte differentiation [BP],
nervous system development [BP] |
| CG_adsipsc_promoter_p_RM_14_204_12 |
 |
 |
4 |
0.4 |
2.64E-04 |
HIC1,
FZD7,
CCND1,
FZD9,
FGF9,
NOD2,
PDPK1,
SNX32,
GATA3,
TRAF4 |
positive regulation of phosphorylation [BP],
Wnt receptor signaling pathway [BP],
negative regulation of toll-like receptor signaling pathway [BP],
vasculature development [BP],
negative regulation of interleukin-2 production [BP],
negative regulation of interferon-gamma production [BP],
positive regulation of signal transduction [BP],
gonad development [BP],
positive regulation of JNK cascade [BP],
response to X-ray [BP],
mesenchymal to epithelial transition [BP],
Wnt-activated receptor activity [MF],
male gonad development [BP],
cell communication [BP],
canonical Wnt receptor signaling pathway [BP],
positive regulation of epithelial cell proliferation [BP],
positive regulation of stress-activated MAPK cascade [BP] |
| CG_adsipsc_promoter_p_RM_14_119_4 |
 |
 |
2 |
0.2 |
3.64E-04 |
MTO1 |
mitochondrial tRNA wobble uridine modification [BP] |
| CG_adsipsc_promoter_p_RM_12_443_11 |
 |
 |
4 |
0.8 |
1.54E-04 |
MESP2,
FOXF1,
FGF2,
FOXB1 |
mammary gland epithelial cell differentiation [BP],
epithelial cell differentiation involved in mammary gland alveolus development [BP],
somitogenesis [BP],
mammary gland lobule development [BP] |
| CG_adsipsc_promoter_p_RM_14_399_3 |
 |
 |
3 |
0.4 |
2.18E-04 |
AGBL5,
STRA8,
HIF1AN |
protein branching point deglutamylation [BP],
peptidyl-histidine hydroxylation [BP],
peptidyl-histidine dioxygenase activity [MF],
peptidyl-asparagine 3-dioxygenase activity [MF],
meiotic cell cycle DNA replication checkpoint [BP],
peptidyl-asparagine hydroxylation [BP] |
| CG_adsipsc_promoter_p_RM_16_44_8 |
 |
 |
11 |
1.0 |
4.87E-04 |
SUDS3,
MLL5,
HOXD11,
MAPKAPK2,
ADORA2A,
SAP30,
IRX5,
SNRNP70,
TSPYL2,
SUV39H1,
ARID2,
SALL3,
NFATC2IP,
KL,
GNAS,
NOG,
INSM1,
ADRB1,
STAT5A,
ZNF778,
PDX1,
ACTR5,
GATAD2A,
PTPRJ,
YY1 |
histone deacetylase complex [CC],
gene expression [BP],
Ino80 complex [CC],
response to wounding [BP],
negative regulation of vascular permeability [BP],
RNA metabolic process [BP],
regulation of inhibitory postsynaptic membrane potential [BP],
response to fatty acid [BP],
regulation of transcription, DNA-dependent [BP],
DNA methylation [BP],
transcription, DNA-dependent [BP],
type B pancreatic cell differentiation [BP],
embryonic skeletal system development [BP],
endocrine pancreas development [BP],
adenylate cyclase-activating G-protein coupled receptor signaling pathway [BP],
activation of adenylate cyclase activity [BP],
transmembrane receptor protein tyrosine kinase signaling pathway [BP],
vitamin D binding [MF] |
| CG_adsipsc_promoter_p_RM_14_139_5 |
 |
 |
2 |
0.2 |
2.91E-04 |
GPT2 |
L-alanine:2-oxoglutarate aminotransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_271_13 |
 |
 |
4 |
0.8 |
3.02E-04 |
KLHL17,
UHMK1 |
dendrite cytoplasm [CC] |
| CG_adsipsc_promoter_p_RM_12_265_9 |
 |
 |
3 |
0.6 |
2.22E-04 |
TRIB1,
MAPK8IP1 |
mitogen-activated protein kinase kinase binding [MF] |
| CG_adsipsc_promoter_p_RM_12_451_9 |
 |
 |
5 |
1.0 |
2.50E-04 |
PTK2B,
NDST3,
CTNNB1 |
glial cell proliferation [BP],
regulation of myelination [BP],
heparan sulfate proteoglycan biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_14_285_9 |
 |
 |
2 |
0.2 |
2.87E-04 |
MAPKAPK5,
PTPRJ,
PLEKHA2,
ERBB2 |
positive regulation of cell-matrix adhesion [BP],
mitogen-activated protein kinase binding [MF],
positive regulation of cell adhesion [BP] |
| CG_adsipsc_promoter_p_RM_12_129_11 |
 |
 |
3 |
0.6 |
2.23E-04 |
DKK1,
CTNNB1,
SHROOM2,
HS3ST3B1,
FOXF2,
CHD7 |
camera-type eye morphogenesis [BP],
heparan sulfate proteoglycan biosynthetic process [BP],
genitalia development [BP],
embryonic limb morphogenesis [BP],
endoderm formation [BP],
embryonic hindlimb morphogenesis [BP],
camera-type eye development [BP],
endodermal cell fate commitment [BP],
lens morphogenesis in camera-type eye [BP] |
| CG_adsipsc_promoter_p_RM_12_381_14 |
 |
 |
4 |
0.8 |
2.17E-04 |
ALDH1A3,
HADH |
NAD+ binding [MF] |
| CG_adsipsc_promoter_p_RM_14_172_8 |
 |
 |
2 |
0.2 |
2.63E-04 |
NAT8L |
aspartate N-acetyltransferase activity [MF] |
| CG_adsipsc_promoter_p_RM_16_46_4 |
 |
 |
2 |
0.2 |
5.42E-04 |
GIGYF2,
SLC12A2,
KLF2 |
multicellular organism growth [BP] |
| CG_adsipsc_promoter_p_RM_16_6_3 |
 |
 |
3 |
0.4 |
4.57E-04 |
PPCDC,
ACSL3 |
positive regulation of phosphatidylcholine biosynthetic process [BP],
phosphopantothenoylcysteine decarboxylase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_358_7 |
 |
 |
3 |
0.4 |
2.68E-04 |
MPDU1,
MGAT2 |
oligosaccharide biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_14_59_6 |
 |
 |
1 |
0.2 |
2.21E-04 |
AGBL5,
TBCD,
BCL2L11,
SPAST,
CMPK1 |
BIM-BCL-xl complex [CC],
tubulin binding [MF],
protein branching point deglutamylation [BP],
beta-tubulin binding [MF],
CDP biosynthetic process [BP],
BIM-BCL-2 complex [CC],
dCDP biosynthetic process [BP],
UDP biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_263_7 |
 |
 |
2 |
0.4 |
4.36E-04 |
TRIM71,
PFKFB3 |
miRNA metabolic process [BP],
fructose metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_14_212_8 |
 |
 |
2 |
0.2 |
3.50E-04 |
THBS4,
EIF2AK4,
CHIA,
FGF17,
PAK2,
BMP2 |
cell wall chitin metabolic process [BP],
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [BP],
phosphorylation [BP],
protein phosphorylation [BP],
positive regulation of Wnt receptor signaling pathway by BMP signaling pathway [BP],
growth factor activity [MF] |
| CG_adsipsc_promoter_p_RM_14_163_6 |
 |
 |
2 |
0.2 |
1.25E-04 |
NQO2 |
dihydronicotinamide riboside quinone reductase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_320_10 |
 |
 |
3 |
0.4 |
1.03E-04 |
SWI5 |
Swi5-Sfr1 complex [CC] |
| CG_adsipsc_promoter_p_RM_16_21_12 |
 |
 |
9 |
0.8 |
2.93E-04 |
PPARD |
fatty acid transport [BP] |
| CG_adsipsc_promoter_p_RM_12_449_12 |
 |
 |
3 |
0.6 |
1.38E-04 |
FAM20C,
FAHD1 |
fumarylpyruvate hydrolase activity [MF],
acylpyruvate hydrolase activity [MF],
odontoblast differentiation [BP],
dentinogenesis [BP],
acetylpyruvate hydrolase activity [MF],
osteoclast maturation [BP] |
| CG_adsipsc_promoter_p_RM_12_251_6 |
 |
 |
2 |
0.4 |
1.95E-04 |
TFAP2C |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_137_7 |
 |
 |
4 |
0.4 |
2.88E-04 |
AK4,
ARHGEF10 |
tetracycline metabolic process [BP],
positive regulation of GTP catabolic process [BP],
nucleoside triphosphate adenylate kinase activity [MF],
carbon tetrachloride metabolic process [BP] |
| CG_adsipsc_promoter_p_RM_14_78_9 |
 |
 |
2 |
0.2 |
3.42E-04 |
FOXG1,
KL,
IGFBP2 |
aging [BP] |
| CG_adsipsc_promoter_p_RM_14_342_3 |
 |
 |
2 |
0.2 |
2.40E-04 |
PDK1,
ELK3,
PDK3,
PAX2,
ATF5,
PRRX2,
PBX3,
E4F1 |
positive regulation of optic nerve formation [BP],
vestibulocochlear nerve formation [BP],
transcription corepressor activity [MF],
regulation of acetyl-CoA biosynthetic process from pyruvate [BP],
optic chiasma development [BP],
sequence-specific DNA binding transcription factor activity [MF],
anterior compartment pattern formation [BP],
sequence-specific DNA binding [MF],
pyruvate dehydrogenase (acetyl-transferring) kinase activity [MF],
hypoxia-inducible factor-1alpha signaling pathway [BP],
pyruvate metabolic process [BP],
posterior compartment specification [BP] |
| CG_adsipsc_promoter_p_RM_12_419_7 |
 |
 |
5 |
0.8 |
3.25E-04 |
RAD23A |
polyubiquitin binding [MF] |
| CG_adsipsc_promoter_p_RM_14_214_4 |
 |
 |
2 |
0.2 |
2.83E-04 |
MAPRE1 |
cortical microtubule cytoskeleton [CC] |
| CG_adsipsc_promoter_p_RM_14_170_7 |
 |
 |
2 |
0.2 |
4.09E-04 |
PKN3,
PRKCZ,
SUDS3,
SERPINF2,
KAT8 |
positive regulation of cell differentiation [BP],
protein kinase C activity [MF],
enzyme binding [MF] |
| CG_adsipsc_promoter_p_RM_16_42_5 |
 |
 |
11 |
1.0 |
4.45E-04 |
FOXA3 |
positive regulation of hepatocyte differentiation [BP] |
| CG_adsipsc_promoter_p_RM_12_262_11 |
 |
 |
4 |
0.8 |
2.31E-04 |
SMAD5,
BHLHE22,
SMAD1,
VSX2,
CHAC1,
PRDM16 |
neurogenesis [BP],
retinal bipolar neuron differentiation [BP],
osteoblast fate commitment [BP],
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [BP],
transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [MF] |
| CG_adsipsc_promoter_p_RM_12_410_9 |
 |
 |
6 |
1.0 |
3.46E-04 |
DDIT4,
DYRK2 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [BP] |
| CG_adsipsc_promoter_p_RM_14_350_7 |
 |
 |
2 |
0.2 |
2.39E-04 |
FZD2,
RPS6KA4,
ZFPM1,
FGFRL1,
VEGFA,
EPAS1 |
positive regulation of CREB transcription factor activity [BP],
surfactant homeostasis [BP],
ventricular septum morphogenesis [BP],
primitive erythrocyte differentiation [BP],
outflow tract morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_18_5_1 |
 |
 |
1 |
0.2 |
2.38E-04 |
PLOD1,
ACTN2 |
FATZ binding [MF],
titin Z domain binding [MF],
positive regulation of potassium ion transmembrane transporter activity [BP],
procollagen-lysine 5-dioxygenase activity [MF],
negative regulation of potassium ion transmembrane transporter activity [BP],
hydroxylysine biosynthetic process [BP],
microspike assembly [BP] |
| CG_adsipsc_promoter_p_RM_12_458_10 |
 |
 |
4 |
0.8 |
1.48E-04 |
CUL1,
USP47 |
SCF ubiquitin ligase complex [CC] |
| CG_adsipsc_promoter_p_RM_14_131_4 |
 |
 |
1 |
0.2 |
3.35E-04 |
MOG,
TUBB3,
LLGL1,
PALM |
axon [CC],
positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_303_20 |
 |
 |
5 |
0.8 |
3.92E-04 |
CDK5R1,
FOXQ1 |
embryo development [BP] |
| CG_adsipsc_promoter_p_RM_14_369_8 |
 |
 |
2 |
0.2 |
3.25E-04 |
LPIN3,
LRP5,
NUB1,
ITGB8,
HLA-A,
EGFR,
HLA-F,
HLA-E,
ST8SIA2,
TMEM59L,
BMPR1B,
RINT1,
RDH10,
FOXF1,
FAM69B,
PAX2,
GORASP2,
PTF1A,
SOX8,
PTDSS2 |
MHC class I protein complex [CC],
endoplasmic reticulum membrane [CC],
phagocytic vesicle membrane [CC],
MHC class I receptor activity [MF],
response to interferon-gamma [BP],
integral to lumenal side of endoplasmic reticulum membrane [CC],
positive regulation of kidney development [BP],
eye development [BP],
ureter morphogenesis [BP],
ganglioside metabolic process [BP],
embryonic camera-type eye development [BP],
morphogenesis of a branching structure [BP],
retina morphogenesis in camera-type eye [BP],
retina development in camera-type eye [BP],
ureter development [BP],
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP],
Golgi membrane [CC],
metanephric nephron tubule formation [BP],
camera-type eye development [BP],
ER to Golgi transport vesicle membrane [CC],
morphogenesis of a branching epithelium [BP] |
| CG_adsipsc_promoter_p_RM_14_50_4 |
 |
 |
2 |
0.2 |
3.16E-04 |
SPAG6 |
axoneme [CC] |
| CG_adsipsc_promoter_p_RM_12_346_9 |
 |
 |
5 |
0.8 |
4.15E-04 |
LLGL2 |
intracellular membrane-bounded organelle [CC] |
| CG_adsipsc_promoter_p_RM_14_114_5 |
 |
 |
2 |
0.2 |
4.23E-04 |
QSOX1,
SLC6A8 |
creatine transmembrane transporter activity [MF],
creatine transport [BP],
creatine:sodium symporter activity [MF],
flavin-linked sulfhydryl oxidase activity [MF] |
| CG_adsipsc_promoter_p_RM_12_120_13 |
 |
 |
6 |
1.0 |
2.61E-04 |
CD274,
HLA-A,
NBR1,
HLA-F,
HLA-E,
USP13,
USO1,
MIB2,
PLEKHA3,
ABL1,
F2RL1,
GALNT13 |
interferon-gamma-mediated signaling pathway [BP],
MHC class I receptor activity [MF],
early endosome membrane [CC],
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [BP],
mitogen-activated protein kinase binding [MF],
phagocytic vesicle membrane [CC],
endomembrane system [CC],
interleukin-10 secretion [BP],
integral to lumenal side of endoplasmic reticulum membrane [CC],
autophagy [BP],
MHC class I protein complex [CC],
antigen processing and presentation of exogenous peptide antigen via MHC class I [BP],
antigen processing and presentation of peptide antigen via MHC class I [BP],
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP],
endosome [CC],
Golgi membrane [CC],
ER to Golgi transport vesicle membrane [CC],
type I interferon-mediated signaling pathway [BP],
Golgi apparatus [CC] |
| CG_adsipsc_promoter_p_RM_14_375_6 |
 |
 |
2 |
0.2 |
2.44E-04 |
HHEX |
hepatic duct development [BP] |
| CG_adsipsc_promoter_p_RM_12_323_15 |
 |
 |
5 |
0.8 |
6.55E-04 |
RALB,
INSIG1,
RBM4 |
circadian regulation of translation [BP],
IRES-dependent translational initiation [BP],
cap-independent translational initiation [BP],
pre-mRNA intronic pyrimidine-rich binding [MF],
negative regulation of cargo loading into COPII-coated vesicle [BP],
regulation of exocyst assembly [BP] |
| CG_adsipsc_promoter_p_RM_14_133_4 |
 |
 |
2 |
0.2 |
3.75E-04 |
TCF7L1,
ING2,
ARNT2,
SMAD4 |
transcription factor complex [CC],
positive regulation of transforming growth factor beta receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_14_210_3 |
 |
 |
2 |
0.2 |
2.69E-04 |
SNAI1,
MUM1,
JAK2 |
mineralocorticoid receptor signaling pathway [BP],
negative regulation of cell differentiation involved in embryonic placenta development [BP],
histone kinase activity (H3-Y41 specific) [MF],
histone H3-Y41 phosphorylation [BP],
mesoderm development [BP],
chromatin organization [BP],
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_177_13 |
 |
 |
4 |
0.8 |
3.14E-04 |
RET,
MID1IP1,
GATA3 |
ureter maturation [BP],
positive regulation of ligase activity [BP] |
| CG_adsipsc_promoter_p_RM_14_242_16 |
 |
 |
2 |
0.2 |
3.06E-04 |
DMBX1,
LEP |
adult feeding behavior [BP] |
| CG_adsipsc_promoter_p_RM_12_471_6 |
 |
 |
3 |
0.4 |
2.67E-04 |
BUB3,
CCNA1,
TREX1,
MSH6,
THBS1,
ING2,
GPS1 |
male meiosis I [BP],
meiosis [BP],
MutLalpha complex binding [MF],
cell cycle [BP],
mismatch repair [BP],
positive regulation of transforming growth factor beta receptor signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_369_20 |
 |
 |
2 |
0.4 |
2.38E-04 |
MGAT2,
BBS5,
COG2 |
flagellum assembly [BP],
oligosaccharide biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_383_21 |
 |
 |
7 |
1.0 |
3.52E-04 |
CXADR |
transepithelial transport [BP] |
| CG_adsipsc_promoter_p_RM_18_7_1 |
 |
 |
2 |
0.2 |
2.20E-04 |
DSP,
ACADS |
butyrate catabolic process [BP],
butyryl-CoA dehydrogenase activity [MF],
ventricular compact myocardium morphogenesis [BP] |
| CG_adsipsc_promoter_p_RM_14_377_7 |
 |
 |
4 |
0.6 |
3.77E-04 |
RAC1,
LPIN1 |
epithelial cell morphogenesis [BP],
ruffle organization [BP] |
| CG_adsipsc_promoter_p_RM_12_335_15 |
 |
 |
5 |
0.8 |
2.37E-04 |
PKD2,
MPST,
MOCS3,
PAX2,
PTEN |
metanephric collecting duct development [BP],
mesonephric duct development [BP],
sulfurtransferase activity [MF],
optic cup morphogenesis involved in camera-type eye development [BP],
metanephric distal tubule development [BP],
thiosulfate sulfurtransferase activity [MF],
negative regulation of G1/S transition of mitotic cell cycle [BP] |
| CG_adsipsc_promoter_p_RM_12_472_12 |
 |
 |
3 |
0.4 |
3.18E-04 |
CHST7,
CHST12 |
chondroitin sulfate biosynthetic process [BP] |
| CG_adsipsc_promoter_p_RM_12_350_24 |
 |
 |
4 |
0.6 |
2.31E-04 |
COL15A1 |
collagen type XV [CC] |
| CG_adsipsc_promoter_p_RM_12_408_14 |
 |
 |
4 |
0.8 |
2.77E-04 |
SHROOM2,
GNAI2,
NTRK1,
RIPK1 |
activation of MAPKK activity [BP],
neurotrophin p75 receptor binding [MF],
regulation of ATP:ADP antiporter activity [BP],
eye pigment granule organization [BP] |
| CG_adsipsc_promoter_p_RM_14_330_8 |
 |
 |
5 |
0.8 |
1.06E-04 |
UPF3A,
FPGS,
HSP90AB1 |
positive regulation of translation [BP],
sulfonylurea receptor binding [MF],
tetrahydrofolylpolyglutamate synthase activity [MF],
CTP binding [MF] |
| CG_adsipsc_promoter_p_RM_14_71_2 |
 |
 |
1 |
0.2 |
1.91E-04 |
NTMT1,
FNTB |
N-terminal peptidyl-alanine trimethylation [BP],
N-terminal peptidyl-serine trimethylation [BP],
protein farnesyltransferase complex [CC],
N-terminal peptidyl-serine dimethylation [BP],
N-terminal peptidyl-proline dimethylation [BP] |
| CG_adsipsc_promoter_p_RM_16_22_3 |
 |
 |
3 |
0.2 |
1.77E-04 |
SOX17,
NTRK1 |
inner cell mass cellular morphogenesis [BP],
neurotrophin p75 receptor binding [MF],
cardiogenic plate morphogenesis [BP],
regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification [BP] |
| CG_adsipsc_promoter_p_RM_12_126_4 |
 |
 |
3 |
0.6 |
7.67E-05 |
PTK2B |
response to hormone stimulus [BP] |
| CG_adsipsc_promoter_p_RM_12_249_8 |
 |
 |
3 |
0.6 |
3.04E-04 |
CACNA1G,
DOLPP1 |
dolichyldiphosphatase activity [MF],
response to nickel cation [BP] |
| CG_adsipsc_promoter_p_RM_14_277_10 |
 |
 |
2 |
0.2 |
2.86E-04 |
HSF1,
ARID5A,
ISL1,
ZFYVE9,
ZIC2,
SKI,
ADAMTSL2 |
negative regulation of transforming growth factor beta receptor signaling pathway [BP],
chromatin binding [MF],
retinal ganglion cell axon guidance [BP] |
| CG_adsipsc_promoter_p_RM_16_20_2 |
 |
 |
9 |
0.8 |
3.78E-04 |
STK11 |
response to glucagon stimulus [BP] |
| CG_adsipsc_promoter_p_RM_14_248_6 |
 |
 |
2 |
0.2 |
1.19E-04 |
NPL |
N-acetylneuraminate lyase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_191_17 |
 |
 |
5 |
0.8 |
3.11E-04 |
SGPL1,
NTMT1,
SOX12 |
spinal cord development [BP],
sphinganine-1-phosphate aldolase activity [MF],
N-terminal peptidyl-proline dimethylation [BP],
N-terminal peptidyl-serine dimethylation [BP],
N-terminal peptidyl-alanine trimethylation [BP],
N-terminal peptidyl-serine trimethylation [BP] |
| CG_adsipsc_promoter_p_RM_14_401_8 |
 |
 |
5 |
0.6 |
4.06E-04 |
TNFSF9,
TRAF2 |
tumor necrosis factor receptor binding [MF] |
| CG_adsipsc_promoter_p_RM_14_332_4 |
 |
 |
1 |
0.2 |
1.17E-04 |
PPIA |
uncoating of virus [BP] |
| CG_adsipsc_promoter_p_RM_12_432_3 |
 |
 |
4 |
0.8 |
1.71E-04 |
NUDT16,
TDGF1,
EDN1 |
ITP binding [MF],
regulation of vasoconstriction [BP],
endothelin A receptor binding [MF],
positive regulation of endothelial cell migration [BP],
protein kinase C deactivation [BP],
XDP catabolic process [BP],
XTP binding [MF],
snoRNA catabolic process [BP],
phospholipase D-activating G-protein coupled receptor signaling pathway [BP],
endothelin B receptor binding [MF],
dITP catabolic process [BP] |
| CG_adsipsc_promoter_p_RM_12_275_13 |
 |
 |
3 |
0.6 |
1.89E-04 |
ABCD1 |
peroxisomal long-chain fatty acid import [BP] |
| CG_adsipsc_promoter_p_RM_14_234_5 |
 |
 |
4 |
0.6 |
3.37E-04 |
NFYA,
TNKS2,
RHBDD1,
MOCS3 |
protein binding [MF],
URM1 activating enzyme activity [MF] |
| CG_adsipsc_promoter_p_RM_12_34_11 |
 |
 |
3 |
0.6 |
1.77E-04 |
SLC12A5 |
thermosensory behavior [BP] |
| CG_adsipsc_promoter_p_RM_14_403_7 |
 |
 |
5 |
0.8 |
1.15E-04 |
SOX1,
SOX9 |
core promoter sequence-specific DNA binding [MF] |
| CG_adsipsc_promoter_p_RM_16_2_14 |
 |
 |
9 |
1.0 |
4.90E-04 |
SIRT1,
DAG1,
IL4R,
ALMS1,
TRIM24 |
ovulation [BP],
negative regulation of protein kinase B signaling cascade [BP],
nuclear euchromatin [CC] |
| CG_adsipsc_promoter_p_RM_12_10_12 |
 |
 |
7 |
1.0 |
2.45E-04 |
BRSK1,
SPATC1 |
gamma-tubulin binding [MF] |
| CG_adsipsc_promoter_p_RM_20_10_1 |
 |
 |
1 |
0.2 |
7.89E-04 |
PCDHA13,
PCDHA7,
PCDHA5,
PCDHA12 |
homophilic cell adhesion [BP],
calcium ion binding [MF],
cell adhesion [BP] |
| CG_adsipsc_promoter_p_RM_16_24_5 |
 |
 |
2 |
0.2 |
5.12E-04 |
ADRB1,
MIS12,
HSF1 |
MIS12/MIND type complex [CC],
beta1-adrenergic receptor activity [MF],
positive regulation of the force of heart contraction by norepinephrine [BP],
positive regulation of cell growth involved in cardiac muscle cell development [BP],
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure [BP],
RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [MF] |
| CG_adsipsc_promoter_p_RM_12_435_14 |
 |
 |
4 |
0.8 |
3.24E-04 |
NRF1 |
generation of precursor metabolites and energy [BP] |
| CG_adsipsc_promoter_p_RM_14_405_9 |
 |
 |
3 |
0.4 |
4.20E-04 |
PTPRM,
BHLHE22,
P2RX4,
IRX5 |
retinal bipolar neuron differentiation [BP],
cadherin binding [MF] |
| CG_adsipsc_promoter_p_RM_14_157_5 |
 |
 |
2 |
0.2 |
2.25E-04 |
SNCAIP,
CRTAP,
ZNRF2 |
peptidyl-proline hydroxylation to 3-hydroxy-L-proline [BP],
presynaptic membrane [CC] |
| CG_adsipsc_promoter_p_RM_12_273_14 |
 |
 |
3 |
0.6 |
2.81E-04 |
AGAP3,
TRAFD1,
ASAP2,
IRAK3,
AGAP1 |
regulation of ARF GTPase activity [BP],
ARF GTPase activator activity [MF],
negative regulation of innate immune response [BP] |
| CG_adsipsc_promoter_p_RM_14_336_8 |
 |
 |
1 |
0.2 |
3.26E-04 |
PGS1,
TARBP2 |
CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF],
miRNA loading onto RISC involved in gene silencing by miRNA [BP] |
| CG_adsipsc_promoter_p_RM_12_484_8 |
 |
 |
4 |
0.6 |
3.12E-04 |
NPY5R,
PPYR1 |
pancreatic polypeptide receptor activity [MF],
neuropeptide Y receptor activity [MF],
peptide YY receptor activity [MF] |
| CG_adsipsc_promoter_p_RM_14_337_2 |
 |
 |
2 |
0.2 |
1.65E-04 |
AVL9,
LMTK2,
DECR1 |
myosin VI binding [MF],
recycling endosome [CC],
2,4-dienoyl-CoA reductase (NADPH) activity [MF] |
| CG_adsipsc_promoter_p_RM_12_195_10 |
 |
 |
8 |
1.0 |
2.84E-04 |
INHBB |
cell differentiation [BP] |
| CG_adsipsc_promoter_p_RM_14_217_8 |
 |
 |
2 |
0.2 |
1.58E-04 |
RBM24,
F2RL1,
RBM38,
BRSK2,
FOXO3 |
regulation of myotube differentiation [BP],
interleukin-1 beta secretion [BP],
glucose homeostasis [BP],
mRNA 3'-UTR binding [MF],
regulation of insulin secretion involved in cellular response to glucose stimulus [BP] |
| CG_adsipsc_promoter_p_RM_14_153_13 |
 |
 |
3 |
0.2 |
2.96E-04 |
SYNGR3 |
positive regulation of transporter activity [BP] |
| CG_adsipsc_promoter_p_RM_18_3_2 |
 |
 |
2 |
0.2 |
4.22E-04 |
SLC25A5,
RGCC,
SLC6A6 |
positive regulation of extracellular matrix constituent secretion [BP],
regulation of M/G1 transition of mitotic cell cycle [BP],
adenine transmembrane transporter activity [MF],
taurine:sodium symporter activity [MF],
negative regulation of exit from mitosis [BP],
negative regulation of fibroblast growth factor production [BP],
taurine binding [MF],
positive regulation of gene expression involved in extracellular matrix organization [BP],
taurine transport [BP] |
| CG_adsipsc_promoter_p_RM_16_28_2 |
 |
 |
1 |
0.2 |
5.61E-04 |
PAX2 |
positive regulation of optic nerve formation [BP],
optic chiasma development [BP],
vestibulocochlear nerve formation [BP] |
| CG_adsipsc_promoter_p_RM_20_9_1 |
 |
 |
1 |
0.2 |
2.54E-06 |
KCNAB2 |
juxtaparanode region of axon [CC] |
| CG_adsipsc_promoter_p_RM_16_4_18 |
 |
 |
9 |
1.0 |
4.22E-04 |
FOXO3,
CLK3,
HIC1,
CERS6,
SNRK,
ZBTB18,
RING1,
HABP4,
EN2,
DYRK2,
MAFK,
BDP1,
ZC3H18,
SAMD4B,
POU2F3,
URI1,
HSF1 |
sequence-specific DNA binding [MF],
nucleus [CC],
sequence-specific DNA binding transcription factor activity [MF],
regulation of transcription, DNA-dependent [BP],
regulation of transcription from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_12_243_5 |
 |
 |
5 |
1.0 |
3.00E-04 |
VAX2 |
dorsal/ventral axis specification [BP] |
| CG_adsipsc_promoter_p_RM_16_27_4 |
 |
 |
3 |
0.4 |
3.01E-04 |
PPARD,
PPP1R1B,
CRHR1,
FABP5 |
visual learning [BP],
corticotropin-releasing hormone receptor activity [MF],
fatty acid binding [MF],
linoleic acid binding [MF] |
| CG_adsipsc_promoter_p_RM_14_4_11 |
 |
 |
2 |
0.2 |
3.48E-04 |
EGR1,
SOX8 |
RNA polymerase II core promoter sequence-specific DNA binding [MF] |
| CG_adsipsc_promoter_p_RM_14_108_33 |
 |
 |
7 |
1.0 |
4.29E-04 |
MTMR14,
GNAS,
HOXD4,
RYR2,
NR4A1,
KL,
CUX2,
SETD1B,
PLEKHA1,
MLL5,
IRX5,
FOXB2,
ADM,
PTPRJ,
HOXD11,
FOXJ2 |
embryonic skeletal system morphogenesis [BP],
skeletal system morphogenesis [BP],
negative regulation of vascular permeability [BP],
positive regulation of heart rate [BP],
histone methyltransferase activity (H3-K4 specific) [MF],
organ development [BP],
sequence-specific DNA binding [MF],
ruffle [CC],
regulation of heart rate [BP],
embryo development [BP],
vitamin D binding [MF] |
| CG_adsipsc_promoter_p_RM_18_9_1 |
 |
 |
1 |
0.2 |
8.11E-05 |
RRP1,
EHMT1 |
preribosome, small subunit precursor [CC],
histone methyltransferase activity (H3-K27 specific) [MF] |
| CG_adsipsc_promoter_p_RM_14_391_9 |
 |
 |
4 |
0.6 |
3.39E-04 |
GABRG3,
CACNA1E,
GABRA5 |
behavioral fear response [BP],
GABA-A receptor activity [MF],
gamma-aminobutyric acid signaling pathway [BP] |
| CG_adsipsc_promoter_p_RM_12_438_8 |
 |
 |
4 |
0.8 |
3.17E-04 |
SEPT7,
SPAG16,
PPCDC |
cilium axoneme [CC],
phosphopantothenoylcysteine decarboxylase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_54_16 |
 |
 |
5 |
0.6 |
3.44E-04 |
EGR1,
ID2,
FSTL3,
OSR2,
FST |
kidney development [BP],
oligodendrocyte differentiation [BP],
negative regulation of activin receptor signaling pathway [BP],
activin binding [MF],
metanephros development [BP] |
| CG_adsipsc_promoter_p_RM_12_412_17 |
 |
 |
5 |
0.8 |
2.36E-04 |
SMARCB1,
FOS,
MAF1,
PRDX5,
FOXO3,
SOX8,
TBX1,
ZIC1,
ING5,
GATA3,
LHX2 |
RNA polymerase III regulatory region DNA binding [MF],
positive regulation of transcription, DNA-dependent [BP],
transcription regulatory region DNA binding [MF],
ear development [BP],
inner ear morphogenesis [BP],
otic vesicle development [BP],
sequence-specific DNA binding [MF],
pharyngeal system development [BP],
cellular response to fibroblast growth factor stimulus [BP],
ear morphogenesis [BP],
negative regulation of transcription from RNA polymerase III promoter [BP],
embryo development [BP],
regulation of organ morphogenesis [BP],
parathyroid gland development [BP],
positive regulation of transcription from RNA polymerase II promoter [BP] |
| CG_adsipsc_promoter_p_RM_18_10_18 |
 |
 |
3 |
0.4 |
5.00E-04 |
MTMR3,
PTEN |
phosphatidylinositol dephosphorylation [BP],
phosphatidylinositol-3-phosphatase activity [MF] |
| CG_adsipsc_promoter_p_RM_14_149_6 |
 |
 |
1 |
0.2 |
3.04E-04 |
SH3GL2,
RPS6KB2,
PDPK1 |
epidermal growth factor receptor signaling pathway [BP] |